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Abstract 
This dissertation examines associations between clinician attitudes both towards 
Psychiatric Advance Directives (PADs) and towards coercive intervention with 
consumers' decisions regarding PADs. In addition, it examines associations between 
characteristics of clinician/consumer relationships and consumers' PAD decisions. The 
research is grounded in the Health Beliefs model expanded to include the theory of 
relational autonomy. A secondary analysis of data from a randomized trial of Facilitated 
PADs (N=469) was completed. Multilevel logistic regression analyses examined 
whether clinician characteristics and attitudes were significant predictors of PAD 
completion by consumers and whether consumers valued PADs more highly for 
proscriptive purposes. Multivariate logistic regression analyses examined whether 
characteristics of the clinician/consumer relationship were significant predictors of these 
same dependent variables. Results showed that neither dependent variable was 
significantly associated with clinician characteristics and attitudes. PAD completion was 
significantly more likely if consumers were older, demonstrated greater PAD 
understanding, valued treatment for relational purposes, and reported having a friend; it 
was significantly less likely if consumers reported medication satisfaction, victimization, 
or if consumer and clinician were discordant on PAD attitudes. Valuing PADs as a 
proscriptive tool was significantly more likely if consumers were white, had experienced 
involuntary hospitalization, reported treatment dissatisfaction, or reported having no one 
to trust, and showed a trend towards significance if the consumer reported avoiding 
treatment for fear of forced treatment; it was significantly less likely if consumers 
reported not knowing enough about PADs, reported avoiding treatment for fear of being 
lll 
put in seclusion, agreed that consumers should talk with their provider about PADs, and 
if neither consumers nor their clinicians agreed that people should have a PAD to protect 
them from hospitalization. Findings suggest that consumers make decisions regarding 
PAD completion and purpose based on: 1) prior experiences with treatment; 2) 
perceptions regarding treatment benefits/barriers; 3) understanding ofPADs; and 4) the 
relational context in which they make decisions. Due to the exploratory nature of the 
study and limitations of a secondary data analysis additional research is needed to 
understand the dynamics of these factors in greater detail. 
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Chapter 1 Introduction 
Individuals with serious mental illnesses (SMI) may episodically have times of 
psychiatric crises and as a result experience coercive interventions such as involuntary 
hospitalization. Though justified by providers as necessary for the prevention of harm, 
these interventions are often described as frightening and traumatic times by the 
individual with SMI. One possible way to prevent or reduce the need for coercive 
intervention is through the use of Psychiatric Advance Directives (PADs). PADs are 
legal documents that allow individuals, when well, to document their wishes for care 
during times of psychiatric crisis (Joshi, 2003). With a PAD an individual may continue 
to receive the treatment they prefer even when they have lost capacity to express their 
wishes. They thus have the potential of increasing autonomy, decreasing the need for 
coercive intervention, and may enhance the connection and levels of trust and 
communication between the individual with SMI and the treatment system. Despite this 
potential, little is known about how individuals make decisions regarding whether to 
create a PAD or whether PADs are more valuable for proscriptive or prescriptive 
purposes. The factors potentially associated with these decisions, such as prior coercive 
experiences, relationship with mental health providers, and attitudes towards mental 
health treatment, are not yet fully understood. 
This dissertation describes research examining the creation of Psychiatric 
Advance Directives (PADs) by individuals with serious mental illnesses (SMI). More 
specifically, this research examines the association between clinician attitudes towards 
PADs and towards coercive intervention in mental health care and the decisions 
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individuals with SMI make regarding PAD creation and the purposes they wish the PAD 
to serve. In addition, the research examines the association between characteristics of the 
relationship between the clinician and individual with SMI and individual's decisions 
regarding PAD creation and purpose. Specific aspects of the relationship examined 
include the working alliance between clinician and individual, the concordance between 
clinician and individual ratings of the working alliance, and concordance on views 
regarding PADs and regarding coercive interventions in mental health treatment. 
This dissertation begins by providing an overview of the research including a 
rationale for the study, followed by the study's specific aims, specific research questions, 
and hypotheses. This is followed by a comprehensive review of the relevant literature, 
including the literature on autonomy and coercion in the treatment of individuals with 
SMI, the theoretical and empirical PAD literature, the literature on clinician attitudes 
regarding PADs, and literature on the impact of the working alliance between clinician 
and individual with SMI on clinical outcomes. This literature is used to provide a 
theoretical and practice context within which to conceptualize the research questions, 
demonstrating the study as a relevant and logical next step in the field. 
The dissertation next provides an original synthesis and conceptualization 
grounded in the literature, resulting in presentation of a framework and conceptual model 
for the research. Using this model the dissertation then provides a description of the 
methodology used. Since this study engaged in an analysis of secondary data, this 
description includes a discussion of the purposes and design of the original study from 
which the data are derived. Discussion of the methodology includes a description of the 
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statistical analyses completed as well as a power analysis demonstrating that the data set 
was of adequate size for the purposes of the analyses. The dissertation then provides the 
results of these analyses. The document concludes with a discussion of the findings, of 
potential study limitations, and of the implications of the findings for practice, teaching, 
and an ongoing research agenda. 
1.1 Definition ofTerms 
Before entering a detailed discussion of this study, it is important to ensure clarity 
of the key concepts in the research. To that end I provide the following definitions and 
brief discussions of key terms as they are used in this study. 
1.11 Psychiatric Advance Directive (PAD) 
Psychiatric Advance Directives (PADs) are legal documents that may be created 
by competent individuals, that is, individuals able to understand, appreciate, make, and 
communicate mental health care decisions (Appelbaum, 2004). PADs allow individuals 
to express their wishes for mental health care and to communicate relevant information 
regarding their condition at a future time when, because of SMI relapse, they may lack 
capacity and no longer be able to do so (Appelbaum, 2004; Backlar, McFarland, 
Swanson, & Mahler, 2001; Geller, 2000). PADs allow competent individuals to state 
their preferences for mental health care through two mechanisms: advance instructions 
and health care power of attorney. Advance instructions (Ais), can include statements of 
consent for or refusal of certain medications or other treatments such as electroconvulsive 
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therapy, provision of information regarding actions to occur ifhospitalized (e.g. 
contacting a family member, caring for a pet), and advance informed consent for 
hospitalization. Health Care Power of Attorney (HCP A) allows individuals to appoint a 
proxy decision maker for times when they are no longer capable of making treatment 
decisions (Backlar et al., 2001; Geller, 2000). 
1.12 Serious Mental Illnesses (SMI) 
For the purposes of this work I define serious mental illnesses as mental disorders 
which include schizophrenia, schizoaffective disorder, psychotic disorder Not Otherwise 
Specified, or mood disorders with psychotic features. These disorders interfere 
significantly with functioning and usually require psychiatric hospitalization at some 
point in the individual's life (American Psychiatric Association, 2000). Throughout this 
work I refer to those who experience these illnesses as "individuals with SMI" or 
"consumers." 
1.13 Clinician 
For this study a clinician is defined as a professional providing and/or overseeing 
mental health assessment and treatment for an individual with SMI. When the individual 
has multiple mental health service providers, the clinician is defined as the person who 
knows the most about the individual's mental health treatment, as identified by the 
consumer. 
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1.14 Working Alliance 
The working alliance is the relationship between clinician and individual 
receiving mental health services, usually thought to include both a collaborative 
agreement between clinician and individual regarding mental health treatment goals and 
specific tasks within treatment, as well as the affective bond between the clinician and 
individual (Bordin, 1976). 
1.15 Autonomy 
The term autonomy is derived from the Greek auto, self and nomos, law, i.e., 
having one's own laws. The term, when applied to an individual, is defined as the liberty 
to follow one's will, or personal freedom (The Philological Society (Ed.), 1933). Two 
conditions are thought to be essential to autonomy: independence from controlling 
influences; and competence, or capacity for intentional action (Olsen, 2003). Intentional 
action involves both the ability to identify a course of action based on information 
regarding options and consequences and the ability to operationalize the chosen course 
(Reinardy, 1999). Autonomy thus requires independence, the ability to reason, the ability 
to choose an action, and the ability to act. 
1.16 Relational Autonomy 
Relational autonomy is a term used to describe an alternative conception of what 
it means to be an autonomous person. It expands autonomy beyond a conceptualization 
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of independent free agent to include a consideration of the relational context in which the 
individual is embedded (Christman, 2004). The construct of relational autonomy is used 
in a wide range ofliterature, including feminist and constructionist works (Nedelsky, 
1989). However, it is used in a variety ofways, some broader and others narrower in 
scope. At its broadest, relational autonomy considers the individual's embeddedness in 
both social relationships and the wider net of socially structured determinants of identify, 
such as race, class, and gender (Oshana, 1998). However, for the purposes of this 
research, the construct relational autonomy will more narrowly refer to a 
conceptualization of the individual as a social being whose decisions and identity are 
shaped by and connected with his/her interpersonal relationships. 
1.17 Coercive Treatment 
Coercion is derived from the Latin coercere meaning to shut in, restrain, or 
confine. The definition of coercion includes the concepts of constraint, restraint, or the 
application of force to control the action of a voluntary agent (The Philological Society 
(Ed.), 1933). In mental health care, coercive assessment and treatment are justified on 
the principles ofnonmaleficence (the prevention ofharm) and beneficence (doing good 
for the individual). Nonmaleficence can be used to justify actions to prevent harm either 
to the individual or to others (Hoyer et al., 2002; Wettstein, 1987). Beneficence can be 
used to justify actions such as forced mental health treatment for individuals who have 
limited capacity to understand their situation and refuse treatment that would be of 
benefit to them (Verkerk, 1999). 
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1.2 Background 
In the United States, about 2.6 percent of the adult population has a diagnosis of a 
SMI (Mental health: A report ofthe Surgeon General, 1999), and ofthese individuals 
about 30 percent experience a crisis resulting in hospitalization during a year's time (R. 
Coffey et al., 2001). Many ofthese hospitalizations involve coercive treatment such as 
involuntary commitment or forced medication. Though mental health providers argue 
that coercive interventions are done under the principles of beneficence and 
nonmaleficence, to protect or prevent harm to the individual or to others (Blecher & 
Blank, 1989; Munetz, Galan, & Frese, 2003), some individuals with SMI and some 
advocates have countered that involuntary treatment may be in itself harmful and should 
be avoided whenever possible (Hoge & Grottole, 2000). In addition, they argue that 
support for coercive intervention is based in stigmatizing perceptions of individuals with 
SMI as being highly dangerous or having "bad character" (Watson, Corrigan, & Angell, 
2005). 
Involuntary treatment, particularly involuntary hospitalization, has been described 
by individuals with SMI as frightening, dehumanizing, and as a barrier to recovery 
(Marsh, 2000). Involuntary commitment may result in iatrogenic psychosocial effects 
such as increased stigma in the community, loss of housing or employment during 
confinement, as well as physical harm through side effects from medication that may be 
forced during hospitalization (Bentley, 1993; Rogers, 1999). Though results are mixed 
and additional studies are required (Salize & Dressing, 2005), some research suggests 
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that positive outcomes of long term hospitalization may be reduced if the individual 
perceived the hospitalization as coercive (Kaltiala-Heino, Laippala, & Salokangas, 1997). 
In addition to direct harmful effects of involuntary treatment, fear of future forced 
intervention may decrease individuals' willingness to seek out mental health treatment. 
One study found that 28 percent of individuals with SMI surveyed reported avoiding 
mental health treatment because of fear of hospitalization, and 26 percent because of fear 
of forced medication. This fear and resultant treatment avoidance was significantly 
associated with prior involuntary hospitalizations and with repeated warnings and 
pressure regarding medication compliance from providers (Swartz, Swanson, & Hannon, 
2003). 
Given the potential negative impact of involuntary treatment, it is of benefit to 
individuals with SMI to identify alternative strategies for provision of mental health care 
which may minimize the need for coercion. One such strategy is the use of a Psychiatric 
Advance Directive, or PAD. PADs are legal documents that allow individuals with SMI 
to express their wishes for care and communicate relevant information regarding their 
condition during a time when they are capable and psychiatrically stable, so that at a 
future time, when they may be in crisis and no longer able to express their wishes, their 
preferences are clear to providers. They may include both statements of acceptance or 
refusal of certain treatments as well as provision of information regarding actions that 
would be of help during a crisis or hospitalization. In addition, PADs may designate a 
surrogate healthcare decision maker (Joshi, 2003; Ritchie, Sklar, & Steiner, 1998; 
Swanson, Tepper, Backlar, & Swartz, 2000). PADs are created or revoked when an 
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individual is presumed to be competent and capable of making mental healthcare 
decisions, and go into effect only at such time as the individual is determined to have lost 
this capacity. (Joshi, 2003; Swartz, Swanson, & Elbogen, 2004; Widdershoven & 
Berghmans, 2001 ). 
PADs have the potential to decrease the harmful effects of involuntary treatment 
by identifying medications the individual knows are tolerable and effective and thus 
reducing the risk of side effects and need for forced medication. In addition, PADs can 
document needed actions to prevent psychosocial harms such as lost housing or 
employment. PADs may also prevent involuntary hospitalizations by providing 
emergency mental health workers with information that may be used to resolve crises 
without hospitalization. Finally, with a PAD in place, individuals with SMI may be less 
reluctant to seek out mental health care for fear of coerced treatment. Increased 
engagement in treatment may in and of itself decrease crises and thus the need for 
coercive intervention (Swanson, Tepper et al., 2000). 
Despite the promise of PADs, there are concerns that they may not be utilized to 
the benefit of individuals with SMI. Individuals may refuse to create them, seeing PADs 
as either unnecessary or as futile in a system that does not listen to their preferences 
(Backlar et al., 2001; O'Connell & Stein, 2005). Providers express concerns that PADs 
will be used as a way to refuse all care [which was, in fact, the initial intent of Thomas 
Szasz when he first proposed them (Szasz, 1982)], or that PADs will be so proscriptive 
that their ability to guide treatment effectively is minimal (Appelbaum, 2004; Srebnik & 
Brodoff, 2003; Srebnik et al., 2005). For PADs to have maximal impact, increasing 
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consumer voice, decreasing involuntary treatment, providing useful clinical information, 
and increasing consumer engagement in treatment, I would argue that two conditions are 
necessary: a) the individual must create a PAD; and b) the PAD should have at least a 
balance of proscriptive and well as prescriptive elements, so that practitioners are given 
guidance in what to do as well as what not to do, in order to best provide effective care 
for the individual in a respectful manner. 
There are a number of factors that may influence an individual's decision to 
create a PAD, and their view ofthe PAD as useful for predominantly proscriptive or 
prescriptive purposes. These could include the individual's demographic characteristics, 
their understanding of and attitudes towards mental health treatment, and their prior 
experiences with coercive mental health treatment. Preliminary studies support these 
factors; a survey of over 1,000 individuals with SMI at five sites found that interest in a 
PAD was higher for individuals who were non-white, female, had a history of self harm, 
and who had experienced coercion via arrest or pressure to take medication. Individuals 
in this study who reported already having a PAD were more likely to have higher insight 
into SMI and higher experience of external pressure to be in treatment from the criminal 
justice system or those controlling the individual's finances (Swanson, Swartz, Ferron, 
Elbogen, & Van Dom, 2006) Though not specific to PADs, a relevant related study 
found that the desire of individuals with schizophrenia to be involved in treatment 
decisions was positively associated with prior involuntary treatment, younger age, and 
negative attitudes to psychotropic medications (Hamann, Cohen, Leucht, Busch, & 
Kissling, 2005). 
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In addition to characteristics and experiences of the individual with SMI it may be 
important to consider characteristics of the individual's clinician and of the clinician's 
relationship with the individual with SMI as influential factors in PAD decisions. 
Specifically, it is of interest to examine the clinician's support for PADs and attitudes 
towards coercive intervention. In addition, within the clinician/individual relationship, it 
is important to examine the working alliance between clinician and individual, and the 
concordance between the clinician's and individual's attitudes towards coercive 
treatment. The literature supports examination of this area. In the PAD-specific 
literature, a study completed by Srebnik and colleagues (2003) found that the interest of 
individuals with SMI in completing a PAD was significantly associated with their case 
manager's support for PADs (Srebnik, Russo, Sage, Peto, & Zick, 2003). A recent study 
by Swartz and colleagues (2006) found that individuals reporting that they trusted their 
psychiatrist were more likely to value PADs as a prescriptive tool to access treatment 
rather than proscriptive tools to avoid treatment (Swartz, Swanson, Van Dom, Elbogen, 
& Shumway, 2006). In the broader mental health literature a positive working alliance 
between clinician and individual with SMI has been associated with longer engagement 
with treatment (Frank & Gunderson, 1990), more positive attitudes towards medication 
(Day et al., 2005), and increased medication compliance (Weiss, Smith, Hull, Piper, & 
Huppert, 2002). 
Based on these studies one can argue that both clinician attitudes towards PADs 
and the quality of the relationship between the clinician and individual may shape 
individuals' willingness to create a PAD. In addition, these variables may shape 
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individuals' view oftreatment and, by extension, their view ofPAD utility. However, to 
date there has been no extensive examination of the impact of the characteristics of 
clinician, individual, and clinician/individual relationship upon the decision of the 
individual with SMI to create a PAD and his/her valuing of PADs as useful for 
proscriptive or prescriptive purposes. This study address these questions, as outlined in 
the specific aims discussed below. 
1.3 Specific Aims, Research Questions, and Hypotheses 
1.31 Aim 1 
To examine the association between clinician attitudes regarding PADs and PAD 
completion by individuals with SMI. 
Research question 1. Is clinician support for PADs a significant variable in a 
predictive model of PAD completion by individuals with SMI? 
Hypothesis 1 a. Individuals are more likely to complete a PAD if clinician support 
for PADs is high. 
Hypothesis 1 b. The impact of clinician support on PAD completion will be 
moderated by how well the clinician knows the individual; clinician knowledge of the 
individual will be based on self-report. 
1.32 Aim 2 
To examine the association between clinician/individual concordance in views on their 
working alliance (including the elements of agreement on goals and tasks, and affective 
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bond in the relationship), in PAD attitudes, and in views on coercion in mental health 
treatment on PAD completion by individuals with SMI. 
Research question 2.1. Is clinician/individual concordance on the working 
alliance a significant variable in a predictive model of PAD completion? 
Hypothesis 2.1. PAD completion is significantly associated with concordance in 
the working alliance between clinician and individual, and with whether both rate the 
alliance as positive. 
Research question 2. 2. Is clinician/individual concordance in PAD attitudes a 
significant variable in a predictive model of PAD completion? 
Hypothesis 2. 2. PAD completion is significantly associated with concordance in 
PAD attitudes between clinician and individual (no direction to hypothesis.) 
Research question 2. 3. Is clinician/individual concordance in views on coercion 
in mental health treatment a significant variable in a predictive model of PAD 
completion? 
Hypothesis 2.3. PAD completion is significantly associated with 
clinician/individual concordance in views on coercion in mental health treatment (no 
direction to hypothesis.) 
1.33 Aim 3 
To examine the association between clinician views on coercion in mental health 
treatment and the individual's valuing of the PAD as a proscriptive tool. 
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Research question 3. Is clinician support for coercion in mental health treatment 
a significant variable in a predictive model of the individual's valuing of PAD as a 
proscriptive tool? 
Hypothesis 3a. Individuals are more likely to value PADs as a proscriptive tool if 
clinician support for coercion in mental health treatment is high. 
Hypothesis 3b. The impact of clinician support for coercion in mental health 
treatment on the individual's likelihood of valuing PADs as a proscriptive tool will be 
moderated by how well the clinician knows the individual; clinician knowledge of the 
individual will be based on self-report. 
1.34 Aim 4 
To examine the association between clinician/individual concordance in views on their 
working alliance and in views on coercion in mental health treatment, on the individual's 
valuing of PADs as a proscriptive tool. 
Research question 4.1. Is clinician/individual concordance on the working 
alliance a significant variable in a predictive model of the individual's valuing of PADs 
as a proscriptive tool? 
Hypothesis 4.1. Individuals are less likely to value PADs as a proscriptive tool if 
there is concordance in the working alliance between clinician and individual and both 
rate the working alliance as positive. 
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Research question 4. 2. Is clinician/individual concordance in views on coercion 
in mental health treatment a significant variable in a predictive model of the individual's 
valuing of PADs as a proscriptive tool? 
Hypothesis 4.2. Individuals' valuing of PAD as a proscriptive tool is significantly 
associated with clinician/individual concordance in views on coercion in mental health 
treatment (no direction to hypothesis.) 
15 
Chapter 2 Literature Review 
The belief in the importance of client self-determination and the desire to respect 
client choice often come into conflict with the perceived need for coercive intervention in 
mental health treatment; tension is seen between the wish to support autonomy and to 
prevent harm. This is particularly true in mental health services for individuals with SMI, 
where symptoms may decrease an individual's capacity for sound judgment and safe 
behavior. Controversy about coercive interventions has reached new heights in the past 
decade, with a recovery-focused consumer movement emphasizing the need for 
partnership and choice in treatment conflicting with high profile media coverage of acts 
of violence committed by individuals with SMI and with an increased ability to 
involuntarily treat individuals through legal tools such as involuntary outpatient 
commitment. 
Psychiatric Advance Directives (PADs) have been proposed as a mechanism to 
reduce the need for coercive mental health treatment and strengthen autonomy in 
individuals with SMI. If PADs are to be effective they will require the support of 
clinicians, both in creating them and in honoring them during times of crisis. In addition 
to this direct role, clinicians may also play an indirect role in the creation of PADs 
through their influence upon and relationship with the individuals with SMI whom they 
serve. Thus, in order to examine the issues of interest to this investigation, which are: 1) 
associations between clinician characteristics and the individual's decisions regarding 
PAD creation and the purpose they wish the PAD to serve; and 2) associations between 
the relationship of the clinician and individual with SMI and PAD creation and purpose, 
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it is essential to ground the discussion within the broader conceptual and empirical 
frameworks of both issues of autonomy and coercion in mental health care and 
clinician/client relationship. 
This literature review therefore begins with an examination of autonomy and 
coercion in the treatment of individuals with SMI, including both theoretical debate and 
empirical studies. Next this review synthesizes the existing PAD literature, discussing 
the legal contexts of PADs, the conceptualization of PADs as tools to increase autonomy 
and decrease coercion, and summarizes the existing empirical studies on PAD creation, 
content, and effectiveness. Given the important direct and indirect roles clinicians may 
play in PAD creation, the review next examines what is known about clinician views and 
attitudes regarding PADs. The review then includes an exploration of the concept of the 
working alliance and how the clinician relationship with the individual with SMI may 
shape the individual's ongoing engagement with and desire for mental health treatment, 
treatment adherence, and clinical outcomes. In closing, this section describes my 
conceptual model for the dynamics of an individual's decisions regarding PAD creation 
and purpose that was tested by this research. 
2.1 Autonomy and Coercion in the Treatment of Individuals with SMI 
2.11 Autonomy and Coercion: Ethical Debates 
It has been suggested that PADs may be tools that can increase the autonomy of 
individuals with SMI and decrease their need for coercive intervention. To understand the 
importance of this claim it is essential to ground our PAD discussion within the larger 
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context ofthe struggle between autonomy and coercion in the treatment of individuals 
with SMI. 
Autonomy is an ethical principle across contemporary clinical medicine, 
including mental health practice (Jonsen, Siegler, & Winslade, 2002). In social work a 
client's right to self-determination, which is the exercise of autonomy, is emphasized 
throughout the ethics literature (Lowenberg, Dolgoff, & Harrington, 2000; Reamer, 
1993). Social workers' responsibility to support this client right is articulated in their 
codes of ethics, including the Preamble of the Canadian Association of Social Workers 
Code of Ethics (Canadian Association of Social Workers, 2005), and the code ofthe 
National Association of Social Workers (NASW, 2000). As stated in Section 1.02 of the 
NASW Code (p. 7) "Social workers respect and promote the right of clients to self-
determination and assist clients in their efforts to identify and clarify their goals." 
Given the importance of the ethical principle of autonomy, why is it such a 
challenge in the treatment of individuals with SMI? The answer is due in part to the link 
between autonomy and reason. Autonomy requires both liberty and capacity, and 
capacity requires the ability to reason and to act (Reinardy, 1999); thus it could be argued 
that individuals with SMI have less right to autonomy because their disorder limits the 
ability to reason. However, the issue is more complex, since individuals with SMI often 
experience fluctuating symptoms, may be asymptomatic for extended periods of time, or 
have symptoms such as lack of energy or lack of ability to experience enjoyment, which 
do not result in loss of capacity (American Psychiatric Association, 2000). Thus it is not 
simply a question of "Should individuals with SMI have a right to autonomy in their 
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mental health treatment decisions or should they not?" but the more complex question 
"What level of capacity to make treatment decisions does an individual with SMI have at 
this time and should his/her right to autonomy be limited as a result?" 
When considering ethical justifications for overriding the autonomy of individuals 
with SMI, two principles are usually invoked (Rothman, 1998). The first is 
nonmaleficence, the prevention of harm. This can include both actions to stop a harmful 
event such as suicide, homicide, or fire-setting, as well as interference with actions that 
may have permanent harmful consequences, such as refusal to eat or drink (Sasson, 
2000). In these cases coercive actions prevent harm to the individual or to other 
individuals (Hoyer et al., 2002; Wettstein, 1987) or are necessary for the protection of the 
larger society (Rogers, 1999). 
The second principle invoked is beneficence, doing good for the individual by 
providing beneficial treatment. It has been argued that individuals who have limited 
capacity to understand their situation may refuse treatment that would be of benefit to 
them. In these cases, coercive interference to force individuals to accept treatment would 
be for their own good, a form of individual paternalism or "compassionate interference" 
(Belcher & Blank, 1989; Davis, 2002; Monahan, Swartz, & Bonnie, 2003). Without 
involuntary treatment during times of poor judgment it will be impossible for individuals 
to ever move towards recovery and their health and lives may be at risk (Belcher & 
Blank, 1989; Fuller Torrey, 2004; Munetz & Frese, 2001; Munetz et al., 2003). By 
violating autonomy now, the individual may over time gain greater autonomy through the 
19 
benefits obtained from treatment, and may ultimately be appreciative ofthe coercive 
intervention (Verkerk, 1999). 
In contrast, two major arguments against coercive intervention are often seen. 
One position, taken particularly by individuals with SMI and some advocates and 
thinkers with a more civil rights perspective, is the deontological, or rights-based, 
argument that coerced treatment for an individual not declared legally incompetent is 
wrong, cannot be justified, and is the result of the social control efforts of the state 
(Arrigo & Williams, 1999; Hoge & Grottole, 2000; MadNation, n.d.; Szasz, 1970). If 
individuals with SMI have harmed someone they should be incarcerated just as other 
citizens, but dangerousness does not justify forced treatment (Giordano, 2000). Slightly 
more moderate forms of this position argue that it is wrong to take away the liberty of an 
individual based on what they may do in the future, particularly given our empirically 
proven poor predictive powers regarding who may become dangerous (Dallaire, 
McCubbin, Morin, & Cohen, 2000; Holloway & Szmuckler, 2003). Also, it is argued 
that it is wrong to take away an individual's rights because of something that is the fault 
of the larger society, i.e., if there were sufficient service capacity and if services were 
provided in acceptable ways involuntary treatment would not be necessary (M. Allen & 
Fox, 2001; Brown, 2003). 
Opponents to coercive intervention take issue with the assumptions that treatment 
is not harmful, and that coercive treatment is effective. Treatment, particularly 
psychotropic medication, has serious and sometimes lethal side effects (Carpenter, 2002). 
Hospitalizations can result in the loss of the individual's home, job, and social supports, 
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and put him/her at risk for abuses in institutional settings. Coercive processes, such as 
being physically restrained, are traumatizing and may result in reactant anger or learned 
helplessness. A coercive experience may disrupt the therapeutic alliance or make 
individuals reluctant to return to treatment for fear of additional coercion (M. Allen & 
Fox, 2001; Hoge & Grottole, 2000; Rogers, 1999; Stastny, 2000). The use of coercion 
may also reinforce stigma, labeling individuals with SMI as so dangerous that they must 
be forced into care, and thus increasing the social rejection of people with SMI. A final 
argument offered is that there is no definitive evidence that coercive interventions such as 
Involuntary Outpatient Commitment (IOC) are broadly effective, thus they cannot be 
justified (M. Allen & Fox, 2001; Carpenter, 2002). 
It is clear from this literature that the ethical debate between autonomy and the 
need for coercive intervention looms large in the mental health field. One of the 
promises of PADs is that they may be a tool that can decrease the struggles surrounding 
this debate. By allowing the individuals' wishes to be heard during crises, PADs may 
reduce or obviate the need for coercive intervention during crises for many individuals 
with SMI while ensuring that they obtain needed and effective care. 
2.12 Autonomy and Coercion: Empirical Studies 
Beyond ethical rhetoric, recent research has attempted to answer some of the 
questions raised by the arguments between autonomy and coercion in mental health 
treatment, with conflicting results (Salize & Dressing, 2005). Several studies in the 
United States, Canada, and Australia have examined the effectiveness of Involuntary 
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Outpatient Commitment (IOC). IOC is a commonly used form of court ordered 
community based mental health treatment; a study of five communities in the United 
States found that between 12 and 20 percent of consumers surveyed reported 
experiencing IOC at some point in their lives (Swartz, Swanson, Kim, & Petrila, 2006). 
Results were mixed, suggesting that if IOC is effective in decreasing psychiatric crises, it 
may be so primarily for subsets of individuals with SMI (Kisely, Xiao, & Preston, 2004; 
O'Brien & Farrell, 2004; Swartz et al., 2001). The largest randomized controlled trial of 
IOC demonstrated positive outcomes (e.g. fewer days in hospital) in post hoc analyses for 
individuals with psychotic disorders who received IOC for more than 180 days and 
received intensive case management as a part of their treatment (Kisely et al., 2004; 
O'Brien & Farrell, 2004; Swanson, Swartz et al., 2000; Swartz et al., 2001). A time-series 
analysis of the same data demonstrated a significant effect for IOC on hospitalization 
irrespective of diagnostic category (Swartz, Swanson, Wagner, Bums, & Borum, 1999). 
A recent review by the Cochrane Collaboration (Kisely, Campbell, & Preston, 2007) 
pointed out the lack of a strong evidence base for IOC, identifying only two randomized 
trials of the intervention. The Collaboration's review combined data from the two studies 
and found "little evidence for the effectiveness of compulsory community treatment in 
any of the main outcome indices: health service use, costs, social functioning, mental 
state, quality of life, or satisfaction with care. We were only able to establish a 
statistically significant effect for one outcome, social functioning (victimization)." (p.9). 
These criticisms have been refuted by the researchers who conducted the large IOC trial, 
who reiterated their positive findings of decreased hospital admission for individuals in 
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the IOC arm of the study (Swanson & Swartz, 2007). Clearly the effectiveness ofiOC 
remains a controversial topic. 
When reviewing these studies it must be remembered that subjective benefit as 
experienced by the individual may be different than objectively measured outcomes. The 
randomized trial discussed above found that IOC increased quality of life for individuals, 
but that this effect was significantly moderated by the individual's level of perceived 
treatment coercion (Swanson, Elbogen, Wagner, & Bums, 2003). A study of individuals 
with SMI under IOC found that only 27.6 percent personally endorsed benefits ofiOC 
after completion; this increased to over 50 percent endorsing IOC if they personally had 
benefited from the IOC (Swartz, Swanson, & Monahan, 2003) 
Research exploring the effectiveness of coercive hospitalization has shown 
interesting results. A recent literature review concluded that involuntarily admitted 
consumers showed substantial clinical improvement over time, that 39 to 75 percent 
subsequently viewed their hospitalization as necessary, and that 39 to 81 percent reported 
benefiting from the hospitalizations (Katsakou & Priebe, 2006). However, studies 
comparing voluntary and involuntary hospitalizations had somewhat different findings. 
Three studies found that individuals hospitalized involuntarily did not have significantly 
different clinical outcomes or post-discharge compliance from voluntary controls 
(Cournos, MacKinnon, & Stanley, 1991; Rain, Williams, Robbins, & et al., 2003; 
Steinert & Schmid, 2004) and do suggest that involuntary hospitalization is no less 
effective than voluntary care. However, another study found a negative correlation 
between involuntary hospitalization and self-reported treatment adherence one month 
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post-discharge (Rain, Steadman, & Robbins, 2003). In addition, a survey of the impact 
of involuntary treatment on engagement found that 28 percent of individuals with SMI 
reported fear of coerced treatment as a barrier to seeking mental health care, and found 
this was significantly associated with prior involuntary hospitalizations as well as 
compliance pressures from community based providers (Swartz, Swanson, & Hannon, 
2003). 
Surprisingly, research regarding coercive intervention and individuals with SMI 
has demonstrated that voluntary or involuntary status is only loosely associated with 
coercion as perceived by the individual and is more closely associated with individuals' 
perceptions of how they were related to and treated by others, termed procedural justice, 
during the coercive process, as well as the timing and number of coercive interventions 
experienced (Hoyer et al., 2002; McKenna, Simpson, & Coverdale, 2003; Monahan et al., 
1999). One study showed that individuals perceived longer IOC to be more coercive, but 
that this effect was mediated by the way they were treated by their case manager, 
specifically by the case manager's verbal warnings and reminders of the outcomes of 
noncompliance (Swartz, Wagner, Swanson, Hiday, & Burns, 2002). Other studies have 
shown that multiple coercive interventions applied together may be experienced as 
coercive, even if the interventions are not seen as coercive individually (Elbogen, 
Swanson, & Swartz, 2003; Swartz et al., 2006). However, even studies using perceived 
coercion as an independent variable have shown no consistent results in outcomes 
(Bindman, Reid, Szmukler, & et. al, 2005; Kaltiala-Heino et al., 1997). 
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The current research in this area provides no clear guidance in resolving the 
tensions between autonomy and coercion in the treatment of individuals with SMI. It 
does, however, suggest that the experiences of individuals and their perceptions of 
process and interaction are central to the issue; context and relationship influence 
perceptions regarding coercion. If this is the case, one can argue that context and 
relationship may also influence perceptions regarding autonomy, that is, an individual 
thinks about and exercises autonomy while considering and influenced by the 
relationships within which s/he is embedded. This contextualized concept of autonomy is 
sometimes referred to as "relational autonomy" by feminist ethicists and those interested 
in structural and cross cultural ethics (Clifford, 2002; Furlong, 2003a, 2003b ). Similar to 
Foucault's conceptualization of power (Foucault, 1980), relational autonomy is seen as 
created through process with others rather than the exercise of isolated and independent 
choice by an individual. Autonomy is thus a process grounded in a relationship among 
people. PADs, which support the autonomy of individuals with SMI, should therefore be 
considered in the context of relationships, particularly relationships with clinicians. 
2.2 Psychiatric Advance Directives: What Does the Literature Tell Us? 
2. 21 Definition and History 
PADs, as described previously, are legal documents that allow individuals with 
SMI, when capable, to express their wishes for care and communicate relevant 
information regarding their condition at a future time when they are in psychiatric crisis. 
The historical origins of PADs are twofold. First, in the 1980s Thomas Szasz developed 
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the idea of the "psychiatric will" as a way for individuals to refuse all psychiatric 
treatment and stay free of (in his view) psychiatric oppression (Swanson, Tepper et al., 
2000). Second, a series of cases in the United States, most notably the Cruzan and 
Quinlan cases, highlighted the issue of decision-making regarding life-prolonging 
treatment when an individual has lost competence and is not expected to recover. The 
Cruzan case in particular stimulated interest in documenting patient preferences, an 
impetus for the development of the medical advance directive. Though medical advance 
directives were intended to be used primarily in end of life situations rather than for 
conditions of fluctuating capacity such as SMI, the idea ofthe advance directive was 
adopted within the mental health community as a way of maintaining individual 
autonomy during times of psychiatric incapacity (Ritchie et al., 1998). 
PADs have extensive legislative support; twenty five states in the United States 
have some specific PAD legislation (Swanson, 2007). In addition PADs are supported 
by the U.S. Patient Self-Determination Act of 1990, which mandates that health facilities 
ask patients if they have an advance directive, including a PAD, and provide them with 
information regarding advance directives upon request (Backlar, 2004; Backlar & 
McFarland, 1998). However, individual state laws also allow PADs to be overridden in a 
number of situations, including involuntary commitment and conflicts with physician 
opinion of standard of care (Swanson, McCrary, Swartz, Van Dom, & Elbogen, 2006). 
This override has been successfully challenged in federal appellate court under the 
Americans with Disabilities Act in Hargrave v. Vermont, where it was argued that since 
there is no such override for medical advance directives, having an override in psychiatric 
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advance directives is discriminatory. Therefore the future of a physician's ability to 
legally override a PAD is not yet clear (Appelbaum, 2004). This ambiguity in the power 
of providers to override PADs may contribute to the ambivalence providers express 
regarding their endorsement of PADs, as is discussed later in this section. 
2.22 Conceptualization of Benefits of PADs 
An extensive literature describes the potential benefits of PADs; it has been 
proposed that PADs have the potential to increase autonomy, decrease coercive 
hospitalization and forced medication, and promote recovery. Discussions have focused 
on both improved clinical outcomes as well as the enhanced sense of empowerment 
individuals may experience as a result of PADs. These conceptual discussions can be 
sorted into two areas: the benefit of creating a PAD and the benefits of invoking a PAD. 
It has been suggested that the process of creating a PAD may be of benefit in a 
number of ways. First, it provides the individual with an opportunity to voice his/her 
lived experience and knowledge gained from having a SMI and to have that knowledge 
valued and used in the development of crisis plans (Widdershoven & Berghmans, 2001 ). 
Through the process of creating a PAD the individual can more directly shape his/her 
treatment, and may also talk with a provider to gain greater understanding of treatments 
and make better informed treatment choices (Backlar, 1995; Srebnik & LaFond, 1999). 
This increased sense of choice, of being listened to and respected, and of ownership of a 
plan may result in the individual's increased willingness to engage in and adhere to 
treatment, and may also increase some individuals' sense of self-efficacy and hope for 
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recovery (Backlar & McFarland, 1998; Miller, 1998; Winnick, 1996). By examining past 
crises and discussing lessons learned for future care when preparing a PAD, the 
individual may also gain increased self-awareness regarding his/her SMI and its patterns, 
and may be able to identify preventive actions, coping skills, and self-management 
techniques s/he can use in the future, thus reducing future crises and the need for coercive 
intervention (Backlar, 2004). Since work by Swartz and colleagues (2003) has shown 
that 28 percent of individuals with SMI report avoidance of mental health treatment 
because of fear of coercion, individuals creating a PAD may have less anxiety and 
concern about the potential for coercion and be more willing to come for mental health 
treatment, again improving chances for positive outcomes and recovery. From this 
discussion it seems likely that PADs may be of clinical utility even if never invoked; 
PAD creation in and of itself may be a positive intervention. 
During times of crisis, it has been posited that invoking a PAD may be of great 
benefit to an individual with SMI. With a PAD the individual is able to continue to have 
his/her choices honored during a time of incapacity, receiving the treatments s/he knows 
from experience are most effective and having a say in crisis management (Howe, 2000). 
Similarly, a PAD can provide mental health professionals with valuable psychosocial 
information regarding the individual in crisis (Backlar, 2004). A PAD with informed 
consent for hospitalization or medication can obviate the need for a court commitment 
and coercive care (Backlar, 1995), and if clear instructions on crisis management and 
hospital diversion strategies are included, may decrease hospitalization rates (Backlar, 
2004). 
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2.23 Empirical PAD Literature: Demand, Creation, Content, Effectiveness 
Despite the growing interest in PADs over the past fifteen years, and despite the 
existing debate about their effectiveness and appropriateness for use with individuals 
with SMI, surprisingly little empirical research had been completed on PADs (O'Connell 
& Stein, 2005) prior to the mid-2000s. The research discussed here falls into four 
categories: studies of interest in PADs by individuals with SMI; studies regarding PAD 
creation; studies of PAD content; and randomized controlled trials of PAD (or similar 
tool) effectiveness. 
Studies exploring views on PADs among individuals with SMI have found little 
knowledge of but substantial interest in PADs. One study interviewing individuals with 
SMI and multiple hospitalizations found that when introduced to the concept 53 percent 
were interested in creating a PAD. Reasons given for interest in PADs included a desire 
to prepare for future crises and to ensure that preferred treatment was obtained (Srebnik 
et al., 2003). Similar results were found in another study; when individuals with SMI 
were asked about the utility of PADs in a range of situations between 7 4 and 90 percent 
saw PADs as useful in at least some settings (O'Connell & Stein, 2005). A large study of 
five urban United States sites (N=200 at each site) found that though only between four 
and 13 percent of individuals with SMI had completed a PAD, between 70 and 83 percent 
were interested in doing so when introduced to the concept. This interest was higher for 
individuals who were non-white, female, had a history of self harm, and who had 
experienced coercion via arrest or pressure to take medication (Swanson, Swartz, Ferron 
et al., 2006; Swartz, Swanson, Van Dorn et al., 2006). 
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In addition to an examination of the latent demand for PADs among individuals 
with SMI, efforts have been made to begin to understand the reasons an individual may 
have for wanting a PAD, i.e. how individuals with SMI see a PAD's usefulness and 
purpose. In a randomized trial of a facilitated PAD process at Duke University a baseline 
survey found that participants placed the highest value on using PADs prescriptively to 
specify treatment recommended by their doctors (median value 8.5; 1-10 scale), with 
lower value placed on proscriptively avoiding unwanted treatment (median value 7.0) and 
identifying surrogate decision makers (5.0). Researchers also found that those 
individuals wishing both the Advance Instruction (AI) and Health Care Power of 
Attorney (HCP A) parts of a PAD were most interested in continuing recommended care 
during crises and enabling surrogate decision making, while individuals wishing only an 
AI were most interested in using the PAD to avoid unwanted treatment (Swartz, 
Swanson, VanDorn et al., 2006). 
PAD creation can be a challenging process for individuals with SMI, with barriers 
such as lack of awareness and understanding of PAD law as well as lack of resources to 
complete, notarize, and submit the actual document (Swanson, Swartz et al., 2003). 
However, research has demonstrated that with support individuals with SMI are capable 
of completing a PAD. One research team has demonstrated that an interactive software 
package can effectively assist individuals in successful completion of a PAD (Srebnik et 
al., 2005). The Duke randomized trial has demonstrated the effectiveness of facilitation 
using a standardized process to help individuals complete PADs (61 percent PAD 
completion vs. 3 percent in control group) (Swanson, Swartz, Elbogen et al., 2006). In 
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this study researchers also examined variables associated with actual PAD completion 
and found that actual completion of a PAD for those in the intervention arm was 
positively associated with older age, and higher scores on an independent help seeking 
scale, an adverse medication experience scale, and a scale measuring ability to reason 
about PADs, as well as negatively associated with recent violent victimization (Swanson, 
Swartz, Elbogen et al., 2006). No variables related to clinician characteristics or 
clinician/consumer relationships were examined in this study. 
Three studies have examined the contents of PADs created by individuals with 
SMI. No study found that the PAD was used exclusively to refuse all treatment. 
However, PADs were used for both proscriptive and prescriptive purposes. Most 
frequently PADs were used to provide information about specific treatment wishes, 
including specific medications requested or refused, actions professionals should engage 
in or avoid to de-escalate crises, and individuals that providers were asked to or 
prohibited from contacting during crises (Papageorgiou, Janmohamed, King, Davidson, 
& Dawson, 2004; Srebnik et al., 2005; Swanson, Swartz, Elbogen et al., 2006). Two of 
these studies also examined these PADs for clinical utility, defined as the degree to which 
PADs were clinically feasible, useful, and consistent with standards of care. In one study 
of 469 individuals with SMI 90.5 percent of PADs were found to have clinical utility 
(Swanson, Swartz, Elbogen et al., 2006), and another study of 106 individuals found that 
95 percent of PADs met these criteria (Srebnik et al., 2005). Neither of these studies, 
however, examined closely the level of proscriptiveness versus prescriptiveness in PADs, 
nor predictors of more heavily proscriptive or prescriptive PADs. 
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A few studies have looked at the impact of PADs on individuals with SMI. A 
qualitative study conducted in New York, where state-wide training on PADs has 
occurred, found that participants reported the PAD creation process required a review of 
painful experiences and current resources but that it was meaningful and provided both a 
sense of empowerment and security (Amering, Stastny, & Hopper, 2005). A small study 
of 40 individuals invited to complete PADs found that 30 agreed to do so, that the 
majority (87 percent) endorsed PADs, and that most said having a PAD gave them a 
feeling of empowerment. In follow-up interviews eight to ten months after baseline, 46 
percent of consumers expressed concern or dissatisfaction with PADs, particularly 
regarding provider lack of education on PADs and lack of willingness to honor the PAD 
(Backlar et al., 2001 ). A qualitative study interviewing consumers with a PAD after a 
crisis event also found that individuals with SMI saw PADs as tools for empowerment 
and self-determination, but were concerned about providers' lack of knowledge about 
PADs and the difficulty in communicating with providers regarding their PADs (Kim, 
Van Dorn et al., 2007). 
Only two randomized controlled trial of PADs and one of crisis cards, which are 
clinical, non-legal documents similar to PADs but created through a process involving 
provider, facilitator, and individual with SMI, have been published to date; several 
additional studies are in progress. One PAD study, completed in 2002, randomly 
assigned 156 individuals with SMI being discharged from a psychiatric hospital to PAD 
or control group and followed them for one year. No significant differences were seen 
between groups in involuntary readmission rates, days spent in hospital, or satisfaction 
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with psychiatric services (Papageorgiou, King, Janmohamed, Davidson, & Dawson, 
2002). A study of 160 individuals randomized to crisis cards or control group were 
followed for fifteen months; here researchers found a significantly lower rate of 
involuntary hospitalization in the crisis card group (13 percent vs 27 percent,) and lower 
number of involuntary bed days (14 vs. 31), perhaps due to the providers' involvement in 
and awareness of the crisis card process. There was also a trend towards lower rates of 
hospitalization overall (30 percent vs. 44 percent), but no difference in overall days in 
hospital between the two groups (Henderson et al., 2004). 
Results from the Duke randomized trial suggest benefit to consumers in PAD 
creation. At one month follow up, individuals with SMI who had completed PADs had a 
greater working alliance with their clinicians than those in the control group, and those 
with improved working alliance were more likely to report receiving the mental health 
treatment that they believed they needed (odds ratio=2.45,p<0.05) (Swanson, Swartz, 
Elbogen et al., 2006). At six month follow up after completing a PAD individuals with 
SMI experienced fewer crises (odds ratio=0.66,p<0.05), mediated by an improvement in 
the working alliance with the individual's clinician at one month (Swanson, 2007). At 
twelve months consumers who completed PADs reported significantly greater increases 
in perceived self-determination in treatment compared to the control group, particularly 
among individuals who had good understanding of PADs (43 percent vs. 24 percent) 
(Elbogen et al., 2006). The existing empirical evidence thus suggests that PADs are 
infrequently utilized but there is high latent demand for them among individuals with 
SMI, that individuals wish to use PADs for differing purposes (i.e. proscriptive or 
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prescriptive), and that with support individuals are capable of making clinically useful 
PADs. In addition, research indicates that PADs hold promise as a beneficial 
intervention, that PADs can have a positive impact on clinical outcomes, and that this 
impact may be in part mediated by improvement in the working alliance between 
clinician and consumer. Given individuals' need for support for successful PAD 
development, and the link between alliance and PAD impact, the evidence thus also 
suggests that the clinician may play a pivotal role in PAD creation and effectiveness. 
Thus clinicians' knowledge of and support for PADs and the clinician/individual 
relationship are important elements to consider in PAD research, and are discussed 
below. 
2. 2 4 Clinician Views and Attitudes towards PADs 
The dramatic difference between PAD prevalence and PAD demand suggests that 
PAD awareness is low, not simply among individuals with SMI, but among providers as 
well. Studies examining provider awareness of PADs have found this to be true; a survey 
of mental health professionals, law enforcement, general healthcare providers, clergy, and 
individuals with SMI and their families found that less than 11 percent reported that they 
were very familiar with PADs (O'Connell & Stein, 2005). A recent survey of mental 
health social workers in North Carolina found that only 5 percent reported that they were 
very familiar with the Advance Instruction (AI) portion of PADs and 15 percent with the 
Health Care Power of Attorney (HCP A) portion of PADs (Scheyett et al., in press-b). 
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However, lack of awareness regarding PADs may not be the only provider related 
factor associated with low PAD prevalence. In addition to lack of awareness, there may 
be lack of support for PADs among the provider community. This lack of support may 
stem from multiple sources. First, providers may have concerns that, because of the 
symptoms of SMI, an individual may not have the level of insight and capacity needed to 
exercise autonomy and create an appropriate PAD. In addition, they may foresee times 
when the individual's PAD may hinder the provision of needed service, and when a 
psychiatric crisis would require coercive intervention. Finally, PADs shift the traditional 
power structures in the provider/patient relationship, moving to a greater level of 
partnership with and autonomy for the individual with SMI, and decreasing the authority 
of the traditional provider role; a shift which may be uncomfortable for some clinicians. 
Ambivalence regarding the benefits of voluntary versus involuntary treatment is common 
among front line mental health professionals (Scheyett et al., in press-a). As a result, 
even if aware of PADs, some providers may not be willing to inform individuals with 
SMI about them, to work with them in PAD development, or to honor PADs during times 
of crisis (LaFond & Srebnik, 2002). 
A number of studies have surveyed mental health providers' views on PADs, and 
have found great ambivalence and widely varied levels of support, ranging from 20 to 75 
percent (Atkinson, Garner, & Gilmour, 2004; Backlar et al., 2001). In the majority of 
reports about half of those surveyed endorsed PADs (Amering, Denk, Griengl, Sibitz, & 
Stastny, 1999; Elbogen et al., 2006; Kim, Scheyett et al., in press; Swartz et al., 2005). 
Interestingly, several studies have found PAD endorsement to be significantly associated 
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with correct knowledge of PAD law, particularly knowledge regarding clinician ability to 
override PADs (Elbogen et al., 2006; O'Connell & Stein, 2005; Swartz et al., 2005). This 
suggests that clinicians may be more comfortable with PADs when they do not feel their 
"hands are tied" by the document. 
Clinicians also have been found to differ in their support for the two elements of a 
PAD. One study compared clinician endorsement ofthe AI and HCPA elements of 
PADs across psychiatrists, psychologists, and social workers. In all three disciplines 
providers more frequently supported HCP As than Als. This suggests that clinicians may 
be more comfortable supporting empowerment of a surrogate decision maker than the 
individual's choices via the AI, perhaps seeing these proxies as more reasonable arbiters 
of treatment decisions than an AI (Elbogen et al., 2006). From the literature it is clear 
that lack of PAD knowledge, and ambivalence about PADs and the power shift they 
represent are present among mental health clinicians. The impact of this lack of 
knowledge and ambivalence on PAD creation and the purposes for which PADs are used 
by individuals with SMI has yet to be determined. 
2.3 The Relational Context: Clinicians, Individuals with SML and the Working Alliance 
To date, characteristics of the individual have been the primary variables 
examined when exploring factors associated with PAD decisions. However, these 
decisions have not been contextualized within the clinician/individual relationship or 
working alliance, the focus of this research. It is therefore important to explore the 
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literature regarding the relationship between individuals with SMI and their clinicians 
and its impact, both on clinical outcomes in general and PADs in particular. 
2.31 Working Alliance In Mental Health Treatment 
Since the 1970s there has been a growing literature exploring the relationship 
between provider and client, the working alliance, which might in part account for 
positive outcomes in mental health treatment. The most well-known and widely used 
formulation of the concept of alliance was developed by Bordin, who proposed that the 
working alliance was a real relationship between the client and clinician, grounded in a 
collaborative process that contains three aspects: agreement on goals, agreement on 
tasks, and affective bond grounded in positive regard and trust (Bordin, 1976). 
Examining research in this area, recent literature reviews have found statistical evidence 
for a link between therapeutic alliance and improved outcomes (Hewitt & Coffey, 2005; 
Howgegi, Yellowlees, Owen, & Meldrum, 2003). Two meta-analyses have been done to 
attempt to synthesize this literature and identify underlying patterns, an earlier work by 
Horvath and Symonds (1991) and a more recent work by Martin (2000). The Horvath 
and Symonds study reviewed 24 studies, and found an average effect size of .26 between 
quality of alliance and clinical outcomes (Horvath & Symonds, 1991 ). The more current 
work analyzed 79 clinical studies; here the author found a similar modest effect size of 
.22 between quality of alliance and outcome, and saw that this relationship seemed to be 
consistent regardless of the many variables which differed among the studies, including 
different alliance scales, type of outcome measures, type of outcome or alliance rater, 
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time of alliance assessment, type of treatment, or publication status of the study (Martin, 
2000). 
The research discussed above indicates that the working alliance may be a 
significant factor in successful outcomes of psychotherapy. However, it cannot be 
assumed that this is also true for the relationship between an individual with SMI and a 
mental health service provider. It is therefore important to examine studies specifically 
exploring the association between working alliance and outcomes for individuals with 
SMI, that is, studies not focused on alliance in psychotherapy with individuals with non-
psychotic depression or neurotic disorders but rather studies examining the alliance in the 
context of case management and other services designed for individuals with SMI. In the 
range of existing studies specific to working alliance and individuals with SMI outcomes 
of interest varied and included symptom severity, level of functioning, quality oflife, 
treatment engagement and adherence, violent behavior, discharge outcomes, and 
hospitalization rates (McCabe & Priebe, 2004). Instruments used to measure alliance 
also varied; one frequently used was the Working Alliance Inventory (W AI) (Horvath & 
Greenberg, 1989), which was shown to have good psychometric properties specifically 
with SMI populations (Goldberg, Rollins, & McNary, 2004; Neale & Rosenheck, 1995). 
Though outcomes examined varied, multiple studies found positive associations 
between the alliance and a few key variables. A positive relationship was found between 
alliance and engagement in mental health treatment in a number of studies (D. Coffey, 
2003; Frank & Gunderson, 1990; Loneck, Banks, Way, & Bonaparte, 2002), as well as 
between alliance and adherence to medication (Frank & Gunderson, 1990; Solomon, 
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Draine, & Delaney, 1995; Weiss et al., 2002). Additional outcomes frequently associated 
with working alliance were treatment satisfaction (Calsyn, Morse, Klinkenberg, Yonker, 
& Trusty, 2002; Chinman, Rosenheck, & Lam, 2000; D. Coffey, 2003; Klinkenberg, 
Calsyn, & Morse, 1998; Solomon et al., 1995), level of functioning (J. Allen, Tarnoff, & 
Coyne, 1985; Clarkin, Hurt, & Crilly, 1987; Frank & Gunderson, 1990; Goering, 
Wasylenki, Lindsay, Lemire, & Rhodes, 1997; Neale & Rosenheck, 1995), decreased 
symptomatology (Frank & Gunderson, 1990; Goering et al., 1997; Klinkenberg et al., 
1998; Neale & Rosenheck, 1995), improvement at discharge from hospital (Hansson & 
Berglund, 1992; Svensson & Hansson, 1999), decreased time in hospital (Frank & 
Gunderson, 1990; Priebe & Gruyters, 1992), quality of life (McCabe, Roder-Wanner, 
Hoffmann, & Priebe, 1999; Solomon et al., 1995), employment (Donnell, Lustig, & 
Strauser, 2004; Priebe & Gruyters, 1992) and less violent behavior (Beauford, McNiel, & 
Binder, 1997). For a summary ofthese studies, see Appendix A. 
From this literature two relevant points can be made. First, a positive working 
alliance is associated with a number of positive outcomes. Second, a level of agreement, 
or concordance, between clinician and individual in their views on treatment, specifically 
treatment tasks and goals, is central to alliance. Given these findings, it is reasonable to 
postulate that concordance between clinician and individual views on other aspects of 
treatment, such as the need for coercive intervention, may also be relevant predictors of 
outcomes such as successful PAD completion. 
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2.32 PADs and Working Alliance 
Little work has been done exploring the relationship between PAD creation or 
outcomes and the working alliance between clinician and individual with SMI. As 
discussed above, preliminary results from the Duke randomized trial suggests that 
positive outcomes associated with PADs such as increased functioning, increased 
treatment satisfaction, and decreased crises may be mediated by improved working 
alliance (Swanson, Swartz, Elbogen et al., 2006). In addition, two studies suggest that 
the individual's relationship with a clinician may influence decisions regarding PAD 
creation. A study ofhigh service users with SMI found that 53 percent of study 
participants expressed an interest in having a PAD, and this interest was significantly 
associated with their case manager's endorsement ofPADs (Srebnik et al., 2003). A 
recent study by Swartz and colleagues found that individuals reporting that they trusted 
their psychiatrist were more likely to value PADs as a prescriptive tool to access 
treatment rather than proscriptive tools to avoid treatment (Swartz, Swanson, Van Dom et 
al., 2006). Thus the clinician's views of PADs may significantly influence individuals' 
decisions regarding PAD creation, and the quality of the relationship between clinician 
and individual may influence the purpose for which they wish to use a PAD. 
In summary, from the literature above one can see that the relationship between 
individuals with SMI and their clinicians may impact the individuals' interest in a PAD 
and the type ofPAD they wish to create. Since the working alliance has been associated 
with treatment engagement, one also can posit that a stronger working alliance may be 
associated with a PAD containing more prescriptive (i.e. treatment seeking) content. In 
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addition, the level of concordance between individual and clinician on broader mental 
health treatment issues may influence engagement with the treatment system; one study 
found higher levels of engagement and satisfaction when clinicians and individuals 
shared a biological explanatory model for SMI (McCabe & Priebe, 2004). It is therefore 
logical to suppose that the level of concordance between clinician and individual on 
issues such as the need for coercion in mental health care may impact both the 
individual's interest in creating a PAD and the type of PAD they wish to develop. 
2. 4 Summary and Conceptual Model 
2. 41 Summary of Literature 
There is considerable tension between support for autonomy and the need for 
coercive intervention in the mental health treatment of individuals with SMI. This 
tension is particularly high during times of crisis, where the risk of harm to the individual 
or others may be increased. However, there is a risk of harm in engaging in coercive 
intervention as well. Some individuals with SMI report that they experience involuntary 
treatment as hurtful and frightening, and fear of coercive intervention keeps a number of 
individuals from engaging with the mental health treatment system. 
PADs are legal tools designed to increase autonomy of individuals with SMI by 
allowing them to state their crisis treatment preferences during times when they are stable 
and have full capacity. Creating a PAD and having it honored during crises may decrease 
the need for coercive intervention and increase an individual's engagement with 
treatment. Though few individuals with SMI have created PADs the latent demand for 
them is high; when provided with assistance a majority of individuals with SMI can 
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create a clinically feasible and useful PAD. Individuals with SMI who have completed 
PADs have reported a resultant increased sense of autonomy and empowerment, even if 
the PAD is not invoked or honored (Kim, Van Dom et al., 2007). Thus the creation of 
the PAD may of itself be an important intervention. 
Clinicians are mixed in their opinions of PADs. Most studies indicate that about 
half of clinicians surveyed endorse PADs while others are unsure or have concerns that 
the benefits of PADs may be outweighed by the harm in having individuals refuse helpful 
or needed treatment. Given the demonstrated influence of the clinician and of the 
working alliance on individuals' clinical outcomes, this ambivalence is noteworthy for a 
number of reasons, among which is the possible impact of the clinician on the 
individual's decisions regarding PAD creation and purpose. 
2.42 The Next Questions and a Conceptual Model 
Within the existing research on PADs only a few studies have explored the factors 
associated with an individual's decision to create a PAD (Swanson, Swartz, Elbogen et 
al., 2006) and the factors associated with the purposes individuals wish PADs to serve-
to proscriptively avoid treatment during crises or prescriptively ensure they receive 
specific treatments (Swartz, Swanson, Van Dom et al., 2006). None have explored 
extensively how clinician views of PADs or clinician/individual relationship 
characteristics may impact PAD creation and content. This unexamined question is 
compelling, since it may affect both the broad establishment of PADs by individuals with 
SMI as well as the utility of the PADs that are created. If clinicians' views and 
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relationships with individuals impact PAD creation and content, there are implications for 
clinician training, with the possibility of developing training interventions that help 
clinicians support the creation of maximally useful PADs. 
In developing a conceptual model to use in the examination of these research 
questions, I have built upon two foundations: the Health Beliefs model (Becker & 
Maiman, 1975; Chen & Land, 1986) and the theory of relational autonomy (Furlong, 
2003a). The Health Beliefs model is an explanatory model identifying relevant 
predictors of specific health behaviors. It posits that individuals engage in health 
behaviors based on: a) their perceptions of the seriousness of the condition the behavior 
seeks to address; b) their perception of the risk or threat of the condition; c) their 
perceived benefits of the behavior; and d) their perceived barriers to the behavior. 
Applying this to PAD creation and valuing of PADs more highly for proscriptive 
purposes, I define the behavior as the exercising of individual autonomy in the creation 
of a PAD or valuing of PADs more highly for proscriptive purposes. This has the goal of 
preventing the condition of being coerced, losing autonomy, and receiving crisis mental 
health care that the individual would not choose for him/herself. The behavior the 
individual engages in is based on his/her perception of: a) the seriousness of loss of 
autonomy or experience of coercive intervention during a crisis; b) how high a risk there 
is for loss of autonomy or experience of coercive intervention during crises; c) the 
benefits of having a PAD and/or mental health treatment; and d) the barriers to PAD 
creation and implementation and/or mental health treatment. 
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This model is compelling, but does not consider the relational contexts within 
which individuals make their decisions. I propose, as is argued in relational autonomy 
theory, that we must add to this model. Relational autonomy acknowledges that 
autonomy and choice are not exercised in a vacuum, but in process with others. Thus a 
consideration of the relational supports (or lack thereof) to the individual's goal of 
preventing the loss of autonomy via a PAD or valuing of PADs more highly for 
proscriptive purposes must be added to the model. Do those in relationship with the 
individual with SMI support PAD creation and autonomy? Do their positions regarding 
coercive intervention and mental health treatment concur with and support the 
individual's position? 
In this study, my specific interest is the impact of the relational support of the 
clinician in the PAD decision process; the clinician's support of PADs, support for 
autonomy or coercive intervention, agreement with the individual with SMI on PADs, on 
support for autonomy or on coercive intervention, and agreement with the individual's 
view on the working alliance. As can be seen in Figure 1 below, I examined the impact 
ofthree domains on PAD creation and valuing of PADs more highly for proscriptive 
purposes. First is the individual's perceptions regarding the condition of coerced mental 
health treatment, both seriousness and risk. Seriousness of coercive treatment included 
the individual's report of distress when experiencing coercion in the past, distress over 
present coercion, and overall view of the benefit of coercive mental health treatment. 
Risk of coercive treatment included the number of coercive experiences in the past, the 
number of current coercive conditions experienced, and the overall level of current 
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perceived coercion. Second is the individual's perception regarding the benefits of and 
barriers to PADs and mental health treatment This included insight into the need for 
treatment, view of benefits/harms of psychotropic medications, motivation of mental 
health treatment, and overall endorsement of PADs. Barriers to PADs and mental health 
treatment included a series of questions specific to the issue looking at both logistical 
barriers to creation and barriers to utilization of PADs. Barriers to mental health 
treatment included a series of questions looking at the individual's views as to why s/he 
might not come in for mental health treatment. Finally, relational support was examined, 
including clinician endorsement of PADs, clinician view of the need for coercive mental 
health treatment, clinician concordance with (i.e. support of) the individuals' view of 
coercive treatment, and clinician concordance with the individual's rating of the working 
alliance. In addition, relational support from other sources, i.e. friends and family, was 
included. This model proposes that the variables in each of these three domains would 
predict an individual's decision to create a PAD, and their valuing of PADs for 
proscriptive purposes. In addition, I posit that demographic and clinical characteristics of 
the individual with SMI may be associated with these decisions, and that how well the 
clinician knows the individual may moderate the pattern of associations predicting PAD 
completion and valuing of PADs more highly for proscriptive purposes. More specific 
information regarding the nature of the data set, variables and instruments used, and 
analyses completed are discussed below in Methodology. 
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Individual perceptions 
Coercive MH treatment 
-Seriousness: past distress 
current distress 
view of coercion 
-Risk: past frequency 
current frequency 
overall current perceived coercion 
PAD/ MH Tx Benefits/Barriers 
-Benefits: need for MH treatment 
view of medications 
treatment motivation 
view of PADs 
-Barriers: perceived barriers to PADs 
and/or treatment 
Relational support 
Clinician 
-View of PADs 
-View of coercion 
-Concordance with individual on views of 
coercion, PADs, working alliance 
-Other support 
Figure 1 Conceptual Model for Study 
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Individual 
demographics 
Moderating fac or 
Clinician knowledge of 
consumer 
PAD Completion 
PAD Value 
(proscriptive 
or 
prescriptive) 
Chapter 3 Methodology 
3.1 Description of Original Study 
This study was a secondary analysis of an existing data set abstracted from 
research conducted by Jeffrey Swanson and colleagues in the Services Effectiveness 
Research Program of the Department of Psychiatry & Behavioral Sciences at Duke 
University School of Medicine (funding dates: December 1, 2002 through November 30, 
2006). The study, titled Effectively Implementing Psychiatric Advance Directives (NIMH 
R01-MH063949), is a randomized trial of Facilitated Psychiatric Advance Directives (F-
p ADs), a manualized facilitation intervention to help individuals with SMI in the 
completion of PADs. The F-PAD manual is written for the facilitator and provides a 
step-by-step guide for how to facilitate the development of a PAD with a consumers. It 
was adapted from several medical and psychiatric advance directive planning tools 
(California Protection and Advocacy, nd; Hammes & Rooney, 1998) and includes an 
outline of how to present an introduction to PAD concepts, review past treatment 
experiences with the consumer, and discuss, identify, and document future treatment 
preferences. In the F-PAD process an individual is provided an opportunity to work with 
a facilitator to create an Advance Instruction, designate a Health Care Power of Attorney, 
or both. Study participants in the treatment arm were offered the opportunity to complete 
a F-PAD with a trained facilitator, and were provided assistance in witnessing and 
notarizing the completed document. Participants in the control arm received a brief 
introduction to PADs and information on consumer organizations that could help them 
complete a PAD ifthey so desired. In addition to F-PAD creation, the study had a 
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longitudinal component, evaluating participants at one, six, and twelve months to 
examine the impact of the F-PAD intervention. All participants were asked to identify 
their primary mental health clinician. These clinicians were contacted and asked a series 
of questions regarding their views on the participant, their relationship with the 
participant, and their attitudes towards PADs and coercion. 
The specific aims of the original study were as follows: 
1. To evaluate the effectiveness of a manualized, pilot tested service intervention to 
facilitate completion of PADs; 
2. To evaluate the content and structure ofF-PAD documents; 
3. To examine the effects of the F-PAD intervention on engagement in the outpatient 
treatment process; and 
4. To examine the implementation ofthe F-PAD during mental health crises. 
3.11 Recruitment and Data Collection 
Criteria for eligibility to participate in the study included: a) age 18-65; b) 
documented diagnosis of schizophrenia, schizoaffective disorder, other psychotic 
disorder, or major mood disorder with psychotic features; c) currently receiving mental 
health services through one of two county-based programs in North Carolina that agreed 
to collaborate with the study; and d) able to give informed consent to participate in the 
research project. This ability was determined through a two-step process. First, the 
consumer's treating provider used his/her clinical judgment to determine whether the 
individual should be referred to the study. Second, during the consent process the study 
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research assistants were trained to stop and check with the consumer to ensure his/her 
understanding of the study. If the research assistant had concerns about the individual's 
capacity, a mini-mental status exam was administered. If this revealed a lack of capacity 
and thus ability to provide informed consent, the individual was not accepted into the 
study. Recruitment occurred from August 2004 through August 2005. The county 
mental health programs provided the study with a de-identified list of adult clients pre-
screened for eligibility, and a random sample of individuals was drawn from this list. In 
addition, sequential admissions to the state psychiatric hospital from these counties who 
met study criteria also were identified by the study recruiters. In all cases treating 
clinicians were contacted to verify that the identified individual met study criteria, and 
they sought the person's permission to be contacted by a researcher. The total pool from 
which this sample was drawn was n= 12,615 (the total number of adult clients served by 
the two agencies from August 2004 to August 2005), the random sample was n=636. 
Approximately 20 percent of the sample was recruited from the hospital setting. 
Fifty one individuals declined to participate and 167 were found ineligible for the 
study. Individuals willing to be contacted for the study were interviewed by a research 
team member who was blind to future study assignment of the participant. After 
providing informed consent, the participant received a baseline interview and was then 
randomized to the control or F-PAD arm ofthe study. At the baseline interview 
participants were asked to identify their mental health clinician, defined as the mental 
health provider who knew them the best. The research team then contacted and 
interviewed these clinicians at baseline and throughout the study, both to gather 
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information on clinician characteristics and to corroborate information gathered from the 
study participants. Whether an individual had completed a PAD successfully was 
determined by facilitator report of PAD completion within two months of baseline for 
those in the F-PAD arm ofthe study. Study procedures were approved by the 
Institutional Review Boards of Duke University, the participating county mental health 
centers, and the psychiatric hospital (Swanson, Swartz, Elbogen et al., 2006). Further 
ethical review for this secondary analysis was not required by the Interdisciplinary 
Committee for Ethics in Human Research at Memorial University, whose policies 
indicate that "Research involving secondary use of data which is provided without any 
identifier or group of identifiers which would allow attribution of private information to 
an individual" is considered "Research that does not require ethics review." For the full 
Committee statement, refer to Appendix B. 
3.2 Measures 
All variables used in this dissertation are drawn from baseline data collected in 
the parent study described above, with the exception of the dependent variable PAD 
completion. As mentioned above, PAD completion was determined by facilitator report 
of successful PAD completion within two months of baseline for those in the F-PAD 
am1. Variables and measures are summarized in Appendix C, and established 
instruments are also listed in Appendix D, with references and documented psychometric 
properties. Exact wording used for each item can be found in Appendix E. 
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3.21 Outcome Variables 
Two outcome variables from the original study are of interest in this project. The 
first is PAD completion, whether participants successfully completed a PAD document. 
In analyses of variables associated with PAD completion I chose to use only those 
participants in the F-PAD arm, even though three percent ofthe individuals in the control 
arm also completed a PAD. This was done because the process of completing a PAD 
with a facilitator, as in the F-PAD, may be very different than completing a PAD 
independently, and different characteristics may be associated with these processes. 
Th~;:refore, in order to keep the analysis more clear and not confounded with two types of 
PAD processes, only the F-PAD arm was used. The second dependent variable is 
participants' valuing of PAD purpose as a proscriptive tool. This second variable was 
measured using a series of study-developed questions regarding participants' views of the 
importance of five possible purposes of a PAD. Participants were asked to rate how 
important each of the following statements regarding PADs was to them on a ten-point 
thermometer scale, with 1 representing least important and 10 most important: 
1. Being free to change my mind about my treatment even when I am very ill. 
2. Getting the treatment my doctor thinks is best for me. 
3. Having family or friends make decisions about my treatment when I am very ill. 
4. Avoiding treatment I don't want. 
5. Getting whatever treatment works best for me. 
Th~~ valuing PAD for proscriptive purpose variable was created by calculating the 
proportion of the total score accounted for by the response to #4 ("avoiding treatment I 
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don't want) to measure participants valuing ofPAD importance for proscriptive purposes 
(i.e. score for #4/total score for #1-5.) This variable was not normally distributed, even 
after log transformation efforts, and was therefore dichotomized at the median value of 
0.1617. 
All independent variables used to develop predictive models are described below. 
It should be noted that these varied slightly between the two dependent variables. To 
clarify, Appendix C identifies which independent variables were tested as predictors for 
eac:h dependent variable. It should be noted that all continuous variables in the study 
were tested for normal distribution using the Shapiro Wilks test; those not normally 
distributed were dichotomized at the median to better capture possible non-linear 
relationships when appropriate. All ordinal variables (e.g. likert-type scaled questions) 
were also dichotomized; specific cut points for dichotomization are defined for each 
variable below. 
3.22 Variables Measuring Individuals' Perceptions Regarding Coercion 
Several variables were used in this research project to measure individuals' 
perceptions about the risk of experiencing coercive intervention. This was measured 
using individuals' baseline self-reported: a) number oflifetime coercive interventions; b) 
number ofrecent (past six months) coercive interventions; and c) overall level of 
perceived treatment coercion at baseline. Details of these measures are given below. 
Number of lifetime coercive interventions were measured using participants' 
baseline self-reported: 
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• number of lifetime involuntary hospitalizations; 
• number of types of involuntary intervention the individual had ever 
received as part of an inpatient process (handcuffed for transport to 
hospital, put in seclusion at hospital, put in restraints at hospital, forced 
medication); 
• number of types of community-based treatment leverages the individual 
had experienced in the past (involuntary outpatient commitment, 
mandated to treatment by criminal justice, money from a representative 
payee contingent on treatment, housing contingent on treatment). 
Number of recent coercive interventions were measured by the number of types of 
community-based treatment leverages the individual reported within six months of 
baseline (involuntary outpatient commitment, mandated to treatment by criminal justice, 
money from a representative payee contingent on treatment, housing contingent on 
treatment) and whether there had been an involuntary hospitalization in the past 6 
months. 
Overall current perceived coercion was measured using participant baseline 
responses to : 
• The MacArthur Admission Experience Scale, perceived coercion subscale 
(Gardner et al., 1993), as adapted for assessing coercion in outpatient 
treatment (Swartz, Swanson, & Hannon, 2003). This has shown good internal 
reliability in other studies with individuals with SMI (alpha=0.85 for the 
sample studied by Swartz and colleagues) (Swartz, Swanson, & Hannon, 
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2003) and in this study sample (alpha=0.90 for both the F-PAD arm sample 
and the total sample). It assesses whether participants believed they were 
forced into treatment settings, were able to express their preferences and had 
these opinions considered, and were treated with procedural justice. Each of 
the fifteen items in the scale is rated from 1 to 5, with 1 representing "Strongly 
Agree" with the statement and 5 "Strongly Disagree." Response ranges are 
from 15-75; higher scores indicated higher levels ofperceived coercion. 
• The study-developed General Pressures survey, which asks individuals if in 
the past six months they perceived that if they did not take their medication or 
come for treatment someone would: a) make them go to the hospital; b) 
commit them to the hospital; c) notify criminal justice; d) not give them their 
spending money; or e) force them to leave where they live. Each item is rated 
either Yes=1 or No=O for a response range ofO to 5; higher scores indicated 
increased perceived pressure. Though no prior validity and reliability tests 
have been completed for this instrument, it showed good internal reliability 
with both ofthese study samples (alpha=0.87 for F-PAD arm and alpha=0.86 
for total sample). 
Seriousness of coercive intervention, i.e. how great a negative impact coercion 
has on the individual, was measured using individuals' baseline self reported distress 
regarding coercive interventions .. Details of these measures are given below. 
Distress regarding coercive interventions was measured using individuals' responses 
to the questions: 
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• "How much did ____ bother you?", in reference to seclusion, restraint, and 
forced medication experiences in the past. Responses were on a 5 point scale (1 = 
Not at all, 5=Very much), dichotomized with 1 =Moderately/Quite a bit/Very 
much, O=Not at all/A little bit; 
• "How much did ____ bother you?", in reference to community-based 
treatment leverages the individual experienced in the past, i.e. involuntary 
outpatient commitment, mandated to treatment by criminal justice, money from a 
representative payee contingent on treatment, housing contingent on treatment. 
Responses are on a 5 point scale (1= Not at all, 5=Very much), dichotomized 
with 1 =Moderately/Quite a bitN ery much, O=Not at all/ A little bit. 
3.23 Variables Measuring Individuals' View of Benefits of and Barriers to PADs and/or 
Mental Health Treatment 
Several variables were used to measure individuals' view of the benefits and 
barriers to PADs and/or mental health treatment. These include measures of individuals': 
a) overall view of PAD utility and process; b) view of mental health treatment; and c) 
view of barriers to PAD completion and implementation; d) views of barriers to seeking 
mental health treatment. 
The individuals' view of PAD utility and process was measured using baseline 
responses to a series of PAD attitudes questions; since currently no standardized 
instrument to measure PAD attitudes exists, study-developed questions were used. The 
series contains ten statements about PADs, each with a five point likert-type response 
55 
(1 ==Strongly Agree, 5=Strongly Disagree). This is a study-developed set of questions and 
not a scale or index with known psychometric properties. Therefore, rather than 
calculating a summative score, the mean value of responses across questions was 
calculated. In addition, responses to each question were analyzed independently. 
Individuals' views of mental health treatment were measured using baseline 
responses to several instruments. These are: 
• Insight and Treatment Attitudes Questionnaire (ITAQ) (McEvoy et al., 1989), a 
measure of awareness of mental health problems and need for treatment designed 
for individuals with SMI. Each of the eleven items in the scale is rated No=O, 
Possibly Yes= 1, Y es=2, for a range of 0 to 22; higher scores indicated greater 
insight This measure has demonstrated reliability and validity in studies with 
individuals with SMI (alpha =0.82 for Swartz and colleagues, concurrent validity 
with psychiatrist rating of insight r=0.85 for McEvoy and colleagues) (McEvoy et 
al., 1989; Swartz, Swanson, & Hannon, 2003) and showed good internal 
reliability with the study samples (alpha=0.80 for both F-PAD and total sample). 
• Drug Attitude Inventory (DAI), a measure to assess attitudes toward taking 
psychotropic medication with demonstrated good psychometric properties as 
shown in studies of individuals with schizophrenia by Hogan and colleagues 
(alpha =0.81, concurrent validity with Neuroleptic Dysphoria Scale r=0.76, 
predictive validity for compliance=96 percent and noncompliance=83 percent ) 
(Hogan, Awad, & Eastwood, 1983). It showed acceptable internal reliability with 
the study samples (alpha=0.74 for both F-PAD and total sample). Each ofthe 
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seventeen questions can be answered True=l or Fa1se=O; the inventory has a 
range of 0 to 17 and higher scores indicated more positive views of medication. 
• Individuals' view of coercion in mental health treatment was measured by using 
baseline responses to two study-designed questions asking for level of agreement 
with the statements: "On the whole you are better off because of this 
pressure[ community leverages] to keep appointments (!=Strongly Agree, 
S=Strongly Disagree); and "On the whole you are better off because of this 
pressure[ community leverages] to take medications (1 =Strongly Agree, 
5=Strongly Disagree), dichotomized with 1 =Strongly Disagree/Disagree, 
O=Neutrall Agree/Strongly Agree. Since these study-designed questions are 
analyzed as two independent questions rather than a scale or index, testing of 
psychometric properties has not been undertaken. 
• Treatment Motivation Questionnaire (TMQ), a valid and reliable measure to 
assess internal motivation for treatment, motivation related to belief in the goals 
of treatment, confidence in treatment, and inclination to interpersonal help-
seeking (Ryan, Plant, & O'Malley, 1995) Each of the 28 items can be answered 
from 1 =Not At All True to ?=Very true. Higher scores indicated higher levels of 
motivation. A confirmatory factor analysis was done for the TMQ using the 
sample for this study. Five subscales were identified. The reliability of the 
subscales of"Intrinsic Motivating Factors" (alpha=.78), "Lack of Confidence in 
Treatment" (alpha= .82), "Relatedness in Treatment" (alpha=.87), and 
"Avoidance ofNegative Introject" (alpha=.73) were acceptable, with the fifth 
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subscale, "External Motivating Factors" having minimal reliability (alpha= .51). 
(Ferron, Elbogen, Swanson, Swartz, & Wagner, under review). Concurrent 
validity of the scale has been demonstrated with the Beck Depression Inventory, 
Short Michigan Alcohol Screening Test, and Addiction Severity Index (average 
r=0.31) (Ryan et al., 1995) 
• Treatment Satisfaction Scale, a thirteen item survey developed as part of the 
Mental Health Statistical Improvement Program Adult Consumer Survey. This is 
a measure used with consumers, with good psychometric properties (alpha= 0.73-
0.81 (Jerrell, 2006) and demonstrated good internal reliability with this study 
sample (alpha=0.88 for F-PAD arm, 0.90 for total sample). Each item is 
answered on a 5 point scale (1 =Strongly Agree, 5=Strongly Disagree); higher 
scores indicate greater dissatisfaction. 
Individuals' views ofbarriers to PAD completion and implementation were 
measured by participants' baseline responses to a study-developed series of reasons why 
an individual may not want to create a PAD. There are 9 items (e.g. "You don't 
understand enough about psychiatric advance directives") each with a True= I or False=O 
response. Again, since these study-designed questions are analyzed as independent 
que:stions rather than a scale or index, testing of psychometric properties has not been 
undertaken. 
Individuals' views of barriers/disadvantages to seeking mental health treatment 
were measured with a series of 16 study-developed questions asking why the individual 
might delay getting mental health treatment (e.g. concern about cost, concern about 
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getting in trouble with law.) Each question is scored Yes= I or No=O. Similar to other 
questions discussed, since these study-designed questions are analyzed as independent 
questions rather than a scale or index, testing of psychometric properties has not been 
undertaken. 
3.24 Variables Measuring Relational Support, Clinician and Other 
To examine consumers' relational supports as a context for PAD creation or 
valuing PADs more for proscriptive purposes I examined: a) clinician views of PADs 
and of coercion; b) clinician and consumer view of the working alliance in the therapeutic 
relationship at baseline; c) the concordance between clinician and consumer views on 
PADs, coercion, and their working alliance; d) how well the clinician reported knowing 
the individual; e) individuals' reports ofhaving relationships with others outside ofthe 
clinician; e) individuals' report ofhaving trusting relationships with clinician or others. 
The clinicians' view ofPAD utility and process was measured using baseline 
responses to the study-developed PAD Attitudes questionnaire, clinician version. This 
instrument contains ten statements about PADs, each with a five point Likert-type 
response (1 =Strongly Agree, S=Strongly Disagree). This is a study-developed set of 
que:stions and not a scale or index with known psychometric properties. Therefore, rather 
than calculating a summative score, the mean value of responses across questions was 
caleulated. In addition, responses to each question were analyzed independently. 
Clinicians' view of coercion in mental health treatment was measured by using 
their baseline responses to two study-designed questions asking for level of agreement 
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with the statements: "On the whole a patient who is often non-compliant with treatment 
would be better off with these type of reminders (that they might need to go to the 
hospital, be committed, get in trouble with the law, have their money withheld, or lose 
housing) to keep appointments."; "On the whole a patient who is often non-compliant 
with treatment would be better off with these type of reminders (that they might need to 
go to the hospital, be committed, get in trouble with the law, have their money withheld, 
or lose housing) to take medications." (!=Strongly Agree, 5=Strongly Disagree), 
dichotomized with 1 =Strongly Disagree/Disagree, O=Neutral/ Agree/Strongly Agree. 
Clinician and consumer view of the working alliance were measured using the 
Clinician Working Alliance Inventory (W AI) and the Client W AI. These instruments 
conceptualize the alliance as a collaboration and agreement between clinician and client 
on treatment goals and interventions, and a positive bond between the two people 
(Horvath & Greenberg, 1989). The WAI was adapted for individuals with SMI (Neale & 
Rosenheck, 1995) and has demonstrated good reliability and validity (alpha=0.89 in a 
study of individuals with SMI completed by Chinman and colleagues) (Chinman, 
Rosenheck, & Lam, 1999). Good internal reliability was shown in this study as well (for 
consumer WAI alpha=0.94 for both F-PAD and total sample, for clinician WAI 
alpha=0.92 for F-PAD and 0.91 for total sample). 
Concordance in views between clinician and individual on coercion was 
measured by: 
• A comparison of how consumers responded to the following statements regarding 
coercive interventions "On the whole you are better off because of this pressure 
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(referring to the leverages of reminders that they might need to go to the hospital, 
be committed, get in trouble with the law, have their money withheld, or lose 
housing) to keep appointments." (!=Strongly Agree, S=Strongly Disagree) and 
how their clinician responded to the question "On the whole a patient who is often 
non-compliant with treatment would be better off with these type of reminders 
(that they might need to go to the hospital, be committed, get in trouble with the 
law, have their money withheld, or lose housing) to keep appointments." 
(1 =Strongly Agree, S=Strongly Disagree.) Here each response was dichotomized 
as !=Strongly Agree/Agree and 0= Neutral/Disagree/Strongly Disagree, and then 
responses were categorized as "Both clinician and consumer Strongly 
Agree/ Agree", "Neither clinician nor consumer Strongly Agree/ Agree", "Only 
clinician Strongly Agrees/Agrees" or "Only consumer Strongly Agrees/Agrees". 
• A comparison of how individuals responded to the following question regarding 
coercive interventions "On the whole you are better off because of this pressure 
(referring to the leverages of reminders that they might need to go to the hospital, 
be committed, get in trouble with the law, have their money withheld, or lose 
housing ) to take medications." (1 =Strongly Agree, S=Strongly Disagree) and 
how their clinician responded to the question "On the whole a patient who is often 
non-compliant with medications would be better off with these type of reminders 
(that they might need to go to the hospital, be committed, get in trouble with the 
law, have their money withheld, or lose housing) to take medications" 
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(1 =Strongly Agree, 5=Strongly Disagree). Responses were dichotomized and 
categorized as above. 
• A comparison of how individuals responded to the following question regarding 
PADs and coercion "People should have a PAD because otherwise they might be 
put in the hospital or get medicines they don't want." (1 =Strongly Agree, 
5=Strongly Disagree) and how their clinician responded to the same question. 
Responses were dichotomized and categorized as above. 
Concordance in views between clinician and individual on PADs was measured 
by a comparison of clinician and individual responses to each question of the PAD 
Attitudes Questionnaire. Each response was dichotomized as 1 =Strongly Agree/ Agree 
and 0= Neutral/Disagree/Strongly Disagree, and then responses were categorized as 
"Both clinician and consumer Strongly Agree/Agree", "Neither clinician nor consumer 
Strongly Agree/Agree", "Only clinician Strongly Agrees/Agrees" or "Only consumer 
Strongly Agrees/ Agrees"; 
Concordance in views between clinician and individual on working alliance was 
measured by a comparison of the Clinician Working Alliance Inventory (W AI) and the 
Client W AI. This instrument conceptualizes the alliance as a collaboration and 
agreement between clinician and client on treatment goals and interventions, and a 
positive bond between the two people (Horvath & Greenberg, 1989). The W AI was 
adapted for individuals with SMI (Neale & Rosenheck, 1995) and has demonstrated good 
reliability and validity (alpha=0.89 in a study of individuals with SMI completed by 
Chinman and colleagues) (Chinman et al., 1999). Good internal reliability was shown in 
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this study as well (for consumer W AI alpha=O. 94 for both F-PAD and total sample, for 
clinician WAI alpha=0.92 for F-PAD and 0.91 for total sample). Each score was 
dichotomized at the median, and then categorized as "Both clinician and consumer above 
median", "Both consumer and clinician below median", "Only clinician above median", 
"Only consumer above median." 
How well the clinician knows the individual was measured by the number of 
months the clinician had provided services to the individual and by the clinician's self-
reported knowledge of the individual (1 =Only slightly, 5=Extremely well), dichotomized 
at 1 =Very well/Extremely well, O=Only slightly/Somewhat/Moderately well. 
Individuals' relationships with others outside of the clinician was measured by the 
individual's response to four study-developed questions: a) Do you have any close 
friends who are not family members? (1 =Yes, O=No ); b) Do you have someone who 
regularly helps you with your mental health treatment? (1=Yes, O=No); c) In times of 
trouble can you count on someone at least most or some of the time? (1 =Yes, O=No); and 
d) have you been victimized in the past 6 months (1=Yes, O=No). This last question was 
asked to see if consumers had relationships that were protective and resulted in their 
safety or ifthey were at risk of victimization. In addition, relationship was measured 
using a version of the Duke Social Support Scale, a standardized instrument with 
adequate psychometric properties and an internal reliability of between 0.58 and 0.80 
(Powers, Goodger, & Byles, 2004); in this study the instrument demonstrated adequate 
reliability as well (alpha=0.72 for F-PAD arm and 0.75 for the total sample.) 
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Individuals' views of trusting relationships and mental health care was measured 
by response to the following study-developed items: 
• You don't have someone to trust to make decisions for you (l=Yes, O=No) 
• You don't have a doctor you trust (l=Yes, O=No) 
• People with serious mental health problems should talk to their doctor or therapist 
about what to write down in a PAD (!=Strongly Agree, 5=Strongly Disagree), 
dichotomized with !=Strongly Agree/Agree, O=Neutral/Disagree/Strongly 
Disagree. 
• People with a serious mental illness should choose a family member or someone 
they trust and give them the right to make decisions about their treatment in the 
future ifthey become very ill (!=Strongly Agree, 5=Strongly Disagree), 
dichotomized with 1 =Strongly Agree/ Agree, O=Neutral/Disagree/Strongly 
Disagree. 
3.25 Other Co-variates for the Study 
Additional co-variates were chosen based on prior studies or the conceptual 
model proposed. For individuals with SMI, clinical co-variates included the Brief 
Psychiatric Rating Scale (BPRS) to measure symptomatology (Moemer, Mannuzza, & 
Kane, 1988), the Global Assessment ofFunctioning (GAF) to measure functional 
impairment (Endicott, Spitzer, Fleiss, & Cohen, 1976), identification of substance abuse 
by at least one positive response on the CAGE regarding alcohol or drugs (Ewing, 1984), 
and the Decisional Competence Assessment Tool for Psychiatric Advance Directives 
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(DCA T -PAD) to evaluate understanding and reasoning regarding PADs and regarding 
hospitalization (Elbogen et al., 2006). Demographic variables considered in analyses 
include race, gender, and age. For clinicians, additional variables included race, gender, 
age, educational level, years of mental health experience, and case load size. 
3.3 Data Analysis Plan 
A variety of statistical analyses were conducted in order to test the study 
hypotheses. Analysis began with appropriate univariate statistics to describe the sample, 
including means, standard deviations, and frequencies, followed by analyses specific to 
each hypothesis as outlined below. 
Hypothesis 1 a. Individuals are more likely to complete a PAD if clinician support 
for PADs is high. 
Hypothesis 1 b. The impact of clinician support on PAD completion will be 
moderated by how well the clinician knows the individual; clinician knowledge of the 
individual will be based on self-report. 
To test these hypotheses, data from participants offered the F-PAD intervention 
were examined. Given the multi-level nature of the data (participants nested within 
clinicians), multi-levellogistic regression analysis was used to determine if level-two 
variables (i.e. clinician characteristics) were significant predictor variables of PAD 
completion (Bryk & Raudenbush, 1992). Analyses were completed using the statistical 
package HLM 6.02 for Windows (Raudenbush, Bryk, & Congdon, 2005). First the 
Intraclass Correlation (ICC) was calculated to determine the proportion of variation in the 
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dependent variable explained by level two independent variables, using only the empty 
model, where the dependent variable is expressed as the sum of the general mean, a 
random effect at the clinician level (level-two), and a random effect at the consumer level 
(level-one). The formula used for the ICC wasp 1 ='to 2 I ('to 2+ n/3) (Snijders & Bosker, 
1999). As discussed in Results, the ICC was quite low, and much below the 0.15 
recommended as a minimum for multi-level analysis (Bryk & Raudenbush, 1992). An 
analysis using clinician level variables (not considering any level-one consumer 
variables), including PAD attitudes, coercion attitudes, case size, and years in practice 
was completed to ensure no significant level-two variables existed. The moderating 
effect of clinician knowledge of individual was not examined given the lack of evidence 
for a significant level-two effect.. 
Hypothesis 2.1. PAD completion is significantly associated with concordance in 
the working alliance between clinician and individual. 
Hypothesis 2.2. PAD completion is significantly associated with 
clinician/individual concordance in views on coercion in mental health treatment. 
To test these hypotheses, data from participants offered the F-PAD intervention 
were examined. Bivariate logistic regression analyses were completed for all variables of 
interest. (See Appendix C) Next, variables were grouped into conceptual domains and 
multivariate logistic regression analyses completed for purposes of variable reduction. 
To develop a final model all significant variables from domain analyses were entered into 
a multivariate logistic regression analysis, with stepwise inclusion and exclusion at 
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p=O.l 0, to capture possible trends towards significance. All regression analyses were 
completed using the statistical package SAS 9.1 (SAS Institute, 2002). 
Hypothesis 3a. Individuals are more likely to value PADs as a proscriptive tool if 
clinician support for coercion in mental health treatment is high. 
Hypothesis 3b. The impact of clinician support for coercion in mental health 
treatment on the individual's likelihood of valuing PADs as a proscriptive tool will be 
moderated by how well the clinician knows the individual; clinician knowledge of the 
individual will be based on self-report. 
To test these hypotheses, data from all participants in the sample were examined. 
Given the multi-level nature of the data (participants nested within clinicians), multi-level 
logistic regression analysis was used to determine iflevel-two variables (i.e. clinician 
characteristics) were significant predictor variables of PAD completion (Bryk & 
Raudenbush, 1992). Analyses were completed using the statistical package HLM 6.02 
for Windows (Raudenbush, Bryk et al., 2005). First the Intraclass Correlation (ICC) was 
calculated to determine the proportion of variation in the dependent variable explained by 
level-two independent variables, using only the empty model, where the dependent 
variable is expressed as the sum of the general mean, a random effect at the clinician 
level (level-two), and a random effect at the consumer level (level-one). The formula 
used for the ICC was p 1 ='to 2 I ('to 2+ n/3) (Snijders & Bosker, 1999). As discussed in 
Results, the ICC was quite low, and much below the 0.15 recommended as a minimum 
for multi-level analysis (Bryk & Raudenbush, 1992). An analysis using clinician level 
variables (not considering any level-one consumer variables), including PAD attitudes, 
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coercion attitudes, case size, and years in practice was completed to ensure no significant 
level two variables existed. The moderating effect of clinician knowledge of individual 
was not examined given the lack of evidence for a significant level-two effect. 
Hypothesis 4.1. Individuals are less likely to value PADs as a proscriptive tool if 
there is concordance in the working alliance between clinician and individual and both 
rate the working alliance as positive. 
Hypothesis 4.2. Individuals' valuing of PAD as a proscriptive tool are 
significantly associated with clinician/individual concordance in views on coercion in 
mental health treatment. 
To test these hypotheses, data from all participants in the sample were examined. 
Bivariate logistic regression analyses were completed for all variables of interest. (See 
Appendix C.) Next, variables were grouped into conceptual domains and multivariate 
logistic regression analyses completed for purposes of variable reduction. To develop a 
final model, all significant variables from domain analyses were entered into a 
multivariate logistic regression analysis, with stepwise inclusion and exclusion at p=0.1 0, 
to capture possible trends towards significance. All regression analyses were completed 
using the statistical package SAS 9.1 (SAS Institute, 2002). 
3.31 Sample Size and Statistical Power 
Four hundred sixty nine individuals consented to participate in the study and 
provided baseline information. Of these, 239 were randomized to the F-PAD group, and 
146 (61 percent) ofthese completed PADs. Seventy eight clinicians were interviewed for 
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the study, ofthese 57 provided services to the 239 participants in the F-PAD arm. 
Testing ofhypotheses 1 and 2 (outcome variable: PAD completion) used multilevel 
modeling (Raudenbush, Spybook, Liu, & Congdon, 2005) and logistic regression and 
was based on analysis of the n=239 F-PAD group, with number of clinician clusters j=57 
and average number of individuals per clinician n=4. Testing of hypotheses 3 and 4 
(outcome variable: valuing PAD for proscriptive purpose) used multilevel modeling 
(Raudenbush, Spybook et al., 2005) and logistic regression and was based on analysis of 
the entire sample (N=469), with number of clinician clusters j=78 and average number of 
individuals per clinician n=6. In all cases, power estimates assumed a bidirectional alpha 
level ofp=.05. 
For hypotheses 1 and 2, the probability of completing a PAD when the participant 
has a PAD-supportive clinician was assumed to be 0.7 and when the participant has a 
non-supportive clinician to be 0.5 (NOTE: Overall completion for the entire 
sample=.61 ). With j=57 clusters and n=4 participants per cluster on average the sample 
achieved a power of 80 percent to detect a moderate effect size of 0.4 (See Figure 2). 
69 
1.0 u =0.050 
0.9 
~E = 0.700000 
~c = o.sooooo 
lower plausible value = 0.300000 
0.8 upper plausible value= 0.500000 
0.7 --n=4 
p 0.6 
0 
w 0.5 
e 
0.4 
0.3 
0.2 
0.1 
14 25 36 47 58 
Number of clusters 
Figure 2 Power vs. Number of Clusters for Binary Outcome PAD Completion 
For hypotheses 3 and 4, the probability of placing higher value on a PAD for 
proscriptive purposes when the participant had a coercion-supportive clinician was 
assumed to be 0.6 and when the participant has a non-coercion-supportive clinician to be 
0.4. With j=78 clusters and n=6 participants per cluster on average the sample achieved a 
power of over 90 percent to detect a small effect size of 0.2 (See Figure 3). All estimates 
have been obtained using Optimal Design software (Raudenbush, Spybook et al., 2005). 
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Chapter 4 Results 
4.1 Sample Characteristics 
4.11 Consumer Characteristics 
Characteristics of consumers for both the entire sample and for those participating 
in the F-PAD study arm are summarized in Table 1. On average, consumers were in 
their early 40s (42.2 and 41.9 years, S.D. 10.79 and 10.65, respectively), about 40 percent 
male ( 40.3 percent and 41.4 percent), and slightly over half were Black/ African 
American (57.8 percent and 56.5 percent). Few consumers were married at the time of 
the study (10.7 percent and 11.3 percent). About a quarter ofthe sample reported 
working in the month prior to the study (23.4 percent and 24.4 percent) and slightly over 
half reported living independently (56.9 percent and 57.3 percent). 
Consumers in the sample most commonly had a chart diagnosis of schizophrenia 
(58.6 percent and 60.5 percent), with bipolar disorder (26.9 percent and 24.0 percent) 
and major depression (13.9 percent and 15.6 percent) also present in the sample. Nearly 
a tenth of the sample (7.9 percent and 8.4 percent) had a concurrent diagnosis of 
substance abuse. Mean scores on the Brief Psychiatric Rating Scale were 33.6 and 34.0, 
(S.D. 9.24 and 9.46) indicating moderate symptom severity, not unexpected for 
consumers living in the community. The average Global Assessment of Functioning 
score for both groups was 40 (S.D. 10.31 and 10.32), indicating a moderate level of 
impairment in functioning. About a quarter of consumers reported being victimized in 
the six months prior to the study (24.2 percent and 25.6 percent). The majority of 
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consumers reported some level of social support, with over three quarters reporting that 
they had at least one close friend (77.7 percent and 75.2 percent). 
Most consumers had some experience with involuntary or leveraged treatment. 
Nearly two thirds reported at least one involuntary hospitalization experience (65.5 
percent and 61.1 percent); a little over a tenth had experienced this in the past six months 
(13.2 percent and 13.4 percent). In addition, nearly a third reported experiencing some 
form of community treatment leverage (either outpatient commitment, treatment 
mandated by the criminal justice system, receiving money from a representative payee 
contingent on treatment, or housing contingent on treatment) in the prior six months (31.1 
percent and 33.9 percent). 
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Table 1 
Characteristics of Consumer Sample 
Total Sample F-PAD Group 
(N=469) (N=239) 
Demographics 
Age (Mean, S.D.) 42.2 (10.79) 41.9 (10.65) 
Male 189 (40.3%) 99 (41.4%) 
Race: White 183 (39.0%) 95 (39.8%) 
Race: Black 271 (57.8%) 135 (56.5%) 
Race: Other 15 (3.2%) 9 (3.7%) 
Married 50 (10.7%) 27 (11.3%) 
Years of education (Mean, S.D.) 12.3 (2.46) 12.2 (2.47) 
Lives independently 267 (56.9%) 137 (57.3%) 
Consumer worked in past month 105 (23.4%) 55 (24.4%) 
Functioning and Mental Health 
GAF (Mean, S.D.) 40.0 (1 0.31) 40.0 (1 0.32) 
Brief Psychiatric Rating Scale 
(Mean, S.D.) 33.6 (9.24) 34.0 (9.46) 
Diagnoses: 
Schizophrenia 275 (58.6%) 144 (60SYo) 
Bipolar 126 (26.9%) 57 (24.0%) 
Major Depression 65 (13.9%) 37 (15.6%) 
Substance Abuse 37 (7.9%) 17 (8.4%) 
Consumer victimized in past 6 
months 113 (24.2%) 61 (25.6%) 
Consumer reports a close friend 356 (77.7%) 176 (75.2%) 
Treatment Experiences 
Consumer ever involuntarily 
hospitalized 307 (65.5%) 146 (61.1 %) 
Consumer involuntarily 
hospitalized in past 6 months 62 (13.2%) 32 (13.4%) 
Consumer experienced 
community leverage in past 6 
months 146 (31.1%) 81 (33.9%) 
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4.12 Clinician Characteristics 
Characteristics of the clinicians providing services to consumers in both the entire 
sample and in the F-PAD study arm are summarized in Table 2. Clinicians were on 
average slightly over 40 years old (41.3 and 40.4 years, S.D. 13.74 and 14.65, 
respectively), and slightly over a quarter of the clinicians were male (26.9 percent and 
29.8 percent). Nearly halfthe clinicians were White (46.2 percent and 49.1 percent), 
with the majority of the remainder Black/African American (44.9 percent and 43.9 
percent). Less than half of the samples had a bachelor's degree or less (42.3 percent and 
42.1 percent). Clinicians were on average quite experienced, reporting over 11 years of 
mental health services experience (12.0 and 11.5, S.D. 8.78 and 8.85). Their reported 
caseload size was large, with an average of73.7 (S.D. 94.66) for the total sample and 
92.6 (S.D. 111.25) for the F-PAD group. It should be noted, however, that the range of 
caseload size varied dramatically, from a low of 7 to a high of 450. 
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Table 2 
Characteristics of Clinician Sample 
Total Sample (N=78) F -PAD Group (N=57) 
Age (Mean, S.D.) 41.3 (13.74) 40.4 (14.65) 
Male 21 (26.9%) 17 (29.8%) 
Race: White 36 (46.2%) 28 (49.1 %) 
Race: Black 35 (44.9%) 25 (43.9%) 
Race: Other/Unknown 7 (8.9%) 4 (7.0%) 
Bachelor's Degree or less 33 (42.3%) 24 (42.1 %) 
Years ofMH Experience (Mean,S.D.) 12.0 (8.78) 11.5 (8.85) 
Caseload size (Mean, S.D.) 73.7 (94.66) 92.6 (111.25) 
4. 2 Research Question 1: Clinician Support for PADs and PAD Completion. 
The first research question addressed in this dissertation examined whether 
clinician support for PADs is a significant variable in a predictive model of PAD 
completion for individuals with SMI. Specific hypotheses were: 
Hypothesis 1 a. Individuals are more likely to complete a PAD if clinician support for 
PADs is high. 
Hypothesis I b. The impact of clinician support on PAD completion will be moderated by 
how well the clinician knows the individual; clinician knowledge of the individual will be 
based on self-report. 
Clinician support for PADs is a level-2 variable, with multiple consumers nested 
within one clinician. Therefore, multilevel logistic regression analysis was used to test 
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whether clinician support for PADs is a significant predictor variable for PAD 
completion. Results using only the empty model, where the dependent variable is 
expressed as the sum of the general mean, a random effect at the clinician level, and a 
random effect at the consumer level, are shown in Table 3. 
Based on this level two variance, the Intra Class Correlation (ICC) is calculated 
by p 1 =10 2 I 'to 2+3.29 = 0.18198/0.18198+3.29= 0.0524 (Snijders & Bosker, 1999). 
Thus only 5 percent of the variation in the dependent variable PAD completion is 
explained by clinician level variables. Though small, and much less than the ICC of 0.15 
suggested as a cutoff by the literature (Bryk & Raudenbush, 1992), a second multi-level 
analysis was completed to see specifically if clinician support for PADs was a significant 
level two predictor, and was found to be non-significant. The hypothesis that clinician 
support for PADs is a significant predictor of PAD completion was not supported and 
therefore analysis of clinician knowledge of consumer as a moderating variable was not 
examined. 
Table 3. Empty Model for PAD Completion 
Fixed Effect Coefficient S.E. 
r oo=Intercept 0.448097 0.174759 
Random Effect Variance Component S.D. 
'to =var(U oj) 0.18198 0.42660 
4.3 Research Questions 2.1 through 2.3: Clinician/Individual Concordance and PAD 
Completion 
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The second set of research questions in this dissertation examined whether 
clinician/individual concordance in the working alliance, in PAD attitudes, or in views on 
coercion are significant variables in a predictive model of PAD completion. Specific 
hypotheses were: 
Hypothesis 2.1. PAD completion is significantly associated with concordance in the 
working alliance between clinician and individual, and with whether both rate the 
alliance as positive. 
Hypothesis 2.2. PAD completion is significantly associated with concordance in PAD 
attitudes between clinician and individual. 
Hypothesis 2. 3. PAD completion is significantly associated with clinician/individual 
concordance in views on coercion in mental health treatment, and with whether both have 
high or low endorsement of coercion in treatment. 
A predictive model of PAD completion was developed using the conceptual 
model outlined previously, testing independent variables for risk of coercion, seriousness 
of coercion, benefits of PAD completion and treatment, barriers to PAD, and relational 
context, including concordance between clinician and consumer on working alliance, 
PAD attitudes, and views on coercion. Bivariate logistic regression analyses were 
completed, followed by multivariate logistic regression analyses with variables grouped 
by conceptual domains (completed for purposes of variable reduction.) Variables found 
to be significant at the p<O. 05 level were included in a final multivariate logistic 
regression model. (See Appendix C for a complete listing of all variables and domains 
tested.) 
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In bivariate analyses, the following variables were significantly (p<O. 05) 
associated with an increased likelihood ofPAD completion: 
1) Age (dichotomized at median 42), with older age more likely to complete; 
2) Higher GAF score; 
3) Higher PAD Reasoning score ofDCATPAD; 
4) Higher Hospital Reasoning score ofDCATPAD; 
5) Higher Treatment Motivation Questionnaire (TMQ) total score; 
6) Higher TMQ intrinsic motivation subscale; 
7) Higher TMQ relatedness subscale; 
8) Higher Consumer Working Alliance Inventory (WAI) score; 
9) Only consumer agrees that people with SMI should: 
a) when well, write down their treatment preferences; 
b) have a PAD because otherwise they might be put in the hospital or get 
medication they don't want; 
c) have a PAD because otherwise they might go without treatment they 
need; 
1 0) Clinician reports knowing consumer very well or well; 
11) Consumer reports having at least one close friend. 
Bivariate analyses revealed a significantly (p<0.05) decreased likelihood of PAD 
completion for the following variables: 
1) Potential alcohol abuse; 
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2) Ever arrested; 
3) Having an involuntary hospitalization in the past 6 months; 
4) MacArthur Admission Experience score above the median of30; 
5) Consumer above median in mean score on PAD attitude questions; 
6) Consumer reports not having a doctor to trust; 
7) Consumer but not clinician has above the median mean score on PAD attitude 
questions; 
8) Clinician but not consumer agrees that: 
a) having a PAD will help a consumer stay well; 
b) people with SMI should, when well, write down their treatment 
preferences; 
c) providers should pay a legal penalty if they fail to follow a PAD; 
d) people with SMI should have a PAD because otherwise they might be 
put in the hospital or get medication they don't want; 
9) Both consumer and clinician agree that: 
a) people with SMI should have a PAD because otherwise they might be 
put in the hospital or get medicati~n they don't want; 
b) people with SMI should have a PAD because otherwise they might go 
without the treatment they need. 
1 0) Consumer history of victimization in the past six months 
In domain analyses the following additional variables were associated with a 
significantly (p< 0. 05) increased likelihood of PAD completion: 
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1) Consumer reports delaying treatment because going to treatment might get 
them in trouble with family or friends; 
2) Consumer and Clinician W AI within 4 points; 
3) An interaction of consumer and clinician WAI within four points and clinician 
reports knowing consumer very well/well. 
Additional variables associated with a significantly (p<O. 05) decreased likelihood 
of PAD completion included: 
1) Consumer reported distress at experiencing involuntary outpatient 
commitment; 
2) Drug Attitude Inventory (DAI) above the median score of 14; 
3) Both consumer and clinician have mean PAD attitude question scores below 
the median. 
Table 4 summarizes the significant associations seen in bivariate analyses and 
domain analyses [Note: if all variables for a domain were not significant at bivariate or 
domain level they were not included in this table.] The final model is shown in Table 5 
and was found to explain nearly 27 percent (pseudo R2= 0.269) of the variation in the 
dependent variable (p<O.OOOJ). In this model, PAD completion was significantly more 
likely if the consumer was older than the sample median of 42 (OR=3.399), had a higher 
PAD Reasoning score on the DCATPAD (OR=l.422), had a higher score on the 
Treatment Motivation Questionnaire relatedness subscale (OR=1.072), and if the 
consumer reported having at least one close friend (OR=3.969). PAD completion was 
significantly less likely if the consumer scored above the sample median of 14 for the 
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Drug Attitude Inventory (OR=0.273), the consumer reported any victimizations in the 
prior six months (OR=0.360), and ifthe consumer and clinician were discordant on PAD 
attitudes, specifically if only the clinician agreed that providers should pay a legal penalty 
ifthey fail to follow a PAD (OR=0.137). Concordance in working alliance or in views 
on coercion were not significantly associated with PAD completion. 
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Table 4 
Analyses for PAD Completion (N=239) 
BIVARIA1E MODEL DOMAIN MODEL 
Variable Odds Ratio 95%CI e. value Odds Ratio 95%CI e. value 
Demographics 
Age (dichotomized at median 42) 1.961 1.157-3.393 0.0128 1.758 1.013-3.053 0.04-50 
Gender (male=1) ns ns 
Race (white=1) ns ns 
GAP 1.030 1.001-1.60 0.04-12 ns 
BPRS ns ns 
1 or more YES in CAGE for alcohol 0.424 0.228-0.788 0.0067 0.467 0.247-0.883 0.0190 
1 or more YES in CAGE for drugs n.r ns 
D017PAD 
PAD Understanding ns ns 
Hospital Understanding ns ns 
PAD Reasoning 1.280 1.106--1.480 0.0009 1.280 1.1 06-1.480 0.0009 
Hospital Reasoning 1.212 1.034-1.420 0.0173 ns 
Risk Community Leverages, lifetime 
Number of types of community leverages ns ns 
roc ns ns 
Threat of criminal justice ns ns 
Threat by rep payee ns ns 
Threat of housing loss ns ns 
Ever arrested 0.532 0.310-0.913 0.0221 0.494 0.286-0.855 0.0118 
Risk Coerdon Experiences, in Past 6 
months 
Involuntary hospitalizaton 0.373 0.174-0.798 0.0110 0.373 0.17 4-0.798 0.0110 
Number of types of community leverage ns ns 
Any leverages ns ns 
Arrest ns ns 
roc ns ns 
Threat of criminal justice ns ns 
Threat by rep payee ns ns 
Threat of housing loss ns ns 
Risk Overall Coerdon Perception 
MacArthur Admission Experience Scale 
(dichotomized at median 30) 0.560 0.328-0.957 0.0340 0.571 0.334-0.977 0.04-10 
General Pressures Survey ns ns 
Distress at Community Leverage 
Distress at roc (1 =SA/ A) ns 0.355 0.150-0.839 0.0184 
Distress at crimnal justice (1 =SA/ A) ns ns 
Distress at rep payee (1 =SA/ A) ns ns 
Distress at housing (1 =SA/ A) ns ns 
Any leverage distressing ns ns 
83 
Table 4 
Analyses for PAD Completion (continued) 
Variable 
PAD and .MHTreatment Barriers 
PAD Barriers, sum 
Items: 
Don't understand enough about PAD 
Takes a lot of time and trouble 
Hard to get help 
No one \\ill pay attention to my wishes 
A PAD \\Q111t make a difference 
Don't knowwhat to say in PAD 
Don't have anyone to trust to make 
decisions for rre 
Don't have a 1'viD to trust 
Don't like to sign legal docurrents 
MHTX Barriers 
Number of Barriers to MH treatrrent, sum 
Reports any barriers to MH tx 
Consurrer may delay treatrrent because: 
Problem may get better by itself 
Concern about cost 
Unsure \\here to go 
Treatrrent probably w:>n't do any good 
Transportation or distance 
Concern about what others may think 
Want to solve problem on your own 
Might get you in trouble with the law 
Might get you in trouble with family or 
friends 
Might be forced to take unwanted rredici.ne 
or treatrrent 
Might be placed on IOC 
Might be involuntarily hospitalized 
Afraid may be put in seclusion 
Afraid may be put in restraints 
Afraid may be forced to take medications if 
hospitalized 
Afraid may be given an unwanted injection 
BNARIATE MODEL 
Odds Ratio 95%0 pvalue 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
0.534 0.291-0.979 0.04-26 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
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IX>MAINMODEL 
Odds Ratio 95%0 pvalue 
ns 
n.r 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
3.669 1.002-13.42e 0.04-96 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
Table 4 
Analyses for PAD Completion (continued) 
BIVARIA1E MODEL 001\fAINMODEL 
Variable Odds Ratio 95%0 e_value Odds Ratio 95%0 e_value 
Benefits of PADs and Treatment 
PAD Attitude questionnaire, MEAN 0.392 0.206-0.746 0.0043 0.346 0.173-0.694 OJXJ28 
ITAQ (dichotomized at rredian 20) ns ns 
DAI17 (dichotomized at rredian 14) ns 0.516 0.292-0.913 0.0231 
Pressure Scale ns ns 
Consurrer sees coercion beneficial to keep 
appoint:rrents (SD/D) ns ns 
Consurrer sees coercion beneficial to take 
tredications (SD/D) ns ns 
Treatment MOtivation 
TMQtotal 1.017 1.001-1.034 0.0354 ns 
TMQ external factor, sum ns ns 
1MQ intrinsic factor, sum 1.036 0. 999-1.075 0.0494 ns 
1MQ lack confidence in treat:rrent factor, 
sum ns ns 
1MQ introject factor, sum ns ns 
1MQ relatedness factor, sum 1.050 1.021-1.081 0.0005 1.053 1.022-1.084 OJJ007 
Treat:rrent Satisfaction Scale ns ns 
Relational Supports: W.AI 
Consurrer WAI total score 1.043 1.002-1.086 0.0417 ns 
Oinician WAI total score ns ns 
Both clinician and consurrer rate WAI 
high ns ns 
interaction \\1th clinician knows consurrer 
very well/well ns ns 
Both rate WAI low ns ns 
interaction \\1th clinician knows consurrer 
very well/well ns ns 
Oinician high consurrer low WAI ns ns 
interaction \\1th clinician knows consurrer 
very well/well ns ns 
Oinician low consurrer high WAI ns ns 
interaction \\1th clinician knows consurrer 
very well/well ns ns 
Consurrer and clinician WAI \\1thin 4 
points ns 2.236 1.0684.678 0.0327 
interaction \\1th clinician knows consurrer 
very well/well ns 2.364 1.167-4.787 0.0169 
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Table 4 
Analyses for PAD Completion (continued) 
BIVARIA1El\DDEL DOMAIN MODEL 
Variable G.JdsRatio 95%0 e_value QklsRatio 95%0 e_value 
OnaxcJance, PAD Attitude 
Oinician and C011Sll1rer have PAD attitude 
trean score above nn:lian ns ns 
interaction with clinician know.; cons1.ltl:ff 
very\\dl/Wl ns ns 
Olly clinician has PAD attitude trean score 
above nn:lian ns ns 
interaction with clinician know.; cons1.ltl:ff 
very WI/WI ns ns 
Olly C011Sll1rer has PAD attitude trean 
score above nn:lian 0.333 0.181-0.612 O.rm4- 0.343 0.159-0.740 0.(X)63 
interaction with clinician know.; C011Sll1rer 
very WI/WI ns ns 
Oinician and C011Sll1rer have PAD attitude 
trean score below nn:lian ns 0.362 0.167-0.784 0.0100 
interaction with clinician know.; cons1.ltl:ff 
very WI/WI ns ns 
OJn.cordance ruth individual PAD 
Attitude questions 
A PAD will help people with :Mr stay \\ell 
( C011Sll1rer response) ns ns 
futhSA/A ns ns 
1\bther SA/ A ns ns 
Oinician only SN A 0.173 0.044-0.679 0.0118 0.155 0.026-0.903 0.0381 
Con.surrer only SA/ A ns ns 
People with :Mr should, when WI, mite 
down treatrrmt preferences ( C011Sll1rer 
response) ns ns 
futhSA/A ns ns 
1\bther SA/ A ns ns 
Oinician only SA/ A 0.156 0.041-0.587 O.(X)67 ns 
Con.surrer only SA/ A 3.491 1.627-7.489 0.0013 ns 
People with M should choose sonrone 
they trust and given them right to rrnke 
decisions (COOStJ.trer response) ns ns 
futhSA/A ns ns 
1\bther SA/ A ns ns 
Oinician only SA/ A ns ns 
Con.surrer only SA/ A ns ns 
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Table 4 
Analyses for PAD Completion (continued) 
BIVARIA1E :MODEL OOMAIN:MODEL 
Variable Odds Ratio 95%0 e,value Odds Ratio 95%0 e,vaJue 
O:Jncordance with individual PAD 
Attitude questions (continued) 
Providers should pay a legal penalty if they 
fail to follow a PAD (consu.rrer response) nr nr 
Both SA/A nr nr 
Neither SA/ A nr nr 
Oinician only SA/ A 0.233 0.067-0.807 Q0216 0.256 0.070-0.934 Q0391 
Consurrer only SA/ A nr 
People should have a PAD because 
othe.t\\ise they might be put in hospital or 
get tredications they don't want (consu.rrer nr nr 
Both SA/A 0.488 0.258-0.921 Q0269 nr 
Neither SA/ A nr nr 
Oinician only SA/ A 0.296 0.100-0.875 Q0278 nr 
Gms1.11ret only SA/ A 2175 1.139-4.153 Q0186 nr 
People should have a PAD because 
otherwise they might go \\ithout treattrent 
they need ( consu.rrer response) nr nr 
Both SA/A 0.414 0.211-0.810 0.0101 0.413 0.180-0.951 0.0377 
Neither SA/ A nr 
Oinician only SA/ A nr 
Consurrer only SA/ A 2.504 1.120-5.600 0.0254 
Oinidan nr 
:M:mths worked \\ith consu.rrer nr nr 
Knowledge of consu.rrer (very, ext:reJ:rdy 
'M'll) 1.981 1.069-3.669 0.0298 2064 1.102-3.865 Q0236 
Other Relational 
Have any close fiiends 2336 1.277-4.274 0.0059 2304 1.248-4.254 0.0076 
Sonrone regularly helps you \\ith 11H nr nr 
Can you count on at least sorn:one (rmst 
or sorre of the titre) nr nr 
D.lke Social Support scale nr nr 
Any victimization in past 6 tmnths 0.543 0.301-0.980 0.()427 0.449 0.202-0.999 0.0497 
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Table 5 
PAD Completion Final Model (N=239) 
HNALMODEL 
Variable QldsRatio 95%0 pvalue 
Age dichotomized at tredian 3.399 01.468-7.868 OJXJ43 
DAI dichotomized at tredian 0.273 0.114-0.654 OJXJ36 
IXA1P AD Pad Reasoning score 1.422 1.138-1.776 Q0019 
Treatrrent Mxivation Q.Iestionnaire 
relatedness factor 1.072 1.023-1.124 Q0036 
Only Oinician strongly agrees/ agrees that 
providers should pay a legal penalty if they fail 
to follow a PAD 0.137 0.028-0.666 Q0138 
Do you have any close friends (1 =yes) 3.969 1.658-9.499 Q002 
Consurrer has had any vict:imization in past 6 
rrxmths 0.360 0.145-0.894 Q0276 
Pseudo R-Square=0.2685 
Sorrer's D=0.669 
liklihood ratio Ori.-Square=S25186, p<JXJ01 
4.4 Research Question 3: Clinician Support for Coercion and Valuing PADs as a 
Proscriptive Tool. 
The third research question in this dissertation examined whether clinician 
support for coercion in mental health treatment is a significant variable in a predictive 
model of the individual's valuing of PADs as a proscriptive tool. Specific hypotheses 
were: 
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Hypothesis 3a. Individuals are more likely to value PADs as a proscriptive tool if 
clinician support for coercion in mental health treatment is high. 
Hypothesis 3b. The impact of clinician support for coercion in mental health treatment 
on the individual's likelihood of valuing PADs as a proscriptive tool will be moderated 
by how well the clinician knows the individual; clinician knowledge of the individual 
will be based on self-report. 
Clinician support for coercion in mental health treatment is a level-2 variable, 
with multiple consumers nested within one clinician. Therefore, multilevel logistic 
regression analysis was used to test whether clinician support for coercion in mental 
health treatment is a significant predictor variable for valuing PADs as a proscriptive 
tool. Results using only the empty model, where the dependent variable is expressed as 
the sum of the general mean, a random effect at the clinician level, and a random effect at 
the consumer level, are shown in Table 6. 
Based on this level two variance, the Intra Class Correlation (ICC) is calculated 
by p 1 =-ro 2 I -ro 2+3.29 = 0.03707/0.03707+3.29= 0.0111 (Snijders & Bosker, 1999). 
Thus only 1 percent of the variation in the dependent variable valuing PADs as a 
proscriptive tool is explained by clinician level variables. Though small, and much less 
than the ICC of 0.15 suggested as a cutoff by the literature (Bryk & Raudenbush, 1992), a 
second multi-level analysis was completed to see specifically if clinician support for 
coercion in mental health treatment was a significant level two predictor and was found 
to be non-significant. The hypothesis that clinician support for coercion in mental health 
treatment is a significant predictor of valuing PADs as a proscriptive tool was not 
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supported and therefore analysis of clinician knowledge of consumer as a moderating 
variable was not examined. 
Table 6 
Empty Model for Valuing PADs as a Proscriptive Tool 
Fixed Effect Coefficient S.E. 
y oo=Intercept -0.019408 0.115046 
Random Effect Variance Component S.D. 
to =var(U oj) 0.03707 0.19253 
4.5 Research Questions 4.1 and 4.2: Clinician/Individual Concordance and Valuing 
PADs as a Proscriptive Tool 
The final set of research questions in this dissertation explored whether 
clinician/individual concordance in the working alliance or in views of coercion in mental 
health treatment are significant variables in a predictive model of the individual's 
valuing of PADs as a proscriptive tool. Specific hypotheses were: 
Hypothesis 4.1. Individuals are less likely to value PADs as a proscriptive tool if there is 
concordance in the working alliance between clinician and individual and both rate the 
working alliance as positive. 
Hypothesis 4. 2. Individuals' valuing of PADs as a proscriptive tool are significantly 
associated with clinician/individual concordance in views on coercion in mental health 
treatment, and with whether both have high or low endorsement of coercion in treatment. 
A predictive model of valuing PADs as a proscriptive tool was developed using 
the conceptual model outlined previously, testing independent variables for risk of 
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coercion, seriousness of coercion, benefits and barriers to proscribing certain treatments, 
and relational context, including concordance between clinician and consumer on 
working alliance and views on coercion. Bivariate logistic regression analyses were 
completed, followed by multivariate logistic regression analyses with variables grouped 
by conceptual domains (completed for purposes of variable reduction.) Variables found 
to be significant at the p<O. 05 level were included in a final multivariate logistic 
regression model. (See Appendix C for a complete listing of all variables and domains 
tested.) 
In bivariate analyses, the following variables were significantly (p<O. 05) 
associated with an increased likelihood of valuing PADs as proscriptive tools: 
1) Race, white 
2) Higher PAD Understanding score of DCATP AD 
3) Higher Hospital Understanding score ofDCATPAD 
4) Higher PAD Reasoning score ofDCATPAD 
5) Consumer was ever involuntarily hospitalized 
6) Consumer experienced any involuntary intervention (e.g. seclusion, forced 
medication) while hospitalized 
7) Consumer reports delaying treatment because might be forced to take 
unwanted medicine or treatment 
8) Higher Pressure Scale score 
9) Higher TMQ, lack of confidence in treatment subscale score 
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1 0) Higher Treatment Satisfaction score (where higher score represents increased 
dissatisfaction) 
11) Clinician but not consumer agrees that people with mental illness should talk 
with providers about what to write in a PAD 
12) Consumer reports not having anyone to trust to make a decision for them 
In bivariate analyses the following variables were significantly (p<O. 05) 
associated with a decreased likelihood of valuing PADs as proscriptive tools: 
1) Consumer reports doesn't understand enough about PADs 
2) Higher consumer WAI score 
3) Higher clinician WAI score 
4) Neither clinician nor consumer agree that people with mental illness should 
have a PAD because otherwise they might be put in the hospital or get 
medications they don't want 
5) Consumer reports has someone to count on at least some of the time 
6) Consumer agrees that people with mental illness should talk with a provider 
about what to write in a PAD 
7) Consumer agrees that people with mental illness should choose someone they 
trust and give them the right to make decisions 
In analysis by domains, the additional variable "consumer reports delaying 
treatment because of fear of being put in seclusion" was significantly (p< 0. 05) associated 
with lower likelihood of valuing PADs as a proscriptive tool, and the variable "both 
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clinician and consumer rate W AI low" was associated with a higher likelihood of valuing 
PADs as a proscriptive tool. 
Table 7 summarizes the significant associations seen in bivariate analyses and 
domain analyses [Note: if all variables for a domain were not significant at bivariate or 
domain level they were not included in this table.] The final model is shown in Table 8 
and was found to explain nearly 22 percent (Pseudo R2= 0.217) ofthe variation in the 
dependent variable (p<O. 0001). 
In this model, being above the sample median in valuing PADs as a proscriptive 
tool was significantly more likely if the consumer was white (OR=2.008), had ever 
experienced an involuntary hospitalization (OR=l.963), reported more dissatisfaction 
with treatment (OR=l.059), and if the consumer reported they could not make a PAD 
because they had no one to trust to make decisions for them (OR=2.677). In addition, 
there was a trend (p<.l 0) towards being more likely to value PADs as a proscriptive tool 
if consumers stated they had delayed treatment for fear of being forced to take medication 
or receive treatment they did not want (OR=1.951). Being above the median in valuing 
PADs as a proscriptive tool was significantly less likely if the consumer reported not 
knowing enough about PADs to make one (OR=0.405), reported delaying treatment for 
fear of being placed in seclusion (OR=0.388), agreed that people with a serious mental 
illness should talk with their provider about what to write down in a PAD (OR=0.283), 
and if neither the consumer nor clinician agreed that people should have a PAD because 
otherwise they might be put in the hospital or get medication they don't want 
(OR=0.347). Concordance in working alliance or views of coercion were not 
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significantly associated with being above the sample median in valuing PADs as a 
proscriptive tool. 
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Table 7 
Analyses for Valuing PADs as a Proscriptive Tool (N=469) 
BIVARIA1EMJDFL DCl\WNMJDFL 
OJdsRatio 95%0 evaJzr OJdsRatio 95%0 evaJzr 
D:nngraplics 
Age (did:XJtarized at mrlian 42) ns ns 
Gnh(mlle=1) ns ns 
Race (mte=1) 1.732 1.187-2527 QW/4 1.669 1.141-2440 Q(J)82 
GAF ns ns 
BPRS ns ns 
1 or tmre YES in CAGE for alo::lrl ns ns 
1 or tmre YES in CAGE fur drugs ns ns 
PAD Ch:lerstandirg 
PAD~ 1.054 1.028-1.(81 <QIXXJI 1.041 1.013-1.070 Q()J36 
Ihpital~ 1.076 1.034-1.14) QWJJ ns 
PAD~ 1.135 1.031-1.25) Q01 ns 
Ihpital~ ns ns 
O:nsunr.r rep:xts dooln't urxb:stan:l em.Jgh 
alxmPAD 0.34 0.228-0.9J7 <QWJ1 0.389 0.258-0.585 <QWJ1 
Hsk: /tpltient Cherck.nlifet:inr 
Ever invclunmrily l:nlpitalized 1.755 1.189-2.589 QW/6 1.755 1.189-2.589 QW/6 
liferitre types of iqmient a:x:rcioo ns ns 
Seclrnicn ns ns 
Restnlint:s ns ns 
fu:ced tredicati<n; ns ns 
Hln:Wfed ns ns 
Any involuntary intet:vemicn \\hiJ.e in l:nlpital 1.492 Hlli2213 Q(}/64. ns 
1feat:nrnt rra:iwtim arxJ satisfactim 
ThQtotal ns ns 
ThQ external foctcr, sum ns ns 
ThQinttinsic factor, Sum ns ns 
ThQ lrl ccnficlen:e in treat:trent: factor, sum 1.035 1.CXJJ..1.CXJ1 Q(J)81 ns 
ThQintrgect factor, sum ns ns 
ThQrelat:ech:ss fuctor, sum ns ns 
Treatmrt Sarisfacticn 1.CX'i3 1.036-1. cro <QWJ1 1.059 1.032-1.008 <QWJ1 
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Table 7 
Analyses for Valuing PADs as a Proscriptive Tool (continued) 
BIV.ARIXIEl\DJEL IJCI\-WNl\DJEL 
UJdsRatio 95%0 e.vaJzr QJdsRatio 95%0 e.vaJzr 
Berelits/hmiets to .NIH t:tr:atrn?rX 
N.u:rrer of fear of <Xle.l.'cioo hu:riers to M-I 
t:reat:tn:ot , sutn ns ns 
<J:xJstxrer rmy cr.Jay t:reat:tn:ot OO::ause: 
Prol::iemrmy get better by itself ns ns 
Gn:em. al::rut wst ns ns 
Thsure ~to fP ns ns 
Treattnnt: prd::ebly\\a:it do any gcxxl ns ns 
Tmropcrtatioo or distatre ns ns 
Gn:em. al::rut ~ CJt:ln:s rmy think ns ns 
w.mt to sdve pn:Hemoo yrnr CMn ns ns 
Night get yooin trouble \Uth the law ns ns 
Night get yoo in t:l:o.:Jble \Uth futri1y or fiierx:ls ns ns 
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fuhrnte WAI lo.v ns 1.&JJ 1.181-29]) Q(J)14 
interactioo \Uth clinician kmw.; cx:rnutrer very 
\\ell/~ ns ns 
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Table 7 
Analyses for Valuing PADs as a Proscriptive Tool (continued) 
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Table 7 
Analyses for Valuing PADs as a Proscriptive Tool (continued) 
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Table 8 
Final Model for Valuing PADs as a Proscriptive Tool (N=469) 
Odds Ratio 95% CI p value 
Race (white= 1) 2.008 1.119-3.606 0.0195 
Consumer reports doesn't understand enough 
about PAD 0.405 0.224-0.733 0.0029 
Ever involuntarily hospitalized 1.963 1.065-3.616 0.0306 
Consumer may delay treatment because might 
be forced to take unwanted medicine or 
treatment 1.951 0.960-3.965 0.0646 
Consumer may delay treatment because might 
be put in seclusion 0.388 0.198-0.7 59 0.0057 
Treatment Satisfaction Scale 1.059 1.019-1.101 0.0036 
Neither clinician nor consumer agree that 
people should have a PAD because otherwise 
they might be put in hospital or get medications 
they don't want 0.347 0.128-0.941 0.0376 
Consumer reports can't make a PAD because 
doesn't have anyone to trust to make decisions 2.677 1.373-5.216 0.0038 
People with MI should talk with provider about 
what to write down (consumer response) 0.283 0.118-0.678 0.0046 
Pseudo R square=0.2168 
Somer's D=0.533 
Likelihood ratio Chi Square=64.7722,p<0.0001 
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Chapter 5 Discussion 
Psychiatric Advance Directives (PADs) hold promise as a way to help consumers, 
when well, express their wishes for care during times of crisis and thus avoid unwanted 
and coercive intervention. For PADs to be maximally useful, both proscriptive and 
prescriptive wishes may need to be stated by the consumer, i.e. what treatment does the 
consumer want and what treatment is not wanted. These decisions regarding PAD 
creation and content may be influenced by a number of factors, including the attitudes of 
consumers' clinicians and the relationship between consumers and clinicians. This 
research therefore examined several possible associations: 1) the association between 
clinician attitudes towards PADs and the decisions individuals with SMI make regarding 
PAD creation; 2) the association between clinician attitudes towards coercive 
intervention in mental health care and how much value consumers place on PADs as 
proscriptive tools; 3) the association between characteristics of the relationship between 
the clinician and individual with SMI and individuals' decisions regarding PAD creation; 
and 4) the association between characteristics of the relationship between the clinician 
and individual with SMI and individuals' valuing PAD more for proscriptive purposes. 
The conceptual framework used in this study was a modification of the Health 
Beliefs Model, positing that individuals with SMI engage in health behaviors based on: a) 
their perceptions of seriousness of the condition the behavior seeks to address ; b) their 
perception of the risk or threat of the condition; c) their perceived benefits of and barriers 
to the behavior. Thus it is hypothesized that consumers will choose to complete a PAD 
or value PADs for proscriptive purposes based on: 1) how serious or harmful they 
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perceive coerced treatment to be; 2) how much at risk of coerced treatment they perceive 
themselves to be; and 3) how much benefit they see in completing a PAD and/or getting 
mental health care, versus how many barriers they see to completing PADs and/or getting 
mental health care. To augment this model, the study added an additional construct, the 
relational context. Grounded in the concept of relational autonomy, this construct was 
added to the Health Beliefs model by positing that consumers engage in health behaviors 
when they have relational support for their actions. Thus it is proposed in this conceptual 
framework that an important element of consumers' decisions regarding PADs is the 
relationships supporting these decisions; one of the most important of these relationships 
was hypothesized to be the relationship with their clinician. 
5.1 Support for Hypotheses 
The hypotheses for this study were that consumers are more likely to complete a 
PAD if clinician support for PADs is high, and are more likely to complete a PAD if 
there is a positive and concordant view of the working alliance between clinician and 
consumer. Consumer are also more likely to complete a PAD if there is concordance in 
PAD attitudes and in views on coercion in mental health care between the clinician and 
the individual. In addition, consumers are more likely to value PADs for proscriptive 
purposes if clinician support for coercion in mental health treatment is high. Consumer 
valuing of PADs for proscriptive purposes is also more likely with concordance in the 
working alliance between clinician and consumer and with concordance in views on 
coercion in mental health treatment. 
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The results of this study support these hypotheses only in part (see Tables 5 and 
8). Neither clinician views on PADs or coercive treatment, nor the working alliance 
between clinician and consumer, were predictive of PAD completion or valuing PAD for 
proscriptive purposes. One variable regarding clinician and consumer concordance in 
views was predictive of PAD completion. If consumer and clinician were discordant in 
their views that providers should pay a legal penalty if they fail to follow a PAD, with 
only the clinician endorsing that statement, then consumers were significantly less likely 
to complete a PAD. Consumer and clinician concordance, where neither agreed that 
people should make a PAD because otherwise they might be put in the hospital or get 
medication they don't want, was predictive of consumers being significantly less likely to 
value PADs for proscriptive purposes. 
Interestingly, while hypotheses regarding clinician impact on consumer decisions 
regarding PADs were not strongly supported, the inclusion of a relational context 
component in the study model was supported overall. Valuing relationship with others 
as motivation for treatment and having a close friend were both significantly and 
positively associated with PAD completion. Consumers who reported having no one to 
trust to help them make a PAD were more likely to value PADs for proscriptive purposes, 
and those who trusted clinicians enough to agree that people should consult with their 
provider regarding PAD content were less likely to value PADs for proscriptive purposes. 
Other components of the model, derived from the Health Beliefs model, were 
inconsistently supported. Consumer perception of seriousness of coercive intervention 
was not shown to be significant for either dependent variable. This finding is somewhat 
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different than would be suggested by some of the literature, wherein the consumer's 
subjective experience of coercion (i.e. how serious the coercion was from the consumer's 
point of view) was associated with outcomes such as quality of life and treatment 
engagement (Kaltiala-Heino et al., 1997; Swanson, Elbogen et al., 2003). Risk of 
coercive intervention, based in the experience of a prior involuntary hospitalization, was 
associated with increased likelihood ofvaluing PADs for proscriptive purposes. The 
benefits (or lack thereof) and barriers to getting treatment were significantly associated 
with the outcomes of interest. A higher score on the Drug Attitude Inventory, indicating 
more endorsement of the benefits of medication and therefore possibly less need to avoid 
medication, was negatively associated with PAD completion. Lower overall satisfaction 
with mental health treatment increased the likelihood that one would value PADs for 
proscriptive purposes, as did reporting that one might delay treatment because of 
concerns regarding forced medication or treatment. Reporting that one might delay 
treatment because of concerns regarding seclusion, decreased the likelihood that one 
valued PADs for proscriptive purposes. Thus the findings support the hypotheses in part, 
and indicate that relationships with others beyond the clinician play an important role in 
PAD creation by consumers. 
5.2 Final Models 
5.21 PAD Completion 
The hypothesis that PAD completion was associated with clinician characteristics 
was not supported by the model, nor was the hypothesis that PAD completion was 
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associated with the working alliance between clinician and consumer. This result could 
have a number of explanations. First, it could be that clinicians simply are not that 
influential in consumers' decisions regarding PAD creation. Alternately, clinician 
turnover in public systems is often high and it may be that this disrupts the relationships 
between clinicians and consumers that otherwise could impact decisions such as PAD 
creation. Though the number of months a clinician worked with the consumer was not a 
significant variable in the final model (suggesting that turnover resulting in a brief length 
of time working with the current clinician did not impact PAD completion) we have no 
data on the total number of clinicians a consumer had over his/her mental health "career." 
It may be that cumulative clinician loss decreases consumer willingness or ability to be 
influenced by clinician views. Additional research examining the impact of clinician 
turnover is needed. 
The final predictive model, as shown in Table 5, did reveal some interesting 
findings. Older consumers (those above the median age of 42) were over three times 
more likely to complete a PAD; this may be due to greater maturity and understanding of 
how the mental health system works (or does not work), which could make having a PAD 
more desirable. It also could be a result of more cumulative coercive experiences, both 
formal (i.e. leverages and commitment), and informal (e.g. pressure to be medication 
adherent from family and clinicians), so that a consumer would feel a greater need for the 
protection of a PAD. Finally, younger consumers are sometimes more difficult to engage 
in treatment. Similarly, younger consumers might be more difficult to engage in the PAD 
preparation process than older individuals. 
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Consumers with higher scores on the Drug Attitude Inventory, signifying a more 
positive view of psychotropic medication, were significantly less likely to complete a 
PAD. One could suppose that consumers who felt no need to avoid particular 
medications during a crisis and who felt positively about this form of treatment would 
have less incentive to complete a PAD. Consumers with positive views ofmedications 
might believe that mental health providers had accurately met their needs in the past, and 
assume that it would be similar during times of crises, therefore no specific crisis 
instructions would be necessary. 
The ability to understand and think clearly about PADs, as indicated by the 
DCA TP AD PAD reasoning score, was associated with a greater likelihood of PAD 
completion. Seeing this result, one could posit that consumers who can clearly see the 
benefits of a PAD would be more likely to complete such a document. Similarly, 
consumers who could reason through and engage in the PAD preparation process would 
be more likely to be able to complete a PAD. 
Several variables regarding relational context were associated with PAD 
completion, supporting the overall proposed study model wherein relational context was 
added as a construct to the Health Beliefs Model. Only one of these involved an aspect 
of the consumer/clinician relationship, specifically lack of consumer/clinician 
concordance in opinion. If the clinician but not the consumer supported the statement 
that providers who fail to follow a PAD should pay a legal penalty, then the consumer 
was significantly less likely to complete a PAD. This result could indicate that consumers 
whose clinicians are even more rights-focused than they are do not feel the need for the 
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protection of a PAD. Alternately, it could indicate that consumers who do not believe 
that the legal system will support their rights and are more jaded than their clinicians are 
less likely to believe that PADs will be attended to, and are thus not worth completing. 
Several variables not involving clinicians but rather other relationships were 
found to be significantly associated with PAD completion. The Relatedness subscale of 
the Treatment Motivation Questionnaire, which measures consumers' motivation to 
participate in treatment because of a desire to relate to others (e.g. "I want to share some 
of my concerns and feelings with others.", "I look forward to relating with others who 
have similar problems.") was positively associated with PAD completion. In addition, 
consumers who reported having at least one close friend were nearly four times more 
likely to complete a PAD. These results suggest that consumers who value and are able 
to engage in connection are more likely to complete a PAD. One might argue that this 
also could mean that consumers whose level of functioning is high enough to engage in 
relationship also have a level of functioning high enough to create a PAD. However the 
Global Assessment of Functioning Scale was not a significant variable in the model, 
suggesting that these results are not simply the result of overall functioning. Rather, it 
may be that PADs are seen as a form of connection and relating to others among 
consumers who value relationships, and these individuals are thus more likely to 
complete a PAD. 
Finally, consumers who reported any victimization in the prior six months were 
significantly less likely to complete a PAD. This could indicate that individuals who do 
not have supportive and protective relationships and are at higher risk for victimization 
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are less likely to complete PADs. Victimization could also be a proxy for an overall 
chaotic and stressful life; individuals in such circumstances may have been unable to 
keep track of and attend the appointment for the PAD completion process. Alternately, 
this result may also indicate lowered self-efficacy or lowered trust among consumers who 
have been victimized; those who have been recent victims may believe there is no point 
in creating a PAD because they have no power to impact their life situation or because 
they do not trust anyone to listen to them and honor a PAD. 
5.22 Valuing PADs More Highly for Proscriptive Purposes 
As with the dependent variable PAD completion, the hypotheses that valuing 
PADs more highly for proscriptive purposes was associated with clinician characteristics 
and with the working alliance between clinician and consumer were not supported by the 
model. Possible explanations for this are the same as for the prior dependent variable, 
and could include that clinicians have less influence over consumers than anticipated or 
that clinician turnover may be responsible for this result. 
The final predictive model for valuing PADs for proscriptive purposes is shown in 
Table 8. In this model, consumers were twice as likely to value PADs for proscriptive 
purposes if they were white. This is a somewhat interesting result given that in a study 
by Swanson and colleagues it was found that non-white consumers were more likely to 
wish to create a PAD overall (Swanson, Swartz, Ferron et al., 2006), and one might 
expect individuals with more experiences of oppression, such as racial minorities, to 
value the protection of a proscriptive PAD more highly. However, it may be that racial 
107 
minorities experience disparity in access to treatment, and therefore using PADs as a 
prescriptive tool to ensure receiving treatment, rather than as a proscriptive tool, is a 
valued use of the document. 
Consumers who report that they might have difficulty completing a PAD because 
they do not understand enough about PADs were significantly less likely to value PADs 
for proscriptive purposes. Without fully understanding what a PAD is and how it 
functions it may be that consumers cannot fully grasp its potential as a proscriptive tool. 
Without this, consumers are unable to value PADs for that function. 
One variable related to consumers' conceptualization of the risk of coercive 
treatment was shown to be significant in the final model. Consumers who had ever 
experienced an involuntary hospitalization (and thus fully understood the risk of such 
coercive treatment) were nearly twice as likely to value PADs more highly for 
proscriptive purposes. Interestingly, no other prior coercive experience such as 
community leverage or arrest was shown to be significantly associated with this 
dependent variable. These results may indicate that involuntary hospitalization is a much 
more invasive and upsetting intervention than outpatient leverages. This is supported by 
the work of Swartz and colleagues (2003), who found that involuntary hospitalization, 
but not community leverages, resulted in fear of returning to treatment because of 
concerns about coercive intervention. 
Several variables regarding the benefits of or barriers to mental health treatment 
were associated with valuing PADs more highly for proscriptive purposes. There was a 
trend towards significance for consumers who reported they might delay treatment 
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because they might be forced to take unwanted medicine or treatment. These individuals 
were nearly twice as likely to value PADs more highly for proscriptive purposes. 
Though not statistically significant, this finding may be clinically significant and inform 
clinicians' discussions with consumers regarding PAD content. 
Consumers who were less satisfied with their overall mental health treatment 
were statistically significantly more likely to value PADs for proscriptive purposes. It 
seems that consumers who are afraid of receiving unwanted treatment or who do not 
believe treatment they receive is helpful or of high quality would be concerned about and 
wish to control the treatment they might receive during a crisis, and thus value PADs 
more highly for proscriptive purposes. 
Less understandable is the finding that consumers who reported they might delay 
treatment because they might be placed in seclusion were less likely to value PADs more 
highly for proscriptive purposes. It seems counterintuitive that consumers avoiding going 
for treatment because they feared seclusion would then not value PADs highly for 
proscriptive purposes, as a way to prevent seclusion in the future. It may be that 
individuals who are most concerned about experiencing seclusion do not believe the 
proscriptive function of PADs is a way to avoid seclusion, and thus do not value PADs as 
highly for their proscriptive purposes. Alternately, this may be a spurious finding, a 
result of the number of independent variables examined for this study (see Study 
Limitations for further discussion.) 
Similar to the findings for PAD completion, several variables addressing 
relational context were found to be significant in this final model. When there was 
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concordance between clinician and consumer, where neither agreed that people should 
have a PAD or they might be put in the hospital or get medicines they do not want, 
consumers had a significantly lower likelihood of valuing PADs for proscriptive 
purposes. It may be that the cumulative effect of a relationship where neither clinician 
nor consumer sees coerced hospitalization or medication as a reality or alternately, as a 
negative event, results in a lowered sense of need for proscriptive PAD. Additionally, if 
neither sees PADs as effective in preventing unwanted treatment, then consumers may 
not value the proscriptive function of PADs. 
A second variable related to clinicians also was associated with lower likelihood 
of valuing PADs more highly for proscriptive purposes. Consumers who endorsed the 
statement that individuals with SMI should talk with their provider about what to write 
down in a PAD were significantly less likely to value PADs for proscriptive purposes. 
Implicit in this statement is the idea that consumers see providers as trustworthy people 
with whom they can talk about their needs and who will have useful ideas. Individuals 
with such views may not see a great need for protection from providers' decisions during 
crises via a proscriptive PAD and thus value them less highly. 
A final significant variable regarding relational context did not address the 
clinician/consumer relationship, but rather relationships more broadly. Consumers who 
stated they might not be able to make a PAD because they have no one to trust to make 
decisions for them were over two and a half times more likely to value PADs for 
proscriptive purposes. One could imagine that without a supportive relational context 
consumers might be more reluctant to receive treatment and see PADs as more useful for 
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avoiding treatment. In addition, with no one to trust, using PADs as a way to appoint a 
health care proxy via the Health Care Power of Attorney function of a PAD is impossible, 
increasing the weight of the value placed on proscriptive PAD functions by the consumer. 
Alternately, consumers who have difficulty trusting others might also have difficulty 
trusting treatment and providers and value the protection of a more proscriptive PAD. 
5. 3 Alternate Model 
The conceptual model originally proposed in this study was only in part supported 
by the findings. Upon careful examination of these results, a somewhat different model 
is suggested, which I would like to propose as the subject of further research. In this 
study's modified health beliefs model, the constructs are: 1) the seriousness of the 
condition as perceived by the consumer; here the seriousness of, or how disturbed the 
consumer is by, coercive mental health intervention; 2) the risk of the condition; here the 
likelihood of coercive intervention, based in prior experience; 3) the benefits of or 
barriers to the behavior; here the benefits of or barriers to PADs and/or mental health 
treatment; and 4) the relational context in which treatment and PAD decisions occur. In 
neither original analysis was the seriousness construct supported, and risk was supported 
only for the second dependent variable. Benefits of or barriers to treatment emerged as a 
set of significant variables, and relational context variables, both with clinician and with 
others, was also significant. However, other variables that did not fit the model were 
found significant in the models, specifically age, race, DCATP AD score, and consumer 
report of lack of PAD understanding. 
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An alternate model (see Figure 4 below for a reiteration of the original model in 
contrast with the alternate model depicted in Figure 5), which would include all the 
variables found significant in this study's analyses, could consist of the following 
constructs: 
1) Consumers' experiences with mental health treatment, broadly defined. This 
could include both involuntary treatment and experiences that are the result of 
demographic characteristics such as age (cumulative experiences with the mental 
health system over years) or race (experiences with discrimination, disparity, 
differential access.) 
2) Consumers' perceptions of the benefits or dangers ofmental health treatment. 
This could include perceptions of the utility of treatment, satisfaction with 
treatment, possible unwanted results of treatment. 
3) Consumers' understanding ofthe intervention (i.e. PADs). This could include 
both objective and self-reported ability to understand the intervention. 
4) Consumers' relational context, including relationships with clinicians, others in 
treatment, others outside of treatment. 
Given that this study utilized secondary data, variables that could more specifically 
examine this model are not consistently available. Additional primary data collection is 
necessary to evaluate this model. 
112 
Individual perceptions 
Coercive MH treatment 
-seriousness: past distress 
current distress 
view of coercion 
-Risk: past frequency 
current frequency 
overall current perceived coercion 
PAD/ MH Tx Benefits/Barriers 
-Benefits: need for MH treatment 
view of medications 
treatment motivation 
view of PADs 
-Barriers: perceived barriers to PADs 
and/or treatment 
Relational support 
-View of PADs 
-view of coercion 
-concordance with individual on views of 
coercion, PADs, working alliance 
-other supports 
Figure 4 Original Model 
113 
Other covariates 
Individual demographics 
Clinical characteristics 
Moderating factor 
Clinician knowledge o 
consumer 
PAD 
Completion 
PAD Value 
(proscriptive 
or 
prescriptive) 
Experiences 
with treatment 
Benefits or 
danger of 
treatment 
Understanding 
of PADs 
Relational 
context for 
PADs 
Figure 5 Alternate Model 
5. 4 Study Limitations 
Consumer 
Decisions 
Regarding PADs 
As with all studies, particularly secondary analyses of existing data sets, there 
were a number of limitations to this study. First were limitations resulting from the 
secondary nature of the analysis. Variables identified for this study were useful, but not 
ideal nor what I would have gathered had I engaged in data collection myself. The data 
set contained a number of study-developed questions with untested psychometric 
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properties. Had I the opportunity to design and implement an ideal study the questions 
used would have been ones with tested validity and reliability with this population. 
Additionally, there are variables not contained in the data set that I would have included, 
had I designed the study specifically to answer my research questions An example of this 
is clinician turnover. Anecdotally I have heard of high turnover among the clinicians in 
the agencies participating in this study. However, the median number of months 
clinicians reported working with consumers was 12, and the number of months clinicians 
worked with consumers was not a significant variable. In addition, data were not 
collected on the number of clinicians a consumer had worked with over their mental 
health "careers." Therefore, clinician turnover may have had an effect on the results (e.g. 
multiple turnovers may make the consumer more reluctant to truly engage with the 
clinician) but cannot be measured because of the limitations of the data set. Due to these 
limitations in the existing data set, the alternate model proposed above cannot be 
adequately tested, and must await additional research with more tailored interview 
questions and data collection. 
Additional study limitations resulted from the study design. Since the study was 
limited to subjects in two counties in North Carolina, results may not be generalizable to 
other populations, particularly in other jurisdictions with different mental health systems. 
In addition, since the study limited participants to individuals with capacity to give 
consent, results cannot be generalized to less functional individuals. 
The study may not be generalizable for reasons other than convenience sampling 
as well. Participants in the F-PAD study arm made their decisions regarding PAD 
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completion under circumstances somewhat dissimilar from those in regular clinical 
situations. They were provided with extensive information regarding PADs as well as 
support in completing, witnessing, and notarizing the document from an individual who 
is not their clinician. Predictors of PAD completion in these circumstances may not be 
the same as those in standard clinical settings where such levels of support may not be 
available and where clinicians may also serve as the consumers' PAD facilitators. The 
impact of clinician characteristics on consumer decisions regarding PADs may be greater 
if the clinician plays both a practitioner and PAD facilitator role. Additionally, this study 
examined participants' statements about the purposes for which they value PADs 
(proscriptive versus prescriptive) rather than the actual content of their PADs. It has not 
yet been determined that consumers' statement about how they wish to use a PAD and 
their actual PAD content are the same. This is an important avenue for future study. 
Given all of these limitations, study findings should be generalized with caution. 
Since this was an exploratory study, a large number of independent variables were 
examined. This raises the issue of possible spurious findings because of the number of 
independent variables tested. Had this been a study utilizing more focused and targeted 
questions designed specifically to answer the research questions, rather than an 
exploratory secondary analysis of an existing data set, it would have been appropriate to 
control for possible spurious findings using a Bonferroni correction. This corrects the 
alpha level when n statistical comparisons are done simultaneously by taking each 
independent variable's alpha value and setting it to 0.05/n. The disadvantage of this 
method is that while decreasing the chances of a Type 1 error, it increases the risk of a 
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Type 2 error. Since in an exploratory study one is attempting to identify significant 
variables but anticipates additional study to further confirm and understand the findings, I 
would argue that avoiding a Type 2 error is more important at this point than minimizing 
the risk of a Type 1 error. Thus for this study a Bonferroni correction is premature but 
should be done on subsequent, more targeted studies with fewer and more focused 
independent variables (Kutner, Nachtsheim, Neter, & Li, 2005). 
The study is also limited because of a possible lack of adequate power to detect 
effects of interest. For the PAD completion dependent variable, the study was powered 
to detect a medium effect size (0.35-0.40)-thus any small effects would be missed. 
Power was adequate for the valuing PADs for proscriptive purposes dependent variables, 
even for a small effect size. However, when considering moderating variables higher 
power is needed, thus for both dependent variables the study may have been 
underpowered to detect moderating variables with small effects. 
A final study limitation raises the philosophical and ethical question of whether 
the research processes have supported and been syntonic with the values and principles 
underlying PADs. PADs are ultimately about consumer voice, allowing the individual to 
speak for his/herself and express desires and preferences as much as possible. This study 
was grounded in individual self-report and interview, so data are based on individuals 
speaking for themselves rather than being spoken for by clinicians. However, the 
quantitative nature of the analyses preclude "hearing" the actual voices of the individuals. 
A much fuller research process would include qualitative interviews to allow both 
consumer and clinician participants to expand on and explain quantitative findings. An 
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ongoing research agenda should include such mixed method approaches and is 
recommended in "Next Steps for Research" below. 
5.5 Study Implications 
5.51 For Practice 
The results of this study have a number of implications for practice with 
consumers of mental health services. Findings suggest that clinicians can engage in 
several activities to increase the chances that consumers will complete a balanced and 
maximally useful PAD. First, clinicians can work to educate consumers regarding PADs, 
ensuring that they understand what these documents are and can logically apply PAD 
concepts to their own situation. Education for consumers' families or other supportive 
individuals may also be of importance, given the findings that the consumer's relational 
context is significantly associated with PAD decisions. In addition, consumers who feel 
positively about their mental health treatment, particularly their medications, may not see 
the utility of creating a PAD or of proscriptive PAD content. Clinicians can examine 
these assumptions with consumers, helping consumers understand the range of functions 
PADs can serve and how they may be helpful during times of crisis. 
Similarly, engaging with the consumer in an assessment process of his/her prior 
experiences with coercive or pressured mental health treatment, and possible resultant 
concerns regarding future coercive care, may be a beneficial intervention by clinicians. 
Through a reflective and exploratory process the consumer can share past difficult 
experiences, which may help the consumer process these events. The clinician can gain 
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greater understanding of the consumer, can offer support and validation for past difficult 
coercive experiences, and can provide information and support to address incorrect 
assumptions and possible cognitive distortions regarding the risk of future coercion. This 
process and understanding can be used to inform PAD creation and content. 
Finally, it may be of benefit for clinicians to consider carefully the relational 
context when offering consumers the opportunity to create a PAD. Though the 
importance of human relationship is a fundamental principle in the Code of Ethics of the 
National Association of Social Work (NASW, 2000), the importance ofrelationships, 
particularly relationship beyond the therapeutic alliance, is sometimes forgotten. 
Clinicians should be sure to have an humble and expanded view of relational context, 
realizing that consumers' relationships and lives are only in small part about mental 
health treatment. For consumers who value relating with others, PADs may be appealing 
as a tool for connection and relationship. Clinicians may wish, for these individuals, to 
frame PADs as vehicles for communication and connection with others about treatment 
even during times when consumers themselves are unable to engage in connection 
because of illness. Clinicians may also, with consumer permission, wish to engage 
consumers' relevant others in the PAD creation process, so that friends and important 
others can provide support and encouragement to the consumer regarding PAD 
completion and utilization when needed. Clinicians should be aware not only of the 
support available in a relational context, but of its potential as a barrier to PAD creation 
as well. Lack of a trusting relationship may be associated with inability to complete a 
PAD or with a heavier emphasis on proscriptiveness in the PAD. A context barren of 
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positive relationships or filled with chaos and lacking safety can be a serious barrier to 
many things, including PAD creation. Interventions to create and build on natural 
supportive relationships in the community, as is highlighted in the social work strengths 
model (Rapp, 1998), may increase the likelihood of consumers completing a useful and 
comprehensive PAD. 
5.52 For Education 
If social workers and other clinicians are to help consumers fully understand 
PADs and their uses, it is essential that they themselves have a comprehensive 
understanding of PADs and their functioning. Research has indicated that few social 
workers know a great deal about PADs; a survey of social workers in North Carolina 
found that less than 16 percent reported being very familiar with PADs (Scheyett et al., in 
press-b). PAD content is therefore needed in both university curricula as well as 
continuing education offerings. In addition, training in effective ways to educate 
consumers about PADs is needed; utilization of a psychoeducational model may be of 
benefit. 
Prior experiences with mental health treatment and views of the benefits of 
treatment may play important roles in consumer decisions regarding PADs and other 
interventions. However, traditional clinician education in assessment does not typically 
include training on ways to engage in dialogue with consumers regarding their prior 
experiences with and views of treatment. Helping trainees learn to be comfortable having 
these important but difficult discussions is necessary if clinicians are to understand the 
120 
experiential context from which consumers make decisions. Thus expanded assessment 
skills that include these content areas are important aspects of clinician education. 
Education for social workers and other clinicians usually includes content on the 
importance of relationship, often in the form of content on the therapeutic alliance, on 
social support as a protective factor, and on use of natural supports as a strategy for 
resource acquisition. This study suggests that relationship should be discussed more 
broadly in the curriculum, seen as a context in which consumers make decisions about 
their treatment (and their lives). Learning to assess consumer relational context beyond 
the therapeutic alliance, to identify consumers who lack trusting and supportive 
relationships, and to help consumers build more positive relational contexts may be 
protective for consumers, help them obtain more needed resources, and help them make 
positive decisions regarding treatment-such as the creation of maximally useful PADs. 
5. 6 Next Steps in a Research Agenda 
5. 61 Quantitative Research 
The results of this study raise a number of questions for subsequent research. 
Perhaps the two most pressing of these are: 1) confirmation that consumers' statement of 
how much they value the different potential functions of PADs (proscriptive, 
prescriptive, etc.) are consistent with what they would actually write in a PAD; and 
2) testing ofthe proposed alternate conceptual model for understanding PAD decision-
making. 
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In the current study, all consumers were asked to rate the importance of various 
functions of a PAD, irrespective of study arm assignment. Since what people say they 
value and what they support through actions can be quite different, this rating by 
consumers is informative, but not necessarily the same as the actual content they might 
write in a PAD. If what is wanted is an understanding ofthe variables associated with the 
creation of a more proscriptive PAD, then more than self-report is needed. A necessary 
next step is to examine the rating of PAD functions by consumers who subsequently 
completed PADs in the study, comparing actual PAD content with self-reported rating 
and determining the correlation between the two. If the two are highly correlated, then it 
may more safely be assumed that self-reported ranking ofPAD purposes is indicative of 
the PAD content individuals would specify, and the model developed in this study could 
be seen as more truly predictive of PAD content. 
Research to test the alternate conceptual model proposed in this paper will require 
additional studies. It could be of benefit to modify the current study design by having 
consumers' clinicians serve as PAD facilitators. This would serve two purposes. First, it 
would approximate more closely what may actually occur in "real world" settings where 
separate PAD facilitators do not exist. Second, if the relationship between clinician and 
consumer is influential regarding PAD decisions, the closer proximity of the clinician to 
PAD decision-making through the facilitation process may bring this dynamic to the 
surface for more ready observation. 
In addition to modified study design, careful selection of independent variables 
specifically focused on the testing of the model are needed. Testing of this model, which 
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contains the latent variables experience with treatment, understanding of PADs, views of 
benefits or dangers of treatment, and relational context, would be done most effectively 
with structural equation modeling (SEM) (Kline, 2005). This requires multiple observed 
variables per latent variable. Selection of these observed variables should be tailored 
specifically to the research question, with the use of standardized scales that have been 
shown valid and reliable with this population whenever possible. By careful selection of 
observed variables, use of a sufficiently large sample size (at least 200 subjects), and 
analysis using SEM, one should be able to test the proposed model for consumer 
decisions regarding PAD creation and valuing of PAD purposes. 
One particularly interesting aspect of the alternate conceptual model is the 
importance of the relational context to PAD decision-making. More in-depth exploration 
of a number of questions in this domain are needed. Specifically, it may be of interest to 
understand why individuals with a close relationship are more likely to complete PADs. 
Are their friends directly providing support so that consumers can complete PADs? Is 
this result part of a larger underlying phenomenon wherein consumers who value 
connection both value completing PADs and having close relationships? In addition, 
research examining PAD benefits may wish to explore PADs as an intervention to help 
consumers communicate with and feel more connected to others beyond their clinicians, 
such as fellow consumers or family members. 
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5. 62 Qualitative Research 
One of the limitations of this study, as discussed above, is the lack of direct 
consumer voice. This research identifies variables statistically associated with PAD 
creation and valuing PADs for proscriptive purposes, but does not drill down to the 
consumers' meaning and reasoning behind these decisions. In a study of a tool to 
increase consumer choice and voice, this lack of direct consumer voice is somewhat self-
contradictory. A necessary next step is qualitative research exploring the lived 
experience and personal meaning fueling consumer decisions regarding PADs. 
Qualitative study could include discussion of consumers' conceptualization and 
understanding of PADs and the meanings they ascribe to PADs, followed by an 
exploration of the reasons consumers have for choosing to complete a PAD or not. For 
those who complete a PAD, an exploration ofwhat they hope to gain from a PAD, as 
well as a finely-grained analysis of the PAD content, asking consumers the reasons 
behind each entry, would be informative. Finally, exploratory questions regarding the 
relationships that may have influenced or shaped consumers' decisions regarding PADs 
could occur, providing insight into the importance and dynamics of the relational context 
during PAD decision-making. 
Though qualitative study of consumers and PADs has been done in the past (see, 
for example, the work of Amering, et al., 2005), little has been done to examine the 
relational context and consumer PAD decisions. This could be a fruitful area of research, 
expanding our understanding of the processes by which consumers decide to create 
PADs. In addition, to date there has been no mixed method study of consumer decisions 
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regarding PAD creation and purposes. Triangulation of data from qualitative research 
such as described above with quantitative research such as that completed for this study 
could provide meaningful insight into consumers' reasoning and motivations regarding 
the creation of and valued purposes for their PADs. 
5. 7 Summary Conclusion 
Psychiatric Advance Directives are potentially empowering tools, giving 
consumers voice and choice at a time when they are most vulnerable, helping to resolve 
or avoid crises, and promoting recovery. The results of this study suggest that for 
consumers to utilize fully these tools they may require more than a facilitator who helps 
them in PAD preparation. Consumers require careful and in-depth education in order to 
develop a full understanding of PADs. In addition, clinicians should work with 
consumers in a reflective process to develop understanding of the consumers' views of 
and prior experiences with mental health treatment and how these inform PAD content 
and their view of PAD utility. Finally, consumers need a supportive and safe relational 
context within which to make decisions regarding PADs. Though much additional 
research is needed to understand fully consumers' decisions regarding PAD creation and 
purpose, clinicians who can partner with consumers to educate them regarding PADs, 
reflect on their experiences, and build stronger relationships in and out of treatment may 
well maximize the chances that consumers will create useful and effective PADs. 
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Appendix A 
Summary of quantitative studies examining working alliance and consumer outcomes 
Authors Sample Setting Instrument Results 
Allen et al., Axis I and II Long term Author- Better alliance 
1985 disorders inpatient until developed associated with better 
N=37 alliance rating functioning at 
scale discharge 
Beauford et SMI Inpatient unit Therapeutic Poor alliance 
al., 1997 N=328 alliance scale associated with 
based on displaying violent 
hospital chart behavior during 
notes hospitalization 
Calsyn et al., SMI, Broker or Subscale of the Improved alliance 
2002 homeless or ACTT case Client associated with 
at risk management Expectancies increased consumer 
N=l65 scale satisfaction 
Chinman et SMI, ACCESS Working Higher alliance 
al.,2000 homeless program for Alliance associated with fewer 
N=2,798 homeless Inventory days homeless and 
higher life 
satisfaction 
Clarkin et al., SMI and Inpatient Therapeutic Better working 
1987 personality alliance scale alliance at admission 
disorder based on associated with 
N=96 hospital chart higher functioning at 
notes discharge 
Coffey, 2003 SMI Intensive Structural Higher case manager 
N=55 Case Analysis of alliance associated 
Management Social Behavior with treatment 
instrument participation and 
satisfaction 
Donnell et al., SMI Vocational Study- Working alliance was 
2004 N=305 Rehabilitation developed higher for those 
Working employed, and 
Alliance among those 
Survey employed, for those 
with job satisfaction 
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Appendix A (continued) 
Authors Sample Setting Instrument Results 
Frank & Schizophrenia Inpatient, Psychotherapy Association 
Gunderson, N=143 followed Status Report between working 
1990 outpatient by scale alliance and total 
same provider, length oftime in 
either insight- treatment; 
oriented or medication 
reality adaptive compliance, 
supportive improved 
therapy symptomatology, 
increased 
functioning, 
increased social 
relationships and 
activities over 2 
years; fewer 
number of 
hospitalizations 
Gehrs & Schizophrenia Community- Working Alliance Provider and 
Goering, or based Inventory consumer working 
1994 schizoaffective rehabilitation alliance score 
disorder, in program correlated with 
treatment for consumer goal 
2-7 months attainment, with 
N=22 provider working 
alliance more 
strongly correlated 
with goal 
attainment scores 
than consumer's 
Goering et Homeless, Case Working Alliance All consumers 
al., 1997 primarily management Inventory improved in level 
schizophrenia linked with of functioning and 
N=55 housing symptomatology, 
program but consumer with 
higher working 
alliance scores 
improved more 
quickly 
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Appendix A (continued) 
Authors Sample Setting Instrument Results 
Hansson & SMI Inpatient Study-developed Better alliance 
Berglund, N=l06 questions associated with 
1992 better outcome at 
hospital discharge 
Klinkenberg SMI, homeless ACTT Helping Alliance Working alliance 
et al., 1998 or at risk program Measure scale associated with 
N=105 consumer 
satisfaction with 
treatment, Global 
Severity Index of 
symptoms, and 
level ofhostility 
Loneck et Mentally ill Crisis Vanderbilt Residual working 
al.,2002 with co- intervention Psychotherapeutic alliance score 
morbid clinic attached Process scale and beyond what would 
substance to a Working Alliance be expected for a 
abuse in crisis psychiatric Inventory given level of 
N=39 emergency therapist warmth 
room resulted in more 
successful 
connecting of 
consumer with 
treatment 
McCabe et Schizophrenia Inpatient and Helping Alliance Working alliance 
al., 1999 N=90 first followed in Scale associated with 
admission and outpatient quality of life in 
N=176long clinic long term but not 
term in and first -admitted 
outpatients consumers 
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Appendix A (continued) 
Authors Sample Setting lnstnnnent Results 
Neale& Veterans Veterans Working CollSlllrei' ~ved 
Rosenheck,1995 \\ithSMI Administration Alliance outco~ significantly 
N=143 ACIT program Inventory accounted for by COilSlllrei' 
alliance, and case manager 
perceived outco~ by case 
rnanager alliance. 
Case mmager alliance 
significantly contributed to 
total variance in living skills, 
level of functioning, 
symptom severity 
Priebe & Gruyters, SMI Conm.mity Five study- Lo\\el' alliance associated 
1993 N=72 care system for developed \\ithincreased 
long term questions hospitalization and partial 
1:reatlrent hospitalization; alliance 
correlated \\ith ernploytrent 
SoloiiDn et al., SMiand Constnrer ACf Working Working alliance associated 
1995 significant team or Alliance \\ith quality of life, attitude 
1:reatlrent professional Inventory toWcll'ds rredication 
history ACfteam compliance, satisfaction \\ith 
N=90 1:reatlrent. 
Weiss et al., 2002 SMI Conm.mity California Working alliance significant 
N=162 hospital Psychotherapy predictor of adherence to 
outpatient Alliance Scale 1:reatlrent 
center, 
schiwphrenia 
disorders 
program 
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Appendix B 
Statement of the Interdisciplinary Committee for Ethics in Human Research at Memorial 
University (Interdisciplinary Committee for Ethics in Human Research, 2003) 
4.3 Research not Requiring Ethics Review 
The following kinds of studies do not require ethics review. However, if the investigator 
is in doubt, the relevant REB office should be contacted. 
• Research about an individual(s) in the public arena using only publicly available or 
accessible records without contact with the individual(s). 
• Research involving naturalistic observation in public venues. 
• Research resulting in a case study of one patient with the expectation that written 
informed consent has been obtained from the relevant patient. 
• Quality assurance studies, program evaluations, performance reviews, testing within 
normal educational requirements if there is no research question involved and if there is 
no intention to present or publish the results of the studies to persons outside the relevant 
program. 
• Research based on review of the published/publicly report literature. 
• Research involving secondary use of data which is provided without any identifier or 
group of identifiers which would allow attribution of private information to an individual. 
• Consulting unless carried out under the auspices of the University. 
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Appendix C 
Summary of independent variables, domains, and measures used for dependent variable 
models 
Domain Variables and how measured PAD at 2 Valuing PAD 
months for 
~roscri~tive 
Risk & Seriousness 
of Coercive 
Intervention 
Domain: Risk of Consumer self-report of number of ++ ++ 
inpatient coercion, lifetime coercive interventions, 
lifetime including: 
0 Lifetime involuntary 
hospitalizations 
0 Involuntary interventions while 
in hospital (seclusion, restraint, 
handcuffed, forced medication) 
Domam: Rtsk of Consumer self-report of number of ++ ++ 
community lifetime community coercive 
coercion/leverage, interventions/leverages, including: 
lifetime 0 Involuntary outpatient 
commitment, 
0 Criminal justice mandated 
treatment, 
0 Representative payee controls 
money contingent on treatment, 
0 Housing contingent on 
treatment} 
Domain: Risk of Consumer self-report of number of ++ ++ 
coercion, past 6 coercive interventions in past 6 
months months, including: 
0 Involuntary hospitalizations 
0 Community-based leverages 
(involuntary outpatient 
commitment, criminal justice 
mandated treatment, 
representative payee controls 
money contingent on treatment, 
housing contingent on 
treatment) 
++ variable used in analysis -- variable not used in analysis 
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Appendix C (continued) 
Domain Variables and how measured PAD at Valuing PAD 
2 months for 
proscriptive 
Domain: Risk of 0 MacArthur Admission ++ ++ 
coercion, overall Experience Scale (Gardner et 
perceived coercion al., 1993) as modified for SMI 
(Swartz, Swanson, & Hannon, 
2003). Fifteen items, for each 
1 =Strongly Agree 5=Strongly 
Disagree, higher scores indicate 
higher levels of perceived 
coercion 
0 General Pressures Survey, study ++ ++ 
developed, five questions 
asking ifthe individual was 
treatment nonadherent did they 
fear someone would: hospitalize 
them; involuntarily commit 
them; involve criminal justice; 
withhold their money; force 
them to leave their housing. 
l=Yes, O=No, higher score 
indicates higher perceived 
res sure 
Domain: Distress at 0 Study developed questions on ++ ++ 
inpatient coercive level of distress experienced in 
interventions past during: seclusion; restraint; 
forced medication. For each, 
J-Not at all , S-Very much 
Domain: Distress at 0 Study developed questions on ++ ++ 
community coercive level of distress experienced in 
intervention/leverage past during: outpatient 
commitment; mandate to 
treatment from criminal justice, 
money contingent on treatment, 
housing contingent on 
treatment. For each, 1 =Not at 
all, 5=Very much 
Benefits/Barriers to 
PADs and/or 
Mental Health 
Treatment 
Domain: Benefits of 0 Study developed PAD attitude ++ 
PADs and/or of questions, Ten statements, for 
getting treatment each 1 =Strongly Agree, 
5=Strongly Disagree, higher 
score= less PAD endorsement 
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Domain Variables and how measured PAD at Valuing PAD 
2 months for 
proscriptive 
Domain: Benefits of 0 Insight and Treatment 
PADs and/or getting Attitudes Questionnaire 
mental health (McEvoy, et al, 1989) as ++ ++ 
treatment modified for SMI 
(Swartz, Swanson, & 
Hannon, 2003). 
Measures consumer's 
ability to discern own 
mental illness and see a 
need for treatment. 
Eleven items, for each 
Yes=2, Possibly Yes=1, 
O=No. Higher score 
indicates greater insight 
into disorder 
0 Drug Attitude Inventory 
(Hogan et al., 1983). 
Measures consumers ++ ++ 
perceptions of 
psychotropic medication 
purpose, effectiveness, 
and side-effects. 
Seventeen items, Yes=1, 
O=No. Higher score 
indicates more positive 
attitude towards 
psychotropic medications 
0 Pressure Scale, study ++ ++ 
developed questions 
asking if consumer views 
leverages as positive 
0 Study developed ++ ++ 
questions asking if 
consumer sees leverage 
as helpful in keeping 
appointments and taking 
medication 
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Domain 
Domain: Treatment 
motivation and 
satisfaction 
Domain: Barriers to 
PADs 
Appendix C (continued) 
Variables and how measured PAD at 
2 months 
o Treatment Motivation ++ 
Questionnaire (Ryan et al., 
1995), modified for this study 
(Ferron et al., under review), a 
measure ofmotivation for 
treatment. Twenty eight items, 
1=Not At All True 7= Very 
True, higher score indicates 
greater motivation. Five 
subscales: Intrinsic motivation; 
Extrinsic motivation; Lack of 
confidence in treatment; 
Relating to others in treatment; 
Introject or wanting to avoid 
guilt and shame. 
o Treatment Satisfaction Scale, ++ 
13item survey developed as part 
of the Mental Health Statistical 
Improvement Program Adult 
Consumer Survey (Ganju, 
1999). Each item is answered 
on a 5 point scale (1 =Strongly 
Agree, 5=Strongly Disagree); 
higher scores indicate greater 
dissatisfaction. 
o Study developed list of reasons 
why an individual might not get 
a PAD. Nine items, 1 =True 
O=False, higher scores indicate 
more perceived barriers to PAD 
completion. Used as a sum and 
each individual item: Don't 
understand enough about PADs; 
PADs take a lot oftime and 
trouble; It's hard to get help to 
make a PAD; No one will pay 
attention to my wishes; A PAD 
won't make a difference; I don't 
know what to say in a PAD; I 
don't have anyone I trust to 
make decisions for me; I don't 
have a doctor I trust; I don't like 
to sign legal documents 
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Valuing PAD 
for 
proscriptive 
++ 
++ 
Domain 
Domain: Barriers to 
mental health 
treatment 
Relational Supports 
Domain: W AI, 
consumer and 
clinician 
Appendix C (continued) 
Variables and how measured 
o Study developed list of reasons 
consumer might delay 
treatment, 16 items, 1 =Yes, 
O=No. Used as a sum and each 
individual item: Problem may 
get better by itself; Cost 
concerns; Unsure where to go; 
Won't do any good; 
Transportation; Concern what 
others might think; Want to 
solve on own; Might get in 
trouble with law; Might get in 
trouble with family or friends; 
Might be forced to take 
unwanted medication or 
treatment; Might be placed on 
outpatient commitment; Might 
be involuntarily hospitalized; 
Fear being put in seclusion; 
Fear being put in restraints; 
Fear being forced to take 
medication in hospital; Fear 
being given unwanted injection. 
o Study-developed question 
"People should have an 
Advance Instruction because 
otherwise they might be put in 
the hospital or get medicine 
they don't want" 1 =Strongly 
Agree, 5=Strongly Disagree 
o Working Alliance Inventory 
(Horvath, 1994) as modified for 
SMI (Neale & Rosenheck, 
1995). Seven items in scale, for 
each 1 =Strongly Agree 
5=Strongly Disagree, with 
higher score indicating higher 
alliance. Given to both 
consumer and clinician. 
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Appendix C (continued) 
Domain Variables and how measured PAD at Valuing PAD 
2 months for 
l!roscri(!tive 
Domain: WAI 0 Concordance between clinician ++ ++ 
concordance and consumer W AI. 
Specifically are both above 
median, below median, only 
consumer above median, only 
clinician above median. For 
each, also examined interaction 
with variable "how well does 
clinician know consumer=very 
well/well" 
0 Clinician and consumer W AI ++ ++ 
scores within 4 Eoints 
Domain: 0 Concordance between clinician ++ ++ 
Concordance in and consumer in response to 
attitudes towards benefits of community-based 
coercion coercion because it helps people 
with MI keep their 
appointments, and because it 
helps them take their 
medications. 1 =Not at all, 
5=Very much. Concordance 
defined as in W AI above 
Domain: 0 Concordance between clinician ++ ++ 
Concordance in and consumer in response to 
attitudes towards study developed PAD attitude 
PADs questions (see above). 
Concordance defined as in W AI 
above, examined for mean 
response score and each 
individual item. 
Domain : Relational 0 Number of months clinician ++ ++ 
supports, clinician reports knowing consumers 
knowledge of 0 Clinician report of knowing ++ ++ 
consumer consumer, 1 =Not at all, 5=Very 
well 
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Domain Variables and how measured PAD at Valuing PAD 
2 months for 
l!roscri(!tive 
Domain: Relational 0 Study developed questions: Do ++ ++ 
supports, non- you have any close friends? Do 
clinician you have someone who 
regularly helps you with mental 
health care? Can you count on 
someone at least some of the 
time? 
0 Duke Social Support Scale ++ ++ 
(Powers et al., 2004) 
0 Consumer report of any violent ++ ++ 
victimization in the past 6 
months 
Domain: Consumer 0 Response to study-developed ++ 
views of trusting questions: You don't have 
relationships and someone you trust to make 
mental health care decisions for you; You don't 
have a doctor you trust (l=Yes, 
O=No) 
0 Response to study-developed ++ 
questions: People with SMI 
should talk to their doctor or 
therapist about what to write 
down in a PAD; People with 
SMI should choose a family 
member or someone they trust 
and give them the right to make 
decisions about their treatment 
(1 =Strongly Agree, 5=Strongly 
Disagreel 
Consumer 
Characteristics 
Domain: PAD 0 Decisional Competence ++ ++ 
understanding Assessment Tool for Psychiatric 
Advance Directives (DCA T-
PAD) to evaluate understanding 
and reasoning regarding 
hospitalization and regarding 
PADs (Elbogen, Swanson et al., 
in press) 
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Domain Variables and how measured PAD at Valuing PAD 
2 months for 
eroscrietive 
Domain: 0 Age ++ ++ 
Demographics and 0 Race ++ ++ 
functioning 0 Gender ++ ++ 
0 Brief Psychiatric Rating Scale ++ ++ 
(Moerner et al., 1988) 
0 Global Assessment of ++ ++ 
Functioning (Endicott et al., 
1976) 
0 Alcohol use and drug use : at ++ ++ 
least one positive response on 
the CAGE regarding alcohol or 
drus;s (Ewins;, 1984). 
Clinician 
Characteristics 
Domain: PAD and 0 Study developed PAD attitude ++ 
coercion attitudes questions, Ten statements, for 
(for multi-level each 1 =Strongly Agree, 
modeling only) 5=Strongly Disagree, higher 
score= less PAD endorsement 
0 Study developed attitudes ++ ++ 
toward coercion, asking benefits 
of community-based coercion 
because it helps people with 
SMI keep their appointments, 
and because it helps them take 
their medications. 1 =Not at all, 
s=~Q;: wu~b 
Domain: 0 Age ++ ++ 
Demographics and 0 Race ++ ++ 
professional 0 Gender ++ ++ 
characteristics 0 Years of mental health ++ ++ 
expenence 
0 Level of education ++ ++ 
0 Caseload size ++ ++ 
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Psychometric information for validated instruments used in study 
Instrument 
MacArthur Admission 
Experience Scale 
Insight and Treatment 
Attitudes Questionnaire 
Drug Attitude Inventory 
Treatment Motivation 
Questionnaire 
Source 
Gardner et a!., 1993 
Swartz, Swanson, & 
Hannon, 2003 
McEvoy et al, 1989 
McEvoy, Freter, 
Everett, et al, 1993 
Swartz, Swanson, & 
Hannon, 2003 
Hogan et al, 1983 
Ryan, Plant, & 
O'Malley, 1995 
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Findings 
Constructed the scale for patients' 
perception of hospital admission 
coercion and compared with a 
more extensive patient interview. 
Used correspondence analysis to 
demonstrate internal reliability 
and loading on one latent variable 
(eigenvalue .65) 
Used scale modified for outpatient 
settings, had good internal 
reliability (a=0.85) 
Developed scale and tested 
concurrent validity by comparison 
with psychiatrists' rating of insight 
(r=0.85), 
Demonstrated test~ retest reliability 
at one year follow up (r=O. 70) 
Demonstrated good internal 
reliability (a=0.82) 
Developed scale and demonstrated 
good internal reliability ( a=0.81) 
and test~retest reliability 
(a==0.82) 
Concurrent validity demonstrated 
between DAI and Neuroleptic 
Dysphoria scale (r=0.76). 
Predictive validity demonstrated 
by ability to predict both 
compliance (96% accuracy) and 
noncompliance (83% accuracy) 
Developed scale for motivation in 
alcohol treatment. Principle 
component analysis demonstrated 
internal reliability with four 
factors (a=0.70~0.98). Concurrent 
validity with Beck Depression 
Index, Short Michigan Alcohol 
Screening Test and Addiction 
Severity Index (average r=0.31) 
Appendix D (continued) 
Instrument Source 
Ferron, et al., under 
review 
Treatment Satisfaction Jerrell, 2006 
Scale 
Working Alliance Inventory Horvath & 
Duke Social Support Index 
Greenberg, 1989 
Neale & Rosenbeck, 
1995 
Powers et al, 2004 
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Finding 
Modified scale for SMI population 
and tested on PAD study subjects. 
Confirmatory factor analysis 
revealed five factors. The 
reliability of the four primary 
subscales of "Intrinsic 
Motivation" (a=.78), "Lack of 
Confidence in Treatment" (a= 
.82), "Relatedness in Treatment" 
(a=.87), and "Avoidance of 
Negative Introject" (a=.73) had 
respectable to good Cronbach's 
alpha scores whereas, the fifth 
subscale, "External Motivation" 
has weaker reliability (a= .51) 
Part ofthe Mental Health 
Statistical Improvement Program 
Adult Consumer Survey. Found 
good internal reliability ( a=O. 73-
0.81) and convergent validity with 
the Consumer to Consumer 
Evaluation Team survey (r=0.42-
0. 79 for subscales ). 
Developed scale to measure the 
alliance between client and 
therapist. Found good internal 
reliability (a=0.82-0.85). 
Concurrent validity shown with 
treatment satisfaction (r=0.50) and 
perceived change (r=0.33) 
subscales of the Client Post-
therapy Questionnaire 
Modified scale for work with 
SMI, found good internal 
reliability (a=0.89) 
Measure of social support used in 
a wide range of settings. Internal 
reliability adequate (a=0.58-0.80) 
Appendix E 
Questions and instruments used in analysis 
Questions and instruments are shown here in the same order as they are listed in 
Appendix C 
Risk ofinpatient coercion, lifetime 
o Have you ever, at any time in your adult life, been involuntarily committed to a 
hospital for mental health, alcohol or drug problems? 
Yes (1)_ 
No (0)_ 
o Were you handcuffed (when brought to the hospital or ER by the police or sheriff)? 
Yes (1)_ 
No (0)_ 
o When you were hospitalized: Were you ever put in a seclusion room, that is, a locked 
room? 
Yes (1)_ 
No (0)_ 
o When you were hospitalized, were you ever placed in physical restraints, that is, 
straps or a harness that prevented you from moving (not including handcuffs used 
while transported to the hospital)? 
Yes (1)_ 
No (0) 
o When you were hospitalized: Were you ever forced to take medication against your 
will? 
Yes (1) 
No (0) 
Risk of community coercion/leverage, lifetime 
o Sometimes people with mental health, alcohol or drug problems are put on 
"outpatient commitment" by a judge at a legal hearing. If you are on outpatient 
commitment, the judge orders you to accept treatment in the community, whether you 
want it or not. Are you now on outpatient commitment , or have you ever been on it? 
Yes (1)_ 
No (0)_ 
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o Sometimes a police officer or judge tells you or your lawyer that you can avoid 
having charges filed, or going to jail or prison if you get treatment for your mental 
health, alcohol or drug problems in the community. Did anyone ever tell you this (did 
this ever happen to you)? 
Yes (I)_ 
No (0) 
o Did the representative payee ever require that you stay in treatment for a mental 
health, alcohol, or drug problem (or take your medication) in order to get your 
spending money? 
Yes (1) 
No (0) 
o Sometimes you are told that you can't live in a certain house or apartment unless you 
stay in mental health treatment and stay away from illegal drugs and alcohol. Did you 
ever live some place where you were required to stay in mental health treatment or 
stay away from illegal drugs and alcohol? 
Yes (1)_ 
No (0)_ 
Risk of coercion, past 6 months 
o Have you been involuntarily committed in the past 6 months? 
Yes (1) 
No (0)_ 
o Are you currently on outpatient commitment? [If not currently on OPC] Were you on 
outpatient commitment in the past six months? 
Yes (1)_ 
No (0) 
o Did this [avoiding charges filed or going to jail if you get treatment for your mental 
health, alcohol, or drug problem] happen in the last six months? 
Yes (1)_ 
No (0) 
o Did this [representative payee required that you sat in treatment for a mental health, 
alcohol, or drug problem (or take your medications) in order to get your spending 
money] happen in the last six months? 
Yes (1) 
No (0)_ 
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o Did someone tell you this [you can't live in a certain house or apartment unless you 
stay in mental health treatment and stay away from illegal drugs and alcohol] about 
where you currently live? Did someone tell you this in the past six months? 
Yes (1) 
No (0) 
Risk of coercion. overall perceived coercion 
MacArthur Admission Experience Scale 
Now lets get back to you and your experiences of treatment. Think back over your 
experience of going to the mental health center [or other outpatient mental health 
services] over the past six months. Think about all of the things people might have done 
to keep you going to the mental health center or taking medications as prescribed. Then 
tell me how you feel about the following statements. 
o I felt free to do what I wanted about going to the (mental health center). 
o People tried to force me to go to the (mental health center). 
o I had enough of a chance to say whether I wanted to go to the (mental health center). 
o I chose to go to the (mental health center). 
o I got to say what I wanted about going to the (mental health center). 
o Someone threatened me to get me to go to the (mental health center). 
o It was my idea to go to the (mental health center). 
o Someone physically tried to make me go to the (mental health center). 
o No one seemed to want to know whether I wanted to go to the (mental health center). 
o I was threatened with commitment. 
o They said they would make me go to the (mental health center). 
o No one tried to force me to go to the (mental health center). 
o My opinion about going to the (mental health center) didn't matter. 
o I had a lot of control over whether I went to the (mental health center). 
o I had more influence than anyone else on whether I went to the (mental health center). 
For each: 
Strongly 
Agree 
1 
Agree Neutral 
2 3 
General Pressures Survey 
Disagree 
4 
Strongly 
Disagree 
5 
In the past 6 months, did you feel that if you did not keep your appointments at the 
Mental Health Center or clinic, or if you did not take your prescribed medications for 
mental health, alcohol or drug problems: 
o Someone would make you go to the hospital? 
o Someone would commit you to the hospital? 
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No(O)_ 
No (0)_ 
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o Someone would notify the sheriff/judge/police? Yes (1)_ 
o Someone would not give you your spending money? Yes (1)_ 
o Someone would force you to leave where you live? Yes (1)_ 
Distress at inpatient coercive intervention 
o How much did that [seclusion] bother you? 
Not at all (1) _ 
A little bit (2) _ 
Moderately(3) _ 
Quite a bit (4) _ 
Very much (5)_ 
o How much did that [restraints] bother you? 
Not at all (1) _ 
A little bit (2) _ 
Moderately(3) _ 
Quite a bit (4) _ 
Very much (5)_ 
o How much did that [forced medication] bother you? 
Not at all (1) _ 
A little bit (2) _ 
Moderately(3) _ 
Quite a bit (4) _ 
Very much (5)_ 
Distress at community coercive intervention/leverage 
No(O)_ 
No(O)_ 
No(O)_ 
o Here's a statement. "Being placed on OPC bothered me." Please tell me how you feel 
about this statement. 
Strongly Agree (1) 
Agree (2) 
Neutral (3) 
Disagree ( 4) 
Strongly Disagree (5) _ 
o Here's a statement. "Being told to get treatment by a police officer or judge bothered 
me." Please tell me how you feel about this statement. 
Strongly Agree (1) 
Agree (2) 
Neutral (3) 
Disagree ( 4) 
Strongly Disagree (5) _ 
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o Here's a statement. "Being told that I had to go to treatment to get my money 
bothered me." Do you 
Strongly Agree (1) 
Agree (2) 
Neutral (3) 
Disagree ( 4) 
Strongly Disagree (5) _ 
o Here's a statement. "Being told to get treatment in order to keep my housing 
bothered me." Do you 
Strongly Agree (1) 
Agree (2) 
Neutral (3) 
Disagree ( 4) 
Strongly Disagree (5) _ 
Benefits o(P ADs and/or o(getting treatment 
Insight and Treatment Attitudes Questionnaire 
o Have you at any time had mental ("nerve," "worry") problems that were different 
from most other people's? 
o Have you at any time needed treatment (hospitalization or outpatient care) for mental 
("nerve," "worry") problems? 
o Do you now have mental ("nerve," "worry") problems? 
o Do you now need treatment (hospitalization or outpatient care) for mental ("nerve," 
"worry") problems? 
o Is it possible that in the future you may have mental ("nerve," worry") problems? 
o Will you in the future need continued treatment (outpatient care or, possibly, 
hospitalization) for mental ("nerve," "worry") problems? 
o Have you at any time needed to take medications for mental problems ("nerves" or 
"worries")? 
o Do you now need to take medications for mental problems ("nerves" or "worry")? 
o Will you in the future need to take medications for mental problems ("nerves" or 
"worries")? 
o Will you take the medications? 
o Do the medications do you any good? 
For each: 
No 
0 
Possibly Yes 
1 
Yes 
2 
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Drug Attitudes Inventory 
o For me, the good things about medication outweigh the bad 
True (1 )_ False (0)_ 
o I feel weird, like a "zombie", on medication. 
True (1 )_ False (0)_ 
o I take medications of my own free choice. 
True (1)_ False (0)_ 
o Medications make me feel more relaxed. 
True (1 )_ False (0)_ 
o Medications make me feel tired and sluggish. 
True (1 )_ False (0)_ 
o I take medications only when I am sick. 
True (1 )_ False (0)_ 
o I feel more normal on medication. 
True (1)_ False (0)_ 
o It is unnatural for my mind and body to be controlled by medications. 
True (1)_ False (0)_ 
o My thoughts are clearer on medication. 
True (1)_ False (0)_ 
o By staying on medications, I can prevent getting sick. 
True (1 )_ False (0)_ 
o The medications make me less depressed. 
True (1 )_ False (0)_ 
o The medications help me sleep. 
True (1 )_ False (0)_ 
o The medications help me control my moods. 
True (1)_ False (0)_ 
o Medications help me stay out of the hospital. 
True (1)_ False (0)_ 
o The medications make me feel restless, like I can't sit still. 
True (1)_ False (0)_ 
o The medications interfere with my sexual functioning (my sex life). 
True (1)_ False (0)_ 
o The medications make my hands shake or make my muscles twitch or spasm. 
True (1 )_ False (0)_ 
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Pressure Scale 
Overall, the pressures or things people have done to try to get me to get treatment or stay 
in treatment ... 
o Made me more likely to keep appointments and take my medications. 
o Were done by people who tried to be fair to me. 
o Were for my own good. 
o Were not done out of real concern for me. 
o Helped me get [well] and stay well. 
o Helped me gain more control over my own life. 
o Did not make me feel respected as a person. 
o Should be done again in the future if needed. 
o Made me angry. 
For each: 
Strongly 
Agree 
1 
Agree 
2 
Neutral Disagree 
3 4 
Strongly 
Disagree 
5 
PAD Attitude Questionnaire (for consumer and clinician) 
Thinking about a psychiatric advance directive, tell me how you feel about the following 
statements. 
o An advance instruction will help people with serious mental health problems stay 
well 
o People with serious mental health problems should, at some time when they are 
feeling well, write down what kind of medicine or other treatment they want in the 
future if they become very ill. 
o People with serious mental health problems should choose a family member or 
someone they trust, and give that other person the right to make decisions about their 
treatment in the future if they become very ill. 
o Writing down advance instructions for mental health treatment will probably not do 
any good. 
o People with serious mental health problems should talk to their doctor or therapist 
about what to write down in an advance instruction for mental health treatment. 
o Even if someone has written advance instructions for mental health treatment, they 
should always be allowed to change their mind -- even when they are ill -- about 
whether to go in the hospital and whether to take medicine. 
o Doctors and hospitals should pay a legal penalty if they fail to follow a patient's legal 
advance instruction for mental health treatment. 
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People with serious mental health problems should write down advance instructions for 
their treatment in a crisis, because: 
o otherwise they might be put in a hospital against their will or be given medicine 
that they do not want. 
o otherwise they might go without treatment that they need in order to get well. 
o An advance instruction will give them more control over their own lives and what 
happens to them in the future. 
For each: 
Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
5 1 2 3 4 
Treatment motivation and satisfaction 
Treatment Motivation Questionnaire 
I came for treatment at the clinic because: 
o My family/friend said I should get some help (EM) 
o I really want to make some changes in my life (IM) 
o My doctor/therapist told me that I should be in treatment (EM) 
o I won't feel good about myself if I don't get some help (I) 
o I feel so guilty about my problem that I have to do something about it (I) 
If I remain in treatment, it will probably be because: 
o I'll get in trouble if I don't (EM and I) 
o I'll feel very bad about myself if I don't (I) 
o Others will be angry with me if I don't (EM) 
o I'll feel like a failure if I don't (I) 
o I feel like it's the best way to help myself (IM) 
o I don't really feel like I have a choice about staying in treatment. (EM) 
Rate each of the following in terms of how true each statement is for you. 
o I came to treatment because I was under pressure to come. (EM) 
o I am not sure this treatment will work for me. (LC) 
o I am looking forward to getting some personal support (R) 
o I am confident this treatment will work for me (LC) 
o I wouldn't be here if I really had a choice about it (EM) 
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o I decided to come to treatment because I was interested in getting help (IM) 
o I'm not convinced that this treatment will help much with my concerns or 
difficulties (LC) 
o I wanted to openly relate with others in treatment (R) 
o I want to share some of my concerns and feelings with others (R) 
o It will be important for me to work closely with others in solving my problem (R) 
o I am responsible for this choice of treatment (IM) 
o I doubt that this treatment will solve my problems (IM) 
o I look forward to relating to others who have similar problems (R) 
o I chose this treatment because I think it is an opportunity for change (IM) 
o I am NOT very confident that I will get results from treatment this time (LC) 
o It will be a relief for me to share my concerns with others in treatment (R) 
o I accept the fact that I need some help and support from others to beat my 
problem. (IM and RE) 
For each: 
Not at all true 
1 2 3 4 5 
EM=External Motivation subscale 
IM=Intrinsic Motivation subscale 
6 
Very true 
7 
LC=Lack of Confidence in Treatment subscale 
IN=Introject 
RE= Relatedness 
Treatment Satisfaction Scale 
Now, let's talk about the treatment you have received in the past for mental health, drug 
and alcohol problems. Please tell me how you feel about the following statements: 
o I like the services (treatment) that I have received in the past. 
o If I had other choices, I would still get services from the places I have gotten them (in 
the past). 
o Staff where I received services were willing to see me as often as I felt it was 
necessary. 
o I was able to get all the services I thought I needed. 
o Staff where I received services believe that I can grow, change and recover. 
o I felt free to complain. 
o Staff where I received services encouraged me to take responsibility for how I live 
my life. 
o Staff where I received services respected my wishes about who is and who is not to 
be given information about my treatment. 
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o I deal more effectively with daily problems. 
o I am better able to control my life. 
o I am getting along better with my family. 
o I do better in school and/or work. 
o My symptoms are not bothering me as much. 
For each: 
Strongly 
Agree 
1 
Agree 
2 
Barriers to PADs 
PAD Barriers 
Neutral Disagree 
3 4 
Strongly 
Disagree 
5 
You might have difficulty when trying to complete a psychiatric advance directive (or 
advance instruction) because: 
o You don't understand enough about psychiatric advance directives (advance 
instructions). 
True (1 )_ False (0)_ 
o It will take a lot oftime and trouble. 
True (1 )_ False (0)_ 
o It will be hard to find someone or somewhere to get help to complete the psychiatric 
advance directive (advance instruction). 
True (1)_ False (0)_ 
o You don't think anyone will pay attention to your wishes. 
True (1)_ False (0)_ 
o You don't think a psychiatric advance directive (advance instruction) will make any 
difference in your treatment. 
True (1)_ False (0)_ 
o You don't know what to say or write in the psychiatric advance directive (advance 
instruction). 
True (1)_ False (0)_ 
o You don't have anyone you trust enough to make decisions for you. 
True (1 )_ False (0)_ 
o You don't have a doctor you trust. 
True (1)_ False (0)_ 
o You don't like to sign legal documents (or you don't trust legal documents)? 
True (1 )_ False (0)_ 
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Barriers to mental health treatment 
Barriers 
If you think about getting help for mental health, alcohol or drug problems, do you delay 
getting help because ... 
o You think that your problem might get better by itself? 
Yes (1)_ No (0)_ 
o Are you concerned about the cost? 
Yes (1)_ No (0)_ 
o Are you unsure about where to go for help? 
Yes (1)_ No (0)_ 
o Do you think that going for help probably wouldn't do any good? 
Yes (1)_ No (0)_ 
o Is it too difficult to get care because of distance or transportation problems? 
Yes (1)_ No (0)_ 
o Are you concerned about what others might think if you went for help? 
Yes (1)_ No (0)_ 
o Do you want to solve the problem on your own? 
Yes (1)_ No (0)_ 
o Do you think that going for treatment might get you in trouble with the law? 
Yes (1)_ No (0)_ 
o Do you think that going for treatment might get you in trouble with friends or family? 
Yes (1)_ No (0)_ 
o Do you think that if you went for treatment that you might be forced to take medicine 
or treatment that you don't want? 
Yes (1)_ No (0)_ 
o Do you think you might be placed on outpatient commitment? 
Yes (1)_ No (0)_ 
o Do you think that going for treatment might lead to an involuntary hospitalization? 
Yes (1)_ No (0)_ 
o Do you fear being put in seclusion if you are hospitalized? 
Yes (1)_ No (0)_ 
o Do you fear being placed in restraints if you are hospitalized? 
Yes (1)_ No (0)_ 
o Do you fear being forced to take medication if you are hospitalized? 
Yes (1)_ No (0)_ 
o Do you fear being given an injection you don't want if you are hospitalized? 
Yes (1)_ No (0)_ 
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People should have an Advance Instruction because otherwise they might be put in the 
hospital or get medicine they don't want. 
Strongly 
Agree 
1 
Agree 
2 
Neutral 
3 
Working Alliance Inventory (WAf) 
W AI, Consumer 
Disagree 
4 
Strongly 
Disagree 
5 
Next are some statements about how people might think or feel about their clinician. 
Please think about your experiences with (identified clinician) over the past six months. 
o (identified clinician) perceives accurately what my goals are. 
o The goals of my work with are important to me. 
o and I have established a good understanding of the kinds of changes 
that would be good for me. 
o and I are working toward mutually agreed upon goals. 
o I am confident in 's ability to help me. 
o My relationship with is very important to me. 
o and I trust one another. 
o Overall, I can count on for help when I need it. 
For each: 
Strongly 
Agree 
1 
Agree 
2 
W AI, Clinician 
Neutral 
3 
Disagree 
4 
Strongly 
Disagree 
5 
Please answer the following questions about your current relationship with this client. 
o This client and I have a common perception of his/her goals. 
o The current goals of our work are not important to this client. 
o We have established a good understanding of the kinds of changes that would be 
good for him/her. 
o We are working toward mutually agreed upon goals. 
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o I do not feel confident in my ability to help this client. 
o This relationship is important to this client. 
o This client trusts me. 
o This client and I have established a strong working alliance and rapport 
For each: 
Strongly 
Agree 
1 
Agree 
2 
Neutral 
3 
Disagree 
4 
Strongly 
Disagree 
5 
Attitudes towards coercion, used independently and for concordance between clinician 
and consumer 
Consumer attitude toward coercion 
o On the whole you are better off because of this pressure [leverages] to keep 
appointments. 
o On the whole you are better off because of this pressure [leverages] to take 
medication. 
For each: 
Strongly 
Agree 
1 
Agree 
2 
Neutral 
3 
Clinician attitude toward coercion 
Disagree 
4 
Strongly 
Disagree 
5 
o Please indicate how you feel about this statement: "On the whole a patient who is 
often noncompliant with treatment would be better off with these types of verbal 
warnings or reminders to keep appointments." 
o Please indicate how you feel about this statement: "On the whole a patient who is 
often noncompliant with treatment would be better off with these types of verbal 
warnings or reminders to take medications." 
For each: 
Strongly 
Agree 
1 
Agree 
2 
Neutral 
3 
Disagree 
4 
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Relational supports from clinician 
Clinician Knowledge of Consumer 
o Obviously, case managers and clinicians cannot know everything about all their many 
clients. How well do you think you know (CLIENT'S NAME)? 
Only slightly (1) 
Some knowledge, but not as well as average client (2) 
Moderately well (average client) (3) 
Very well, Better than average client ( 4) 
Extremely well, Much better than average client (5) 
Number of months clinician knows consumer 
o For how many months have you provided case management or other clinical services 
for (CLIENT'S NAME) ? 
Relational supports. non-clinician 
o Now I'd like to know about other people in your life. Do you have any close friends 
who are not family members? 
Yes (1)_ No (0)_ 
o Thinking over the last month, is there a family member, friend, or someone else who 
regularly helps you with your mental health treatment? 
Yes (1)_ No (0)_ 
o In time of trouble, can you count on at least some of your family and friends most of 
the time, some of the time, or hardly ever? 
Most of the time (2) 
Some of the time (1) 
Hardly ever (0) 
Duke Social Support Scale 
Now I want to ask you about some of the ways your family and friends help you out. Do 
your family or friends ever help you in any of the following ways: 
o Shop or run errands for you? 
Yes (1)_ No (0)_ 
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o Help you out with money? 
Yes (1)_ No (0)_ 
o Keep house for you or do household chores? 
Yes (1)_ No (0)_ 
o Provide companionship to you? 
Yes (1)_ No (0)_ 
o Give you advice on dealing with life's problems? 
Yes (1)_ No (0)_ 
o Provide transportation for you? 
Yes (1)_ No (0)_ 
o Prepare or provide meals for you? 
Yes (1)_ No (0)_ 
Violent victimization 
In the past six months, 
o Has anyone thrown something at you? 
Yes (1)_ No (0)_ 
o Has anyone pushed, grabbed, or shoved you? 
Yes (1)_ No (0)_ 
o Has anyone slapped you? 
Yes (1)_ No (0)_ 
o Has anyone kicked, bitten, or choked you? 
Yes (1)_ No (0)_ 
o Has anyone hit you with a fist or object, or beaten you up? 
Yes (1)_ No (0)_ 
o Has anyone tried to force you to have sex against your will? 
Yes (1)_ No (0)_ 
o Has anyone threatened you with a gun or knife or other lethal weapon in their hand? 
Yes (1)_ No (0)_ 
o Has anyone used a knife or fired a gun at you? 
Yes (1)_ No (0)_ 
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Consumer views o(trusting relationships and mental health care 
You might have difficulty when trying to complete a psychiatric advance directive (or 
advance instruction) because: 
o You don't have anyone you trust enough to make decisions for you. 
Yes (1)_ No (0)_ 
o You don't have a doctor you trust. 
Yes (1)_ No (0)_ 
o People with serious mental health problems should choose a family member or someone they 
trust, and give that other person the right to make decisions about their treatment in the future 
if they become very ill. 
o People with serious mental health problems should talk to their doctor or therapist about what 
to write down in an advance instruction for mental health treatment. 
For each: 
Strongly 
Agree 
1 
Agree 
2 
Neutral 
3 
Disagree 
4 
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DCAT-PAD 
INTRODUCTION 
I am going to read some in.fonnation and then rn ask you some questions about what I've said. 
If you miss any part of the information, rn repeat it for you once. We'll keep going \Vith 
information and then questions until the end of tl1e interview. Not all of the things I say will 
apply to you personally, but they often apply to people with the same condition that you have 
and who are recerving the same type of treatment Any questiom before we begin? 
UNDERSTANDING SCORING GUIDELI~S: (The following guidelines are used to 
score each item in the Understanding sections of the MacCAT procedure (the 
~isorder, Trea~ment, and Benefits/Risks sections). 
3 point 
rating 
scale 
1 
0 
SCORING GUIDELINES 
Subject recalls the content of the item and offers a fairly 
clear version of it. A verbatim repetition of the 
interviewer's description is not required; in fac;t, if the 
patient only repeats verbatim, probe further to see if 
patient really understands (paraphrase ~n the subject's o~<m 
words ~s preferred). 
Subject shows sc•me recollection of the item content, but 
describes it ~n a way that renders understanding uncertain, 
even after the clinician has 1:\ade efforts to obtain 
clarification from the subject. Examples include responses 
that could possibly indicate understanding but are too broad 
or vague for one to be sure (e.g., for pain of surgery, "It 
might make me feel uncomfortable"), or responses that contain 
some specific and correct piece of information but lack some 
other part of the critical content (e.g., for hallucinations, 
"I might hear things). 
Subject (a) does not recall the content of the item; <Jr \b) 
describes it in a way that is clearly inaccurate; or (c} 
describes it ~n a way that seriously distorts its meaning, 
even after the clinician has made efforts to obtain 
clarification from the patient; or offers a respor.se that 
is unrelated to the ques~icn or unintelligible. 
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CPla. UNDERSTANDL."'G-DISORDER 
Interviewer: Give Understanding-Disorder show card (card 1) to subject and say, 
''Here is a card that you can read along as I read the infonnation to 
you." 
Interviewer Disclosure: Read all 5 elt>mems of the disclosure below then preface patient 
response lVith: "Now please explain in your own \Vords \Vhat I've said. 
Probe (if necessary): Re-Disclose andRe-Inquire (if necessary). 
Disclosure Subject Response 
# 1 Diagnosis 
You are being seen in this clinic because 
you have been diagnosed as. having a 
mental disorder. 
# 2 Feature of Disorder 
Mental disorders affect a person's thinking 
and understanding of \'\nat's going on 
around them. 
# 3 Feature of Disorder 
Mental disorders can include schizophrenia, 
depression. or bipolar disorder. 
# 4 Feature of Disorder 
People with tnental disorders cau 
re-experience increased symptoms in the 
fiJture. which is called a 'relapse.' 
#5 Feature of Disorder 
\Vhen they have a relapse. people with 
mental disorders sometimes have trouble 
making decisions about their treatment and 
medication;;. 
178 
Rating L 
Rating L 
Rating L 
Rating L 
Rating L 
Appendix E (continued) 
APPRECIATION-DISORDER SCORING GUIDELINES: 
3 pcint 
ratir.g 
scale 
2 
1 
() 
SCORING GUIDELINES 
Subjec-c acknowledges that he or she manifests the disclosed 
dis<:.rder, and all or most of the disclosed sympt•::•ms. OR 
S'..lbject does not agree wi":.h the proceeding, b'..lt offers 
reasons that are not delusional and have sow£: reasonable 
explanation (e.g., "Another doctor told me something 
different. In my culture this is ncrt considered unusual •:·r a 
'sickness.'"). 
Subject acknowledges manifesting -:;he disorder and .some of the 
discl•;:.sed sympto:r:'.s but does not acknowledge ether symptoms 
that are critical to unders-canding the disorder and/or its 
treatment. OR Subject disagrees or is ambivalent about the 
existence of the disorder or the s::.rroptoms, but for reasons 
that are Yague or not clearly expressed. 
Subject clearly does nc•t agree that he or she has the 
disclosed disorder, with reasoning based on a delusional 
premise cr some •::>ther belief that seri•::.usly distorts 
reality and does not haYe a reasc•nable basis in the 
patient's culture or religious backgr•ound. OR Subject 
believe.ll that the symptow.s are related to circumstance 
other than a medical/psychiatric disorder (e.g., 
psychiatric symp"t.o:m.s seen simply as consequences c,f 
work-related stress). OR Subject clearly disagrees wi"t.h 
S}':'t.ptoms ,;;;.f disorder, but with n•::. comprehensive explanati•::.n 
offered. 
CPl b. APPRECIATION -DISORDER 
Inquire: A mental disorder is the kind of problem that your doctor thinks you have been 
having. If you have any reason to doubt that, I'd like you to tell me so. What do you 
think? 
0 Agrees 0 Disagrees 0 Ambivalent 
~That is it that makes you agree/disagree? 
Probe fifnece.ssm}~: If patient disagrees or is arnbivalent, description of disagreement 
and patient's explanation. 
Explanatiou 
Appreciatiou-Disorder 
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CP2a. UNDERSTANDING-TREAT:\IENT [PSYCHIATRIC ADVANCE DIRECTIYESJ 
lY~ten .. iewer: Give Understanding-n·eatment show card (card Z) to subject and say, 
"Here is a card that you can read along as I read the information to you. 
Interviewer Disclosure: Re,.ad all 4 elements of the disclosure below then preface patient 
response with: "Now please explain in your own words what I've said 
about this treatment." 
Probe (if necessaTJ'): Re-Disclose and Re-lnquire (if necessary). 
Disclosure Subject Rt>sponse 
#1 Name of Treatment 
Under De\V laws in North Carolina, people 
can complete a form called a psychiatric 
advance directive. 
# 2 Feature Treatment 
On this form, people can describe the kind of 
mental health treatment they want to receive 
if they can't make decisions for themselves in 
the future. 
# 3 Feature of Treatment 
This can include a person's wishes about 
medications, ECT, or admission to a 
hospital. 
# 4 Feature Treatment 
It is important to realize that someone can 
change these fom1s at any time if they wish. 
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Appendix E (continued) 
CP2b. U:'liDERSTANDING-BENEFITS [PSYCHIATRIC ADVANCE DIRECTIVES] 
lntelTiewer: Give Understanding Benefits show card (card 1) to subject and say, 
"Here is a card that you can read along as I read the information to 
you." 
lnte11'iewer Disclosure: Read all4 disclosures below then preface patient response with: 
"Nmv please explain in your mvn words what I've said about benefits 
and risks about psychiatric advance directives." 
Probe (ifneces.smJ~): Re-Di.sclose andRe-Inquire (if necessary). 
DisClosure 
# 1 Benefit 
One benefit is that people can docmuent 
what medications they would want or not 
want in a crisis.. 
#2 Benefit 
Another benefit is that people can say what 
hehspital they would want or not want to be 
admitted to in a crisis. 
# 3 Benefit 
Psychiatric advance directives. can tell 
clinical r.taff how people would ·want to be 
treated \Vhile in the hospital (like being 
treated with respect). 
# 4 Benefit 
Finally, people can choose someone they 
trust (like a family member) to make 
treatment decisions for them if they can't do 
it themselves. 
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Appendix E (continued) 
CP2c. l.:"'NDERSTANDING- RISKS [PSYCHIATRIC ADVANCE DIRECTIVES] 
Interviewer: Give U11derstanding Risks show card (card 4) to subject and say, 
"Here is a card that you can read along as I read the information to 
you'' 
Interviewer Disclosure: Read at! 4 disclosures below then preface patient response ·with: "No\\ 
please explain in your own words what I've said abotlt benefits and 
risks about psychiatric advance directives." 
Probe (ifnecessmy): Re-Disclose andRe-Inquire (if necessary). 
Disclosure Subjed Response 
# 1 Risk 
One risk is that when these forms are used 
people may have changed their mind about 
the treatment thev want. 
# 2 Risk 
Also, their chosen person may not do exactly 
what they say on the forms they would want 
them to do. 
# 3 Risk 
It is important to realize that the hospitals 
people \\'ish to be admitted to may not haw 
beds at the time of a crisis. 
# 4 Risk 
Finally, doctors can still use commitment 
and don't have to pro-vide treatn1ent they 
believe is mauurooriate. 
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Appendix E (continued) 
APPRECIATION-TREATMENT SCORING GUIDELINES: 
3 point 
rating 
scale 
2 
1 
0 
SCORING GUIDELINES 
Subject acknowledges at least .some potential for the 
treatment ·to produce some benefit, and the rea.son is not 
based on a delusional prem.ise or a serieous dist.c•rtion of 
reality. OR Subject does not belie~.re the treatment haa the 
potential to produce sc•me benefit, but offers rea:;ons that 
are not delusi•:mal and have some reas•::mable explanatic•n 
(e.g., explanations that are consistent with the subject's 
religious beliefs Qr cultural background; explanations based 
on past ex:perience with the treatment in c:uestionl . 
Subject does or does not b~lieve that the treatment has the 
potentia! to produce some benefit but the reason is '<.rague or 
does nc•t allc•w the examiner tc' determine whether the reasc•n 
represents delusional thinking or serious distortion of 
reality. OR Subject is ambivalent concerning whether the 
treatment has potential to produce some benefit . 
.Subject acknowledges at least some potential for the 
treat.-:::.ent tc produce some benefi"::;, but fer reason::;~ that 
seem to be based on a delusional premise <::•r a serious 
distortion of reality. OR Subject does not believe that the 
treatment. has the pcotential to produce any benefit, and 
o.ffers reasons that appear to be delu::>ional or as seric .. u::;~ 
distcortion of reality or strongly influenced by extremes in 
affectiYe symptoms {e.g., severe mania, severe depression). 
CPld. APPRECIATION-PSYCHIATRIC ADVANCE DIRECT!\ "ES 
Inquire: Do you think it's possible that filling out a psychiatric advance directive might be of 
some benefit to you" Why or why not? 
D Agrees D Disagrees D Ambivalent 
What is it that makes you agree/disagree? 
Probe (if necessary): So you feel that it is/isn't possible for that PADs to be of some help for 
your condition. Can you explain tlmt to me? \:V1k'lt makes it seem that 
the treatment would/'.vouldn't be of possible benefit to you? 
Explanation 
Appreciation-Treatment L 
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... 
CONSEQUENTIAL REASONING SCORING GUIDELINES: 
3 point 
rating SCOIUNG GUIDELINES 
scale 
2 Subjec-c mentions at least t\"10 specific consequences when 
explaining the choice. The consequences may be related to 
on!..y one or more than c~ne treatment option. The consequemces 
need not be f;~r treatments or alt:.e:::·natives that were in the 
disclosu.re, The cone~eq.1ences must be more Bpecific than 
" will help me'' or " will make me feel better. .. 
Fo~ example: nwith medicatio~, the voices I hear will go 
a"<ay. ,,, 
1 Sub-iect mentions only one specific consequence when 
exp:aining the choice. 
0 Subjec"!:; menti•:>ns no specific CQnsequences when explaining 
the chr::Jice, even after being asked directly whether there 
were nany mere specific reasons why that choice seems 
best. n 
COMPARATIVE REASONING SC."'RING GUIDELINES: 
3 po:Lnt 
ratir.9 SCOR::::NG GUIDELINES 
scale 
2 Subject offers at least one statement tha.t is a c:'Ornparisr;:tn of 
the tw~:. cptionB. The statement Bhoulct include at leas-e one 
,specific difference be 'tween taking che medication and not 
taki::~g it. 
1 Subiect make.s compa::=ison .statement, 
-
but does ne>t im::lude a 
statement c.f a .sl?eci£ic c.or:,.scquer..ce. For example, stating 
that •:Jne chc,ice :1.5 nbettern than the other without 5t.ating 
why. 
0 Subject makes no comparative statements. 
CP2t>. FIRST CHOICE AND REASONING [PSYCHIATRIC ADVANCE DIRECTIVES] 
Choice: If you \Vere giveu the choice between \Vrihng a psychiatric advance directive and not. \vh: 
of these do you think that you would choose? 
Choice _______________________ _ 
Inquire: Tell me what it is that makes that choice better than the other one. 
Probe: Discus<.. explanation to explore reasoning process. 
Explanation 
r-
L Consequential 
i== 
2. Comparative 
..___ 
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GENERATING CONSEQUENCES SCORING GUIDELINES~ 
3 point 
rating SCORING GUIDELINES 
scale 
2 Subject must give at least two reasonable consequences, 
including at least one for ~h of the two inq->.Iiry cr.J.estions . 
N•:>te: Tneae consequenceB must go beyond those in the 
disclosure, and must refer to practical activities or social 
relationahips. For example, if drowsiness is a side-effect 
Clf medication, nr would be sleepyn is nc•t sufficient; "I 
mi<;rht: have t.rc•uble a\~akenin<;r and be late f-c~r work all the 
ti:-::e" is sufficient. 
1 Subject gi '.•es one CIJ:' rot:J.=:-e reasona.ole consequences for one of 
the inquiry questions, but none for th.e >:>ther. 
0 Subject gives no reasor.able CQnsequences., even \'lith 
adequate encourage:r.ent. 
CP2f. GE.~ERATI~G CONSEQUENCES [PSYCHIATRIC ADVANCE DIRECTIVES] 
Inquire-1: We mentioned some bem•fits of psychiatric advance directives, including 
documenting what medications and hospitals people \Vant and choosing a trusted 
person to make treatment decisions if people can't do it themselves. On the othe.r 
hand, hospitals and medications are not guaranteed because beds might not be 
available or doctors think the treatment is medically inappropriate. A trusted 
person may not act exactly as \vanted, too. How might choosing psychiatric 
advance directives affect your life" 
Consequences- I 
Jnquire-2: 
Consequences-1 
\Vlk'lt are some ways that not writing a psychiatric adva11ce directive might affect 
your life? 
Consequences-2 
C.onsequences-2 
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(continued) 
Final Choice Sc~ring G~idelines: 
3 point 
rating SCORING GUIDELINES 
.scale 
2. Subject's states a choice, or subject indicates 
pr·=•fessional or other responsible person (e.g.' 
make the choice. 
desire fc•r 
relatives) 
1 Subject states two or three choices, seerna ambivalent. 
0 Subject states no choice. 
CP2g. FINAL CHOICE [PSYCHIATRIC ADVANCE DIRECTIVES) 
to 
Inquire: \Vhen I asked you a few tninutes ago 'vhether you would choose to write a 
psychiatric advance directive or not, you said that you (would/would not). V.Tllat 
do you think now that \Ve've discussed everything? \\'hich 'votdd you want to do? 
Choice 
Choice 
Logical Consistency Guidelines: 
3 pcint 
rating SCORING GUIDELI~S 
scale 
2 Subject's final choice (in Expressing a Choice) follo•..:rs 
l•:>gically from the subject's Cl~m reasoning, as explained by 
'the subject in respc,nse to the three previous subparts. 
1 It is not clear whethe.r -r.he choice follows logically from the 
subject's CJ~'n reasoning. 
Subject~s choice clea.rly does not f~~llc~w lc•gically from 
0 en.1bjec~' s own reas•:>ning. 
CP2h. LOGICAL CONSISTENCY OF CHOICE fPSYCHIA TRIC ADV. DIRECTIVES] 
(Rate based 011 previous restxmses) 
Examinee's Explanation 
Logical Consistenc:y l 
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CP3a. UN"DERSTA::\'DING-TREATMENT [HOSPITALIZATION) 
Inte11liewer: Give Understanding-Treatrnent show card (card 5) to subject and say 
"Here is a card that you can read along as I read tbe information to yo· 
Jnten'iewer Disclosure: Read al/4 elements of the disclosure below then preface patient resp4 
with: "Now please explain in your own words what I've said about thi! 
treatment." 
Probe (ifnecessaryJ: Re-Disclose andRe-Inquire (ifnecessal')~· 
Disdo<>ure 
#1 Name of Treatment 
In a psychiatric advance directive, you have 
an option to choos.e \'ithether you want to 
come into the hospital or get help 
sotne\""here else during a time of crisis. 
# 2 Feature Treatment 
Psychiatric hospitalization is sometimes 
needed if a person with a mental disorder 
becomes very ilL 
# 3 Feature of Treatment 
A psychiatric hospital stay is at least 
overnight aud usually lasts until a person is 
\Veil enough to go hotne. 
# 4 Feature Treatment 
In a psychiatric hospital, muses and 
doctors are around to take care of and t:re.'lt 
people_ 
Subject Response 
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Appendix E (continued) 
CP3b. lTNDERST ANDI:'\G-BENEFITS/RISKS [HOSPITALIZATION] 
Interviewer: Give Understanding Benefits I Risks show card (card 6) to subject and 
say, "Here is a card that you can read along as I read the information to 
yon." 
Interviewer Disclosure: Read all4 disclosures below then preface patient response with: "Now 
please explain in your own words what I've sa.id about benefits and risks of 
this treatment'' 
Probe afnecessary): Re-Disclose andRe-Inquire (if necessary). 
Disdosur£' Subjf'ct R£'S[lOUS£' 
# 1 Benefit 
One benefit i'> that psychiatric hospitals 
provide a safe envirotnnent >vhere people 
can't hurt themselves or others. 
# 2 Benefit 
Another benefit is that medications can be 
adjusted more quickly. 
# 3 RiY\: 
Ho\vever, psychiatric hospitals do limit 
some freedoms, such as smoking cigarettes 
and drinking ale ohol 
#4 Risk 
Hospitalito may also not pro-vide tn:~atments 
yon like. 
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Appendix E (continued) 
APPRECIATION-TREATMENT SCORING GUIDELINES: 
3 p4Jint SCORING GUIDELINES 
rating 
sea :i.e 
z 3'-tbject ack.no"'' ledges a 'I: least some potential for the 
treatment to prc:>duce SO!!le benefit, and the reason is ne>t 
based on a dehudonal premise or a serious distortic>n of 
reality. OR subject does not believe the treatment has the 
potential 11:0 produce some benefi11:, but offers reasons that 
are not delusional and have s1~me reasonable expla:1aticn 
(e.g., explanati,:;ns that are consis1:.ent with the subject's 
religious beliefs or cultural background; explanatie>ns based 
Qn past experience with the treatment in question) . 
1 Subject does does not believe chat the treatment has the or 
potential to produce some benefit but the reason is vague or 
does not allo•,.; the examine=: to dete=mine whet-her '.:;!'le reasc•n 
represents delu.sional thinking or serious dist•:•rticm <::Jf 
:=eality. OR subject ~s ambivalent concerning whether the 
treatment has potential to prc•duce s;,;:~roe benefit. 
0 subject acknowledges at least some potem:ial fc:;r the 
treatment t•:> prc.·duce some be.nefit, but for reasons t}:at 
seem tc be based •::tn a del'usional premise or a serious 
distorti>:~:1 c;,£ reality. OR Subject does n~~t believe that the 
treatmen-c has the potential to pr•:•d•.1ce anv benefit, and 
offers reasons that appear to be delusion~l or as serious 
distortion o£ reality or .strongly influenced by extremes in 
affective syn;pt•::~ms. (e.g.' severe mania, .severe depression) . 
CP3c. APPRECIA TIOX- HOSPITALIZATION 
Inquire: Do you think that if you became very ill that psychiatric hospitalization might be of 
some benefit to you'' \Vhy or why not~ 
0Agrees Ooisagrees D Ambivalent 
Probe (if necessru:y): So you feel that it is/isn't possible for that treatment to be of some help 
for your condition. Can you explain that to me? Wbat makes it seem 
that the t1·eatment '\.Vould/wouldn't be of possible benefit to you'? 
Explanation 
Appreciation-Treatment r--
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CONSEQUENTIAL REASONING SCORING GUIDELINES : 
3 point 
rating SCORING GUIDELINES 
scale 
2 Subject mentions at least two specific consequences when 
explaining the choice. The consequences may be related to 
only one or mc>re than t:•ne t.reatment 1:;.ption .. The consequences 
need not be for treatments or alternatives that we1:e in the 
disclosure. The consequences must be rno:::e specific than 
.. wil: help me" c•r " will make me feel better. .. 
For example: "With medication, the vc'»ices I hear will go 
away. .. 
1 Subiect mentions onl:,.• one specific consequence when 
explaining the choice. 
.~ Subject menti.:-•n.s no specific consequences when exp:aining 
'J 
the choice, after being asked directly whethe::: there even 
o;.~1e.re "a!'l.y more specific reasctns why t.hat choice seems 
best. .. 
COMPARATIVE REASONING SCORING GUIDELINES : 
3 point 
rating SCORING GUIDELUlES 
scale 
2 Subject offers at least c•ne statement that is a Ct:mLparison of 
the two c•ptions. The statemen1: should include at least ,Jne 
specific difference bet\..reen taking the medication and not 
taking it. 
1 Subject makes comparison statement, but dc•es not include a 
statement C•f a specific c.::>nsequence. For example, stating 
1:hat one choice is ubettern than the c~ther withc<ut stating 
why. 
0 Subject makes no comparative statements. 
CPJd. FIRST CHOICE AND REASONING [HOSPITALIZATION] 
Choice: If you became very ill and were given the choice between going to a psychiatric 
hospital or not. which of these do you think that you would choose? 
Choice __________________________ _ 
Inquire: Tell me what it is that makes that choice better than the other one. 
Probe: Di<>cuss explanation to explore reasoning process. 
Explanation 
1. Consequential 
2. Comparative 
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GENERATING CONSEQUENCES SCORING GUIDELINES: 
3 po~nt 
rating 
SCORING GUIDELINES scale 
Subject !':mst give at least two reasonable consequences, 
including at least one for each of the t'i'IO inquiry questi.:•ns. 
2 Note: These consequences must go beyond those in the 
disclosure, and must refer to practical activities or social 
relati<:tnships. For example, if drowsiness is a side-effect 
of medication, "I would be sleepy" is not sufficient; "I 
might have trouble awakening a."'ld be late for work all the 
1 time" ~s sufficient. 
Sul:lJect g~ves i.:f!'le c'r more reasQnaJ:l.Le consequenc-es :cor one O:t 
the inquiry que.stion.s, but none for the other. 
0 Subject giYes no reasonable consequences, even with 
adequate encoura.ge!:'lent. 
CP3e. GENERATING CONSEQUENCES (HOSPITALIZATION) 
Inquire- 1: I told you about some of the possible benefits from going to the hospital if 
someone with mental disorder bec.ame very ill. If you were very ill, bow vvould 
going to the psychiatric hospital affect ymu life? 
Consequences- I 
Inquire-2: 
Con.seque.nces-1 [ 
What ·would happen to you if you were very ill and you didn't go to a psychiatric 
hospital? 
Consequeuces-2 
Consequeuces-2 [ 
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Final Choice Soaring ~ddelines: 
3 po~nt 
rating SCORING GUIDELINES 
scale 
2 Subject's states a choice, or subject indicates desire for 
professicr.al •:>r c•ther responsible person {e.g., relatives) to 
make t.!":.e choice. 
1 Subject states two or three choices, seems at!'.bi•,•alent. 
0 Subjec'C states no choice. 
CP3f. FINAL CHOICE [HOSPITALIZATION] 
Inquire: 
Choice 
When I asked you a few minutes ago whether you would choose to go to t1Ie 
psychiatric hospital or not if you becrune very ill, you said that you (would/would 
not). What do you think nmv that we've discussed everything? \Vhich would you 
>vant to do? 
Choice [ 
Logical Consistency Scoring &'uidelines: 
3 point 
rating SCORING GUIDELINES 
scale 
2 Subject's final choice (in Expressing a. Choice) follc•ws 
logically :fr1Jm. the subject's own reasoning, as explained b~l 
the subject in response to the three pre"'TiOU3 subpart.s. 
1 It is not clear whether the choice follows logically from the 
subjec1:.'s own reasoning. 
Subject's choice clearly does not follow logically from. 
D subject' .9 Ct"Wn reasoning. 
CP3g. LOGICAL CONSISTENCY OF CHOICE [HOSPITALIZATION) 
(Rate ba.-.ed on previous response<;) 
Examine£'s Explanation 
Logical Consistency D 
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Consumer Demographics and Functioning 
o What is your birth date? 
o Which of the following best describes your racial background: 
White 
Black 
American Indian 
Asian 
Pacific Islander 
Alaskan Native 
Other (specify below)_ 
o Are you Spanish/Hispanic/Latino(a)? Yes(l) _ No(O)_ 
o RECORD GENDER AS OBSERVED Female Male 
Brief Psychiatric Rating Scale 
SoDlart~ic~----------------------------------------------------------------~ 
Somatic Coucer·n Que"Stions 
Have you been cm1cemed about your phy•m:al health" 
Have you had any problem~ with :your health lately? 
Have you had any ph~ical1llness or ~een a medical doctor? 
[Follo'.v-up to determine the extem ofthe >;l~ect's concem about the~e 
problems E.g .. how nmch do these headaches ·worry :y-ou?] 
X 1. SOMATIC CONCERN:. Degree of concen.1 over pre:>ent bodily health. Rate the 
degret> to which physical health is perceived as a problem by the patient, whether the 
complaint;, ha;·e a reahstic basis or not. Do not rate 01ere reporting of somatic 
symptoms. Rate only concerns for (or worrying about) phy-sical problems (real or 
imagined). 
1 Not Reported. 
2 Very Mild; Occasionally is somewhat concerned about body. symptoms, or 
physical illness. 
3 r.·:Iild; Occasionally i<> moderately concerned, or often is somE-what. 
rvioderate Severe; Occasionally i!'> ve:ry concerned or often is rnoderately concerned .. 
5 Moderately Severe; Often ts very concerned. 
Sevt>re: h very concen.1e>d most oftht> time. 
7 Very Severe; Is very concerned neat·ly all of the time. 
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Anxiety 
~--------------------------------------------------------------. 
Anxiety Questions 
Have you felt ~-orried or anxiou~? 
Do tmple~ant thoughts constantly go round and roUlld m yotu- head? 
Are there {other) things that you are worried about? 
Did yow heart beat fast (or 5\Ve.ating, trembling, choking)? 
Has 1t Ulte-rfered v..jth yow ability to perform yow urmal activitiesl\vork:? 
[follow-up to detenn1ne the extent of tlre subject's anxiety about these things. Do 
iliey make it hard for you to fall asleep? How much do yotu- money problems worry 
;-ou'~] 
X2. An..-.dety: '\Vony, fear. or over concem for present or future. Rate solely ou 
the basis of verbal repmt of patient's own subjective experiences. Do not infer 
anxiety from physical signs or from neurotic defense mechanisms .. Do not rate if 
restricted to somatic concern. 
1 Not reported. 
2 Very mild; Occasionally feels somewhat anxious. 
3 Mild; Occasionally feels moderately an .. '{ious, or often feels somewhat anxious. 
4 Moderate; Occasionally !eels very anxious, or often feels moderately an.x:ious. 
5 Moderately Severe; Often feels very anxious. 
6 Severe: Feels very anxious most of the time. 
7 Very Severe; Feels very aiL~ous nearly all ofthe titne .. 
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Emotional \Yithdrawl 
X3. Emotional "''ithdrawaL Deftciency in rel<1ting to the iuteniewer aud to the 1111erview 
1.ituation. Overt manifestations ofthis deficiency include poor/absence of eye contact, failure 
to orient oneself physically tO\vard the interviewer. and a general lack of involvement or 
engagement in the interview. Distinguish from BLl..TNTED AFFECT, in \Vhich deficits in facial 
expression, body gesntre, and voice pattern are scored. Rate on the basis of observations 
made during the interview. 
1 
2 
3 
5 
6 
7 
Not Observed. 
Very Mild: e.g., Occasionally exhibits poor eye contact. 
Mild; e.g .. As above, but more fi·equent. 
Moderate; e.g .. Exhibits little eye contact, but still seems engaged in the interview and 
i<> appropriately re<oponding to aU question<>. 
Moderately Severe; e.g .. Stares at floor or orient'> self away from inteniewer, but still 
seems IIlOderately engaged. 
Severe; e.g .. A.s above. but more persistent or pervasive. 
Ve1y Severe-; e.g .• Appears "spacey" or "out of it" (total absence of e-motional 
relatedness) and is disproportionately tminvolved or unengaged it1 the i:ntenriew. (DO 
NOT SCORE IF EXPLAINED BY DISORIENTATION) 
Conceptual Disorganization 
X4. Conceptual Disorganization: Degt'e'e of speech incomprehensibility. Include any type of 
fonnal thought disorder (e.g., loose associatiom;, incoherence, fltght of ideas, neologisms). 
DO NOT include mere circumstantiality or pressured speech, even if marked. DO NOT rate 
on the patient's subjective in1pressions (e.g., "My thoughts are racing. I can't hold a thought" 
''My thinking gets all mixed up.") Rate 01\o"L Y on the basis of observations made during the 
iutervie\V. 
l Not Observed. 
2 Vety ~~Iild; e.g., Somewhat vague, but of doubtfill clinical significance. 
3 Mild:. e g., Frequently vague, but the interview is able to progress smoothly; 
occasional loosening of associations. 
4 Moderate; e.g., Occasional in'e'!evant statements. infrequent use of neologisms, or 
moderate loosening of associations. 
5 Moderately Seve-re; As above-, but more fi·et1uent. 
6 Seve-re; Formal thought disorder is present for most ofthe intervtew, and the 
inte-rview is severely stt·aine-d. 
7 Very Severe; Very little coherent infonuation can be obtained. 
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Guilt Feelings 
Guilt Feeling~ Questions 
Have you been thinking about pa~t problems? 
Do you tend to blame yourself for things that have happened? 
Have you done anything ymrre still ashamed of'? 
Are there things that you ha\·e done in the past that you feel guilty about? 
[Follow-up to deterruine the extelll of the subject's guilt. E.g. how badly 
do you feel when you think about having broken off your engagemetlf?] 
X5. Guilt Feelings: Ovt>tTOIH."et·n or retnorse for past behavior. Rate on the patient';, 
subiective experience!. of wilt as evidence by verbal report. Do not infer guilt feelings 
from depression, anxiety or neurotic defenses. 
1 Not Reported. 
2 'lery Iv!ild; OC'casionally feels sontevdlat guilty. 
3 Mild. Occasional!)' feels moderately guilty or often feels somewhat guilty. 
4 Moden'ltt>: Occasionally fet-ls very guilty or often feels moderately gmlty. 
5 Moderately Severe; Often feels very guilty. 
6 Severe~ Feels very guilty n1ost of the tUne or encapsulated deltl~ion of guilt. 
7 Very Severe: Agonizing constant feeling of guilt or pervasive dehlsion(s) of guilt. 
Tension 
X6. Tension: Rate motor restlessne.ss (agitation) observed dm-ing the interview. DO 
NOT rate on the basis of subjective experiences reported by the patient. Disregard 
su~pected pathogenesis (e.g., tardive dyskinesia). 
1 Not Observed. 
2 Very Mild: e.g, Occasionally fidgets.. 
3 Mild; e.g., Frequently fidgets. 
VI 
Moderate; e.g .. Constantly fidgets or frequently fidgets, wrings hands and pulls clothing. 
5 Moderately Severe: e.g., Con<JtanUy fidgets. wrings hands and pulls clothing. 
6 Severe: e.g .. Cannot remam seated (i.e., must pace). 
7 Very Severe; e.g., Paces in a frantic matme1·. 
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Mannerisms and Posturing 
X7. Mannerisms and Posturing: Unusual and unnatural motor behavior. Rate only 
abnormality of movements. Do not rate simple heightened motor activity here. Consider 
tl·equency, duration and degree of bizarreness. Disregard suspected pathogenesis. 
1 
2 
3 
5 
7 
Nor Observed. 
Very Mild: e.g., Odd behavior but of doubt:fhl clinical significance. e.g., occasio11:1l 
unprompted smiling, infrequent lip movements. 
Mild; e.g., Strange behavior but not obviously bizarre, e.g., infrequent head-tilting 
(side to side) in a rhythmic fashion, intermittent abnormal finger movements. 
1vfoderate; e.g .. Assumes mmatural position for a brief period of time, infi·equent 
tongue protrusions, rocking, facial grimacing. 
Moderately Severe; e.g., Assumes and maintains unnatural position throughout 
intervievv, unusual movements in several body areas. 
Severe; As above, but more frequent, intense, or pervasive. 
Very Severe; e.g., Bizarre posturing throughout most of the intervieiv, continuous 
abnorm1lmovements in several body areas. 
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Gnndiosity 
Gmndiosity Que~tions 
ls there a 'ipe<:ldl ptupose or mission to your life? 
Have you thought that you might be somebody rich or famous? 
Do you have powers or abilities that most people don't have? 
[lF YES:] Could you tell me about them? 
[Follow-up to ~tenuine the extent oftll.e subject's belief in the uruqueness ofhi'>''1J.er 
powers. E.g., how many people do you think can play the guitar as well as you do?) 
vv 
X8. Grandiosity: Inflated self-esteem (self-confidence) or inflated appraisal of one's talents. 
powers. abilities, accomplishments, knowledge, importance, or tdentity. Do not score mere 
grandiose quality of claims (e.g., "I'm the worst sitme.r in the vwrld." "The entire country is trying to 
kills me") unless the guilt/persecution is related to some special exaggerated attributt> of the 
individuaL Aho, the patient must claim exa~&rerated attributes; e.g., If patient denies talents, 
powers. etc., even tflle/she states that others inclicate that he/she has these attributes, this item 
should not be scored. 
1 
2 
3 
5 
7 
Not reported. 
Very mild; e.g., Is more confident than most people, but of only possible clinical 
s.ignillcance. 
Mild; e.g., Definitely inflated self-esteem or exaggerates talents some>vhat out 
of proportion to the circumstances. 
l\·1oderate; e.g., Inflated self esteem clearly out of proportion to the 
circumstances, or suspected grandiose deluston(s). 
Moderately severe: e.g., A smgle (defuute) encapsulated grandiose delusion. or 
multiple (definite) fragtnentary grandiose delusions. 
Severe; e.g .. A single (definite) grandiose delusion/delusional system, or 
multiple (definite) grandtose delusiom that the patient seems preoccupied \Vith .. 
Very Severe; e.g., As above, but nearly all conversation is dirE>cted tmvard the 
patient's grandiose delusion(s). 
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Dt'pre<>~ive :Mood 
Depressive l\iood Questions 
Ha"~:e you felt tull1appy or depressed? 
Have you been feeling sad lately? 
[Follow-up to determine the extent of the subject's sadness (duration, frequency)] 
How much of the time? 
.1\re you able to SW1tcll your attention to more pleasant topics when you V.'<Ult to? 
Have your interests U1 work, hobbies, social or recreational activities changed" 
Has it interfered \\'i.tll your ability to perfonn your l.ISUal activities/work? 
X9. Depressive Mood: Subjective report of feeling depressed, blue, "dO\vn in the dumps, etc. Rate 
only the degree of repotted depression. Do not rate on the basis of inferences concerning depression 
ba'>t>d upon general rt>tardation and somatic complaints. 
1 Not Rt>ported. 
2 Very Mi1d; Occas1onal1y teels somewhat depressed. 
3 Mild; Occasionally feels moderately depressed or often feels somewhat depressed. 
4 Ivioderate; Occasionally feels very depressed or often ft>els moderately depre:.sed. 
5 Moderately Severe; Often feels very depressed. 
£ Severe; Feels very depressed most ofthe time. 
7 Vety Severe; Feels very depressed nearly all of the time. 
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Hostirli~n~.·---------------------------------------------------------. 
Hostility QuesUous 
How have you beeu getting along with people (family, board and-care residents, 
co-workers)? 
Have you been irritable or gmmpy lately? 
Have you beetl involved in any argurnents or fights? 
Are there people at vmom you are angry? 
[IF YES:] what is 1.t about them that annoys you? 
[FoUow-up to determine extent of anger. E.g., how liil.JCh do you find yourself 
thinkmg about your neighbor? Do you ever yell at him? Throw things at him? Get 
into physical fights \vith him?] 
X10. Hostility: Animosity, contempt belligereuce. disdain for other people outside the 
interview situation. Ratt> solely on the basis of the verbal rep01i of feelings and actions of 
the patients toward others. Do not infer hostility fi·om neurotic defenses,. anxiety, or 
somatic complaints. 
1 Not reported. 
2 Very mild; Occasionally feels somewhat angry. 
3 Mild: Often reels somewhat angry or occRsionally feels moderRtely Rngry. 
4 Moderate; Occasionally teels very angry or often feeLs moderately angry. 
5 Moderately Severe; Often feels very angry. 
6 Severe; Has acted on his anger by becoming verbally or physically abustve 
on one or t\:vo occasions. 
7 Very Severe; Has acted on his anger on several occasions. 
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Suspiciousness 
Suspiciousness Questions 
Do you ever feel wcomfortable as if people are watching you? 
Is anyone trying to harm or interfere with you in any way? 
.1\.re you concerned about anybody's intentions to\vard you? 
Have you felt that any people are out to get you? 
[IF YES:] Could you tell me what they tried [are trying) to do to you? 
[Follow-up to determine extent of SU'>piciousness_ E.g., do you have any doubt that 
your protessor gave you an ''F' to get even w-ith you for disagreeing with him in 
class?] 
Xl L Suspiciousness: Belief( delusional or otherwise) that others have now. or have had in the 
past, malicious or discriminatory intent toward the patient. On the basis of verbal report rate 
only those suspicions which are currently held. \Vhether they concem past or present 
circumstances. 
1 Not reported. 
2 Very Mtld; Rare mstances of distrustfulness which may or may not be \VatTa11ted t 
the situation. 
3 Iviild; Occasional instances of suspiciousness. 
4 Moderate; More frequent suspiciousness. 
5 Moderately Severe: Pervasive suspiciousness. 
6 Severe; Definite delusion(s.) of reference or persecution that is/are not wholly 
pervasive (e.g., an encapsulated delusion). 
7 
Very Severe; As above, but more widespread. frequent, or intense. 
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Hallurinatory Behavior 
Hallucinatory Behavior Question$ 
In the last week, have you heard any sounds or people talking to you or about 
you \\ilen there has been nobody around? 
Have you seen things that other people couldn't see? 
Have you seen auy visions or smelled any smells others don't seem w notice? 
Have these expenences interfered With your ability to perform your Uilual 
activities/work? 
[IF 'YES: J Could you tdl me what you heard [sa\'\'?] 
[IF AL'DITORY:J Were the voices coming from outside of your head? 
[Follow-up to cletennine the extent of hallucinatory perceptioos. E.g., hmv often do 
you hear the voices? Do they ever leave you aloue?J 
X 12. Hallucinatory Behavior: Perceptions (in any sense modality) in the absence of an identifiab 
external stimulus. Rate only those experiences that have occun·ed during the last \veek DO NOT 
rate "voices in my head" or "visions in my mind" unless the patient can differentiate between thes 
experiences and thoughts. 
1 Not Reported. 
z Very Mild; Suspected hallucinations only. 
3 Mild; Definite halhtcinations, but insignificant, infrequent,. or transient (e.g., 
occasional fonnless visual hallucinations, a voice calling the patient's name). 
5 
6 
7 
Moderate; As above, but more fi:·equent or extensive (e.g., fi·equently sees the 
devil's face, two voices canyon a lengthy conversation). 
Moderately Severe; Hallucin.l\tions are experienced nearly evety day or are a 
source of extreme distress. 
Severe: As above and has had a moderate impact on the patient's behavior (e.g .. 
concentration difficulties leading to impaired work functioning). 
Very Severe; As above and bas had a severe impact (e.g., attempts suicide in 
response to command hallucinatio11s). 
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Motor Retardation 
X 13. Motor Retardation: Reduction in energy level evidenced in slowed movements. Rate on 
the basis of observed behavior of the patient only. Do not rate on the basis of the patient's 
subjective impression of this or her own energy level. 
1 
3 
5 
7 
Not Observed. 
Very M:ild: Of doubtful clinical significance. 
rvfild; e.g., Conversation is somewhat retarded, movements somewhat slo1ved. 
Modt>rate; £>.g., Conven>ation is notably retarded but not strained. 
Moderately Severe; e.g., Conversation is strained, moves very slowly. 
Se'\·ere; e.g .. Conversation is difficult to maintain. hardly moves at all. 
Very Severe; e.g., Conversation is almost impos~ible, does not move at all 
tlu·oughout the interview. 
Uncoope~·ativeness 
X14. Uncooperativeness: Evidence of resistance, unthendliness, resenbnent, and lack of 
readine~s. to cooperate with the interviewer. Rate so1£>ly on the basis of the patient's attitude and 
responses to the interviewer and the iutervie·w situation. Do not rate ou the basis of reported 
resentment or uncooperativeness outside the interview situation. 
1 Not Observed. 
2 Very M:ild; e.g., Does not seem motivated. 
3 Mild; e.g., Seems evasive in certain areas. 
4 Modt>rate; e.g .. Monosyllabic, fails to elaborate spontaneously .. somewhat 
unfi:iendly. 
5 Moderately Severe; e.g., Expresses resentmeut and is unfriendly throughout 
the interview. 
6 Severe; e.g., Refhse~ to answer a number of questions. 
7 Very Severe; e.g., Re:fi.1ses to atlS'\ver most questions. 
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Unusual Thought Content 
Unu~ual Thought Content Questions 
Do you sometime:; have ideas that other people might coru;ider unusual? 
Thd you see any references to yourself on TV or in tlre newspaper? 
Do you have a special relationship with God'? 
How do you explain the things that hav'e been happening (speed~;'?) 
Have you felt that you were u11der the comrol of another person or force? 
[IF YES) Could you tell111e about them? 
[Follow-up to detennine the oddness of the thoughts] 
X 15. Unusual Thought Content: Severity of delu~ions of any t;y;pe - consider conviction and effect on 
actions. Assume full convictions if patient has acted on his of her beliefs. 
1 
2 
3 
4 
5 
6 
Not Reported. 
Very mild; Delusion(s) su!>pected or likely. 
M1ld; At times, patient questions his or her belief(s) (partial delm.ion). 
Moderate: Full delusional conviction, but delusion(~) has little or not influence 
on behavior. 
~vloderately Severe; Full delusional conviction, but delnsion(s) has only 
occasional il.npact on behavior. 
Severe; Dehlsion(s) has significant effect, e.g., neglects responsib1hties because 
of preoccupations with behefthat he/she is God. 
7 Vety Severe; Delnsion(s) has major impact, e.g., stops eating because believes 
food is poisoned. 
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Blunted Affect 
Xl6. Blunted Affect: Dimimshed affective responsivity. as characterized by deficits m facial 
expression., body gesture,, and voice pattern. Distinguish from En10houal Withdrawal, iu which the 
focus i~ on interpersonal impainnent ratht>r than affect. Consider degree and consistency of 
i:mpainneut. Rate based on observations made during interview. 
1 Not Observed. 
2 Very mild; e.g., Occasionally seems indifferent to material that is usually 
accompamed by some show of emotion. 
3 Mild; e.g., Somewhat diminished facial expression or some\vhat monotonous voice 
or somewhat restneted gestures. 
4 Moderate; e.g, As above, but more intense, prolonged. or frequent. 
5 Moderately Severe; e.g., Flattening of affect, including at leas:t two of the three 
features: severe lack of facial expresston, monotonous vo1ce. or restricted body 
gestures. 
6 Severe:. e.g., Profound flattening of affect. 
7 Very Severe;. e.g., Totally monotonous voice and total lack of expressive gestures 
throughout the evaluation. 
Excitt>ment 
Xl7. Excitement: Heightened emotional tone, including irritability and expansiveness (hypomanic 
affect). Do not infer a:tTect from statements or grandiose delusions. Rate based on observations made 
during the interview. 
1 
2 
3 
4 
5 
7 
Not Observed. 
Very Mild and of doubtful clinical significance. 
Mild; e.g .. Irritable or expansive at times. 
Moderate: e.g., Frequently irritable or expansive. 
Moderately Severe; e.g., Constantly irritable or expansive or at times t>trraged or euphonc. 
Severe; e.g., Enraged or euphoric tlu·oughout most ofthe intervie.\v. 
Very Severe; e.g., As above, but to such a degree th.<~t the intervie,:v· must be terminated 
prematurely. 
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Disorieutation 
X18. Disonentation: Confusion or lack of proper association for person place or time. Rate based on 
observatiOns made dm'ing the intervu?'W (and information from Section L [cognitive fundioning]). 
1 Not Observed. 
2 Very mild; e.g., Seems somewhat confused. 
3 Mild: e.g., Indicates 1991 when in fact il is 1992. 
4 Moderate: e.g., Indicates 1978. 
5 Moderately Severe: e.g., Is unsure \Vhere he/she is. 
6 Severe: e.g., Has no idea where he/she is. 
7 Vf!!ry Severe: e.g .. Does not know who be/she is. 
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Global Assessment of Functioning 
GLOBAL ASSESSMENT OF FL~CTIONING SCALE 
Yl. Con:sid<:>r psychological, social, and occupational ftmctioning on a hypothetical 
continuum of mental health-illness. Do not include impairment in functioning due to 
physical (or environmental) limitations. 
Code (Note: Use intermediate codes when appropriate, e.g., 45, 68, 72.) 
100 
91 
90 
I 
81 
80 
I 
71 
70 
I 
61 
60 
I 
51 
50 
I 
41 
40 
I 
31 
30 
J 
20 
I 
11 
10 
I 
I I I I 
Superim· funt'tioning in a wide rauge of acthities, life's problem-; never o;eem to get out of band, is 
sought out by others because of his or her many posith·e qualities. No sy1nptoms 
Absent or· minimal symptmns (e.g .. mild amciety before an exam). good functioning in all areas, 
inh.•1·ested aud involved in a wide unge of adiYiti&s, socially effectivto, generally satisfied with life, 
no more than en•t·yday problems or concern~ (e.g .• au occa!iional argument >vith family members). 
If sympt01ns a1·e prestont, they a1·e tran~ient and expectable reactions to p<>ychmmdal stres.sm·s 
(e.g .• difficulty concentrating after family argument); no more than slight impairment in social, 
occupational, or school functioning (e.g .. temporarily fulling behind in school work). 
Some mild symptoms (e.g., depressed mood and mild insomnia) OR soJnt' difficulty in social 
occupational, m· school functioning (e.g .. occasional truancy. or theft \Vithin the household), but 
generally fltllctioning pretty "IWII, has some meaningftd inte1·pe1·sonal relationships. 
Moderate symptmn~ (e.g., flat affect and circumstantial speech, occasional panic attacks) OR 
moderate difficulty iu social, occupational, or school functioning (e.g., fe>v friends, conflicts with 
peers or co-·worker~). 
Serious symptoms (e.g., suicidal ide.ation. severe obsessional rituals.. frequem s.hoplifting) OR any 
serious impainnt'nt in $Odal, occupation."\!, or $Chool functioning (e.g., no friends, unable to keep a job). 
Some impair·ment in r·eality testing or cmnmtmication (e.g., speech is at times illogical, obscure, or 
irrelevant) OR 1najor impairmt'nt in SE'\'eral areas, such as work or school, family relations, judgment, 
t.hiuking, or mood (e.g., depressed man avoids friends, neglects family, and .is unable to work; child 
frequently beats up yo\lllger children, is defiant at home, and is failing at !>chool). 
Behavim· i>'> considerably influenced bJ>· delusions or hallucinations OR 'lt'riou5 impairment in 
c01mnunication or judgment (e.g ... oometimes incoherem, act.s grossly inappropriately, suicidal 
preoccupation) OR inability to function in almost all art'as (e .. g .. stays in bed all day: no job, home, Ot" 
friends). 
Some danger of hm·ting s&lf or others (e.g., suicide attempts without clear expectation of death; freq 
uently violent; manic excitement) OR occa!iionally fails to maintain minimal personal hygiene (e.g., 
smears feces) OR gross im}lairment in communication (e.g., largely incoherent or mute). 
Ptorsistent danger of severely hurting self or oth£>n (e.g., recurrent violeuce) OR pt>rsistent 
inability to tnaintain 1ninimal personal hygiene OR serious suicidal act with dear el.-pectation of 
death. 
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Alcohol and drug use 
o In the last 30 days ... 
Have you felt you ought to cut down on your drinking? 
Yes(l) _ No (0) _ 
Have people annoyed you by criticizing your drinking? 
Yes(l) _ No (0) _ 
Have you felt bad or guilty about your drinking? 
Yes(l)_ No(O)_ 
Have you had a drink first thing in the morning to steady your nerves or get rid of a 
hangover (eye-opener)? 
Yes(l)_ No(O)_ 
o In the last 30 days ... 
Have you felt you ought to cut down on your drug use? 
Yes(l)_ No(O)_ 
Have people annoyed you by criticizing your drug use? 
Yes(l) _ No (0) _ 
Have you felt bad or guilty about your drug use? 
Yes(l) _ No (0) _ 
Have you taken drugs to steady your nerves or to stop symptoms of withdrawal? 
Yes(l) No (0) 
- -
Clinician demographics and professional characteristics 
o What is your birth date? 
o Which of the following best describes your racial background: 
White 
Black 
American Indian 
Asian 
Pacific Islander 
Alaskan Native 
Other (specify below)_ 
o RECORD GENDER AS OBSERVED Male 
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o How many years of mental health experience have you had (excluding time spent in 
training)? 
o What is your highest degree? (Check one) 
High school 
Some college 
BAIBS 
MSW 
M.A./M.S./M.Ed./Other Master's 
RN 
M.D 
Ph.D. 
Other (Specify Below) 
o For how many clients do you currently act as the primary case manager, clinician or 
care coordinator? 
PAD Purposes 
PL \Vhen yon think about nmking a psychiatric advance directives there are several things 
that may be more or less :important to you. Please look at t11ese 5 cards that have several 
things that may be important to you. Please put the~>e 5 cards in order to show bo'v 
in1portant these things are to yuu. Start with the one that is most important to you and 
work your way down to the one that :i.s least important. [Show Blue Cards and read 
choices] 
{Interviewer: Record answers so that: 
D 
D 
D 
D 
D 
The LEAST important = 1 
And the MOST in1portaut = 5} 
a. Being free to change my tnind about 111y treatlneut even when I am 
very ill 
b. Getting the treatment that Ill)' doctor tlunks 1s best for me. 
c. Having a fauuly or friend Inake decisions about my u·eall'nent \Vhen 
I am very ill. 
d. Avoiding treahnent I don't want. 
e. Getting whatever treahnent that woa·ks best for u1e. 
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You said that [most important--card =5] was most important to you [confrrm]. [Next card= 
5] is somewhat less impot1ant than [card= 5]. Can you put these card on this scale so it 
shows how important it is to you on a scale of 1 to 10? 
So on a scale of 1 to 10 how Important is [card:::: 5] to you? 
[Repeat for card = 4 to card= 1.] 
--10 
--9 
--13 
--7 
--6 
--5 
--4 
--3 
--2 
--1 
[SHOW THERM01v1ETER CARD, Card #7.} 
[Interviewer: Record tllennometer ratings here.] 
[IJ.[IJ 
[IJ.[IJ 
[IJ.[IJ 
[IJ.[IJ 
[IJ.[IJ 
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a. Being free to change my mind about my 
treatment even when I am very ill. 
b. Gettmg the tn~atment that my doctot· rhulks is 
best for me. 
c. Havmg a fiunily or friend make densions 
about my treatment \Vhen I am very ill. 
d. Avoiding treatment I don't want. 
e. Getting whatever treatment that works best 
for me. 




